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Hip shape is an important determinant of hip osteoarthritis (OA) and osteoporotic hip 
fracture; however, little is known about its development in childhood and adolescence. 
In this thesis, I aimed to address this question by exploring factors influencing hip shape 
in adolescence. 
Hip DXA scans were collected in offspring from the Avon Longitudinal Study of Parents 
and Children, at mean ages of 13.8 and 17.8 years. These images were analysed in Shape 
software to quantify hip morphology using a 53-point Statistical Shape Model (SSM). 
Principal component analysis was used to generate independent modes of variation (hip 
shape modes (HSMs) and scores from an adult reference SSM (based on 19,379 images) 
were applied to adolescent data to aid comparability between the time points. The top 
ten HSMs were selected as outcomes and associations with sex, tempo (marker of 
pubertal timing) and BMD were examined, and genome-wide association study (GWAS) 
explored genetic influences on hip shape at both time points. 
Several HSMs showed sex differences. At age 14, there was strong evidence of 
relationships between tempo and hip shape, particularly in males, whereas at age 18 
these associations were weaker in both sexes. Consistent associations between BMD 
and hip shape were observed in males and females, and at both time points. GWAS 
identified five independent variants associated with hip shape (p<5x10-8).  
These findings suggest that sexual dimorphism in hip shape can be discerned in early 
adolescence, and that puberty is a critical period for hip shape development. Observed 
relationships between BMD and hip shape could be partially explained by shared genetic 
factors underlying these traits. Finally, genetic variants implicated in endochondral bone 
formation, which were previously found to be associated with adult hip shape, appear 
to influence hip shape in adolescents, consistent with a contribution of longitudinal 
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CHAPTER 1.  INTRODUCTION AND 
AIMS OF THIS PhD  
 
In this introductory chapter I will describe the structure and function of bone, and the 
process of bone development and maintenance (sections 1.1 -1.3). I will give an 
overview of joints and joint tissues and describe the anatomy of hip joint (sections 1.4 
and 1.5). Sections 1.6 and 1.7 will consider osteoarthritis and osteoporosis, including 
their definitions, epidemiology and pathogenesis, followed by current evidence 
concerning the relationship between bone mineral density and osteoarthritis. Section 
1.9 will describe the application of statistical shape modelling in studies. Finally, section 




1.1. Structure and function of bone  
The human skeleton comprises about 20% of total body weight (White, 2005) and can 
be divided into the axial skeleton (vertebrae, ribs, sternum and skull) and appendicular 
skeleton (limbs and pelvis) (Drake et al., 2015). The skeletal system consists of cartilage 
and bone. Bone, which forms the majority of the skeleton, is a specialised type of living 
connective tissue with mineralized extracellular matrix (ECM). Bone serves a number of 
important functions such as protection and support of organs and soft tissues, and acts 
as an anchor for muscles, tendons and ligaments thus facilitating movement. In 
addition, bone stores fat and minerals and is the primary site of haematopoiesis (White, 
2005).  
Bone consists of an organic phase (mainly type I collagen) and inorganic phase 
(hydroxyapatite - insoluble salt of calcium and phosphorus). Morphologically, it can be 
divided into compact bone (cortical) and trabecular bone (cancellous, spongy) (Figure 
1.1). The latter consists of a network of interconnecting rods and plates (trabeculae) 
separated by spaces filled with bone marrow. Cortical bone, which surrounds trabecular 
bone, is much denser in structure and consists of closely packed osteons. Each osteon 
comprises Haversian canal which is surrounded by lamellae (sheets) of bone (White, 
2005).  
 
Figure 1.1 Compact and spongy bone.  
Reproduced from image publicly available at 
https://training.seer.cancer.gov/anatomy/skeletal/tissue.html  
Image removed due to copyright reasons. 
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Bone is able to repair itself and it contains a number of distinct cell types which are 
responsible for its formation and maintenance. The inner (endosteum) and outer 
(periosteum) layers of bone contain bone lining cells, which are quiescent flat-shaped 
osteoblasts (Florencio-Silva et al., 2015). These cells are derived from mesenchymal 
stem cells (MSCs) and are mainly responsible for bone formation (Capulli et al., 2014). 
Osteoblasts lay down the osteoid, primarily made of collagen type I, which then 
becomes mineralized to form a new bone (Florencio-Silva et al., 2015). Once new bone 
has been formed, osteoblasts can differentiate into lining cells, surround themselves 
with matrix and develop into osteocytes or undergo apoptosis (Florencio-Silva et al., 
2015; Marks Jr & Popoff, 1988). Osteocytes are mature osteoblasts trapped within the 
bone matrix comprising 90-95% of total bone cells (Florencio-Silva et al., 2015). They 
connect with nearby cells via branching cytoplasmic projections which extend through 
canaliculi and travel throughout the mineralized bone matrix. Osteocytes act as 
mechanosensors, responding to stress and stimuli and regulating osteoclast and 
osteoblast activity accordingly (Bonewald, 2011; Florencio-Silva et al., 2015; Marks Jr & 
Popoff, 1988). Osteoclasts are large, multinucleated cells involved in bone resorption 
(breaking down and removal of bone) which are derived from hematopoietic stem cells 
(Charles & Aliprantis, 2014). Osteoclasts reside on bone surfaces and in order to degrade 
bone matrix, they lower the pH at bone resorption sites and then secrete cathepsin, 
matrix metalloproteinase 9 (MMP9), and tartrate-resistant acid phosphatase (TRAP) 
(Buckwalter et al., 1996; Florencio-Silva et al., 2015).  
1.2. Bone development 
The process of bone formation is initiated when embryonic MSCs migrate to the sites of 
future bones where they form condensations of cells outlining the size and shape of 
future bones. Within these condensations, MSCs differentiate to either chondrocytes 
which form cartilage scaffolds which are eventually replaced by mineralized bone (in a 
process of endochondral ossification (EO)) or differentiate into osteoblasts (to form 
bone via intramembranous ossification) (Berendsen & Olsen, 2015). 
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 Intramembranous ossification  
Flat bones (such as skull, mandible or clavicles) are formed via intramembranous 
ossification. During this process MSCs condensate and proliferate to form dense 
ossification centres and become either capillaries or osteoprogenitor cells which 
differentiate further into pre-osteoblasts and subsequently into osteoblasts (Ornitz & 
Marie, 2002). Osteoblasts secrete osteoid, which consists of collagen-proteoglycan 
matrix and binds calcium salts enabling the matrix to become calcified to form woven 
bone trabeculae. Following mineralization, osteoblasts either become trapped in the 
ECM and transform into osteocytes or undergo apoptosis. Surrounding osteogenic cells 
differentiate into new osteoblasts which lay more osteoid resulting in the formation of 
trabeculae matrix and periosteum (Betts et al., 2013; Gilbert, 2000). Cells in the 
periosteum contribute towards appositional growth and form dense bone around the 
trabecular bone (pre-cortical bone) which eventually becomes replaced with cortical 
bone (Rauch, 2005; Roberts et al., 2015).  
 
 Endochondral ossification 
During embryological development, all long bones develop via EO (see Figure 1.2 for 
schematic representation of EO). This process involves the initial development of a 
cartilage template which serves as a scaffold to be later replaced with bone (in a process 
called ossification). This template is formed by mesenchymal progenitor cells which then 
differentiate into chondrocytes. Chondrocytes proliferate, undergo hypertrophy and 
secrete ECM which then becomes mineralized, forming the primary centre of 
ossification (the metaphysis). Hypertrophic chondrocytes attract blood vessels, bringing 
osteoclasts, bone forming cells (precursors of osteoclasts) and bone marrow cells. As 
hypertrophic chondrocytes die, the remaining cartilage matrix is removed by osteoclasts 
and used as a scaffold for osteoblasts to lay new bone (Firestein et al., 2016; 
Kronenberg, 2003; Mackie et al., 2008).   
Chondrocyte proliferation drives bone elongation and as bone enlarges further 
secondary centres of ossification are formed at one or both ends of the bone. Primary 
and secondary centres of ossification are divided by the growth plate (also known as the 
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epiphyseal plate). EO is responsible for longitudinal bone growth and is most active 
during growth, resulting in greater height (Berendsen & Olsen, 2015; Mackie et al., 
2008), however  this process ceases following the closure of the growth plate (i.e. fusion 
of metaphysis and epiphysis) around the time of puberty (Shim, 2015). Interestingly, 
processes involved in osteoarthritis (OA) pathogenesis are thought to resemble that of 
EO (Dreier, 2010; Rosen, 2013). 
EO is tightly regulated and is influenced by a number of locally derived factors (such as 
bone morphogenetic proteins (BMPs), fibroblast growth factors (FGFs), transforming 
growth factor β (TGFβ), Wnts, Indian hedgehog (Ihh), parathyroid hormone-related 
peptide (PTHrP) and retinoids) and systemic factors (such as growth hormone and 
thyroid hormone) (Dreier, 2010). Transcription factors (Runx2, Sox9), myocyte enhancer 
factor-2 (MEF2C)) and proteases also play an important role in EO (Dreier, 2010; Mackie 
et al., 2008).    
While longitudinal bone growth stops around puberty, bones continue to grow in width 





Figure 1.2 Steps involved in endochondral ossification. Image publicly available at 
www.orthobullets.com 
 
1.3. Bone maintenance 
EO and intramembranous ossification yield immature bone which undergoes further 
resorption and formation in order to maintain its structure and shape (and thus 
withstand the loads placed upon it) during the process of bone modelling and 
remodelling. Bone modelling begins in foetal life and continues into adulthood. During 
this process bone is resorbed and formed at distinct locations which results in large 
increases in size and changes in shape of bone (WHO, 2003). While most active during 
periods of active growth, bone modelling has also been shown to occur in adult life by 
contributing to periosteal bone formation which enables bones to enlarge 
circumferentially (Betts et al., 2013). Bone modelling occurs in response to physical 
activity (PA) as demonstrated in tennis players by higher bone mass in the arm used to 
play (Kontulainen et al., 2003). Other factors likely to play a role in bone modelling 
include genetic, environmental and hormonal factors (Langdahl et al., 2016).  
Image removed due to copyright reasons. 
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The adult skeleton is thought to be renewed every 10 years (Langdahl et al., 2016). 
During growth, more bone is formed than resorbed, whereas between the ages of  
30–50 years, the amount of formed and resorbed bone is approximately equal. In 
women, after the menopause, bone resorption significantly exceeds the amount of bone 
formed, while in men this occurs slightly later (WHO, 2003). Any imbalance in bone 
resorption and formation due to sex hormone deficiency, primary hyperparathyroidism 
or excess exposure to glucocorticoids, as well as age-related increase in bone resorption 
and decrease in bone formation (Langdahl et al., 2016), leads to irreversible bone loss 
and consequently osteoporosis (OP) (WHO, 2003). Throughout life, in order to maintain 
bone mass and skeletal strength, the bone undergoes remodelling whereby old bone is 
replaced with new bone. This process involves sequential resorption and formation of 
bone at the same bone remodelling units (BRUs). Remodelling is initiated by activation 
of osteoclasts which then resorb bone and subsequently undergo apoptosis. This is 
followed by recruitment of osteoblasts which lay down new bone which later becomes 
mineralized. Bone remodelling is regulated by locally secreted and systemic cytokines 
(Langdahl et al., 2016; WHO, 2003). 
1.4. Joints 
1.4.1. Types of joints 
A joint is a site where two bones connect together and, according to structure, can be 
classified into three groups: fibrous, cartilaginous or synovial (Drake et al., 2015). 
Synovial joints (also known as diarthrodial joints) constitute the most common type of 
joint in the body and can be further divided into six types: hinge, ball and socket (e.g. 
the hip), pivot, saddle, condyloid and plane. All of these joints share the same basic 
features including joint cavity, articular cartilage which covers the ends of articulating 
bones and fibrous joint capsule which encloses the joint and is lined with synovial 
membrane. One of the essential components secreted by the synovial membrane is the 
synovial fluid which lubricates the joint and reduces friction during motion. Synovial 
joints not only facilitate articulation and thus free movement of the bones that they 
join, but also have the ability to withstand very large loads. For example, previous 
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studies estimated that during running the compressive forces placed upon 
patellofemoral joint can range between 4.3 to 7.6 times of body weight (Flynn & Soutas-
Little, 1995).   
 
1.4.2. Joint tissues 
 Synovium and joint capsule 
The joint capsule surrounds the joint and attaches to bone via the attachment zone 
(Ralphs & Benjamin, 1994). This highly innervated fibrous structure brings nutrients via 
blood vessels and drains waste products via lymphatic vessels (Ralphs & Benjamin, 
1994). The joint capsule is lined with the synovial membrane (synovium), which covers 
all articular joint surfaces except the articular cartilage. The synovium comprises two cell 
types: type A and B synovial cells. The former is a macrophage-like cell responsible for 
combatting infections and maintaining an aseptic environment within the joint. The 
underlying cell, type B synovial cell, is a fibroblastic cell and its main function is to 
lubricate the joint and support joint articulation by synthesis and secretion of 
hyaluronan and lubricin (A. R. Poole, 2010).  
One of the roles of synovium is to produce synovial fluid which enables provision of 
nutrients to the joint and articular cartilage, and also lubricates the joint owing to 
production of lubricin. It also contains high concentrations of hyaluronic acid which 
provides the fluid with high viscosity (Firestein et al., 2016; Tamer, 2013).  
 
 Articular cartilage   
Unlike most tissues, articular cartilage lacks blood vessels, lymphatics and nerves. It is 
between 2 to 4 mm thick and covers the articulating ends of long bones. Along with 
synovial fluid, it allows a smooth, lubricated surface for articulation, absorbs impacts 
and dissipates loads to the subchondral bone (Martel-Pelletier et al., 2008; A. R. Poole, 
2010). The only type of cell that is present in the articular cartilage is the chondrocyte, 
which is responsible for the maintenance and synthesis of a dense ECM. In addition, 
chondrocytes are able to respond to external stimuli via mechanosensors and primary 
cilia located on its surface (Archer & Francis-West, 2003; Martel-Pelletier et al., 2016). 
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The ECM predominantly contains collagens and proteoglycans (aggrecan) with non-
collagenous proteins, smaller proteoglycans, glycoproteins, lipids and phospholipids 
present in smaller amounts. The most abundant cartilage protein is type II collagen 
which represents between 90 to 98% of the collagen ECM. It accumulates into fibrils 
which aggregate to fibres knotted with proteoglycan aggregates. This fibril network is 
formed and supported by collagen types I, IV, V, VI, IX and XI. All collagen molecules 
contain a region with three polypeptide chains and are twisted into a triple helix which 
stabilizes the matrix. The most abundant proteoglycan in cartilage is aggrecan which 
consists of a hyaluronic acid strand with multiple monomers attached to it. The bond 
between each monomer and the hyaluronate is stabilized by a low-molecular-weight 
link protein. These proteoglycan aggregates occupy the interfibrillar space of the 
cartilage ECM and provide the osmotic properties necessary for cartilage to withstand 
compressive loads (Martel-Pelletier et al., 2008). Together, collagens and proteoglycans 
account for articular cartilage dry weight while water contributes between 65% (found 
in the deep zone) to 80% (found near the cartilage surface) of tissue wet weight (Fox et 
al., 2009; Martel-Pelletier et al., 2008).     
Articular cartilage can be separated into four zones (superficial, middle, deep and 
calcified cartilage zone, see Figure 1.3 for schematic representation and histological 
section of articular cartilage zones) which differ in their function. The superficial zone, 
which is in contact with synovial fluid, consist of collagen fibrils, has low proteoglycan 
content and elongated chondrocytes. Its main function is to resist the compressive 
forces imposed during articulating movements. The middle zone, representing 40-60% 
of the total cartilage thickness, consists of thicker collagen fibrils and proteoglycans. 
Here, the chondrocytes have a round shape and are at low density. The deep zone 
contains the highest aggrecan content and the largest collagen fibrils. Chondrocytes are 
similar in shape to those in the middle zone, have lower density and lie perpendicular to 
the articular surface. The calcified cartilage has a scarce cell population and 
hypertrophic chondrocytes. It is separated from the deep zone via the tidemark and is 
mainly responsible for anchoring the cartilage to the subchondral bone via penetration 
of collagen fibrils from deep to calcified cartilage (Martel-Pelletier et al., 2008).  
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Throughout the life course chondrocytes maintain and repair cartilage environment, 




Figure 1.3 Schematic diagram and histological section of articular cartilage zones.  
Image publicly available at www.orthobullets.com 
 
 Subchondral bone 
Situated below the articular cartilage is a layer of bone referred to as subchondral bone. 
It can be divided into distinct regions which differ in their structure and composition.  
Closest to the articular cartilage is a layer of calcified cartilage and these structures are 
separated by the tidemark (Burr, 2004). Subchondral bone plate is located directly 
underneath the calcified cartilage. It is composed of lamellar bone, is poorly vascularised 
and has low porosity (Burr, 2004; G. Li et al., 2013). Arising from subchondral bone plate 
is subchondral trabecular bone, which is more vascular, more porous and less stiff 
compared with the subchondral bone plate. It provides support and has important 
shock absorbing functions in healthy joints and is important for the provision of 
nutrients to the cartilage (Burr, 2004; G. Li et al., 2013). Subchondral bone can dissipate 
about 30% of the load placed upon joints compared with only 1-3% of load attenuated 
by cartilage (Madry et al., 2010). Previous research suggests that subchondral bone 
plays a key part in initiation and progression of OA (Castañeda et al., 2012).  
Image removed due to copyright reasons. 
11 
 
 Ligaments, tendons and muscles 
Muscles attach to bones via tendons and the contraction of muscles across joints 
produces movement. Ligaments are strong elastic bands of connective tissue, mainly 
type I collagen fibres, attached to bones at their ends. They support the joints by holding 
the bones together and resisting excessive loads or movements. Tendons, which 
facilitate attachment of muscles to bone, are similar in structure to ligaments (Betts et 
al., 2013).   
 
1.5. Development and anatomy of the hip joint  
1.5.1. Development of the hip joint 
The majority of tissues in the developing limb arise from MSCs which differentiate into 
various articular tissues, except neural elements and blood vessels (Walker, 1991). The 
majority of joint differentiation is thought to be completed between the 4th and 8th 
week of embryonic development (Lee & Eberson, 2006). The acetabulum forms around 
6 weeks of gestation, as a shallow depression, proximal to the femoral head (Lee & 
Eberson, 2006). Both, the hip joint and acetabulum arise from a cleft formed in the pre-
cartilaginous cells, and by 11th week of gestation the hip joint is fully formed with 
spherical femoral head, short femoral neck, primitive greater trochanter, joint capsule, 
acetabular labrum and transverse acetabular ligament all visible macroscopically (Lee & 
Eberson, 2006; Weinstein & Dolan, 2018). When first formed, the acetabulum is deep 
and almost completely surrounding the femoral head, however as it continues to grow 
throughout the intrauterine life its depth increases at much slower rate compared with 
the rate of increase in the acetabular and femoral head diameters (as a result, the 
acetabulum becomes shallower and femoral head becomes more hemi-spherical) 
(Giorgi et al., 2015; Walker, 1991). In the early postnatal period and during early 
childhood, movement and muscle loading play an important role in shaping of the 
proximal femur and acetabulum (Ford et al., 2017). The expansion of the acetabulum 
occurs via appositional growth of articular cartilage and interstitial growth of triradiate 
cartilage, whereas the longitudinal growth plate, the trochanteric growth plate and the 
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femoral neck isthmus contribute to the appositional growth of the femoral head and 
greater trochanter (White, 2005). The triradiate cartilage (situated where the pubis, 
ischium and ilium meet) begins to ossify between the ages of 15 and 18 years and its 
fusion is completed by the age of 20 to 25 years. The fusion of proximal femoral 
epiphyses occurs by the age of 18 years and the fusion of trochanteric growth plate 
occurs between 16 and 18 years of age (Bonewald, 2011; Marks Jr & Popoff, 1988).  
1.5.2. Anatomy of the hip joint 
The hip joint (Figure 1.4) is a ball and socket which consists of acetabulum (located on 
the pelvis) and femoral head. The femoral head is spherical and articulates with the cup-
shaped acetabulum. The articulating parts of the acetabulum and femoral head are 
covered with articular cartilage (with the exception of the attachments of the 
ligamentum teres ). The femoral head joins to the femoral shaft via the femoral neck 
(FN). Greater and lesser trochanters, which reside on the upper part of the shaft serve 
as points for muscle attachment that move the hip joint. The range of movement 
permitted by hip joint include flexion and extension, abduction and adduction, and 






Figure 1.4 Anatomy of hip joint.  
Reproduced from publicly available image at www.orthobullets.com 
 
1.6. Osteoarthritis  
1.6.1. Definition of OA 
Osteoarthritis (OA) is the most common form of arthritis worldwide (Martel-Pelletier et 
al., 2016) and can be defined by clinical symptoms, structural joint changes or a 
combination of both (Nigel K Arden & Nevitt, 2006). Pathologically it is characterized by 
loss of articular cartilage, presence of osteophytes and subchondral sclerosis, and 
clinically by pain, stiffness and restricted movement (Nigel K Arden & Nevitt, 2006). 
While traditionally regarded as a disease of the articular cartilage it is now recognized as 
a disease of the whole joint.  
Image removed due to copyright reasons. 
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Defining OA is challenging, and various definitions have been proposed. For example, in 
the ‘Global burden of osteoarthritis in the year 2000’ by Symmons et al. (Symmons et 
al., 2003) OA was defined as:  
“…complex disease entity that is difficult to diagnose and define. The Subcommittee on 
Osteoarthritis of the American College of Rheumatology Diagnostic and Therapeutic 
Criteria Committee defined osteoarthritis (OA) as "A heterogeneous group of conditions 
that lead to joint symptoms and signs which are associated with defective integrity of 
articular cartilage, in addition to related changes in the underlying bone at the joint 
margins". Clinically, the condition is characterized by joint pain, tenderness, limitation of 
movement, crepitus, occasional effusion, and variable degrees of local inflammation.”  
 
In their 2015 review, Kraus et al. highlighted the need for the development of 
standardized definitions of OA in order to aid communication across the field and 
facilitate the development of new therapeutics by achieving a global consensus on OA 
definition and classification (Kraus et al., 2015). As a result, the draft definition proposed 
by the Osteoarthritis Research Society International (OARSI) is as follows (Kraus et al., 
2015): 
“Osteoarthritis is a disorder involving movable joints characterized by cell stress and 
extracellular matrix degradation initiated by micro- and macro-injury that activates 
maladaptive repair responses including pro-inflammatory pathways of innate immunity. 
The disease manifests first as a molecular derangement (abnormal joint tissue 
metabolism) followed by anatomic, and/or physiologic derangements (characterized by 
cartilage degradation, bone remodelling, osteophyte formation, joint inflammation and 
loss of normal joint function), that can culminate in illness.” 
 
In a clinical setting, OA diagnosis is primarily based on symptoms, whereas in a research 
setting, a number of grading systems have been developed in an attempt to quantify 
disease severity. Although a number of radiographic grading systems have been 
proposed, the most commonly used is Kellgren and Lawrence (KL) scoring system, which 
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scores OA at various sites based on severity and is divided into five grades: no OA (0), 
doubtful (1), minimal (2), moderate (3) and severe (4) (Kellgren & Lawrence, 1957).  
1.6.2. Classification of OA  
Traditionally OA has been stratified into primary (no known cause) and secondary (due 
to known causes such as metabolic – e.g. ochronosis, anatomic – e.g. slipped femoral 
epiphysis, traumatic or inflammatory) (Nigel K Arden & Nevitt, 2006). However, more 
than a decade ago, Dieppe and Kirwan argued that this classification is not adequate 
given that OA is either the result of local biomechanical influences or systemic factors 
(Dieppe & Kirwan, 1994). Furthermore, in their 2009 commentary, Brandt et al. argued 
that all OA is secondary (Brandt et al., 2009).  
 
While OA can affect any joint, the most commonly affected joints include knees, hips, 
hands, spine and feet (Johnson & Hunter, 2014). OA seldom affects a single joint and 
individuals with OA in one joint often have OA in other joints, a finding which cannot be 
explained by chance or age alone (Nigel K Arden & Nevitt, 2006). For example, Hirsch et 
al. found a strong association between hand and knee OA in the Baltimore Longitudinal 
Study of Aging (Hirsch et al., 1996). According to other studies OA most commonly co-
occurs in the hands, neck, lower back and knees, whereas multiple joint involvement in 
hip OA is less common (Günther et al., 1998; Lawrence, 1969; Ledingham et al., 1992). 
Although multiple joint involvement (or polyarticular OA) has been described previously 
and referred to as ‘generalized OA’ throughout the literature (Nigel K Arden & Nevitt, 
2006), in their 2014 systematic review Nelson et al. concluded that this term has been 
used inconsistently and highlighted the need for standardised definition of generalized 
OA (Nelson et al., 2014).  
 
OA can also be classified based on the appearance of the affected joints. In the case of 
hip OA, it is frequently defined radiographically by the presence of joint space narrowing 
(JSN) and osteophyte formation, however both features do not always occur together 
(Castaño‐Betancourt et al., 2013a). Based on these observations, it has been sub-
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classified into: normotrophic (both JSN and osteophytes are present), hypertrophic 
(presence of osteophytes) and atrophic (presence of JSN) (Castaño‐Betancourt et al., 
2013a; Ishidou et al., 2017; Panoutsopoulou et al., 2016; Solomon, 1976).  
1.6.3. Burden of OA  
OA is associated with a significant economic burden and its prevalence is increasing with 
increasing age and the obesity epidemic. It is though that OA associated pain and loss of 
function account for ~1% to 2.5 % of gross domestic product in the western world 
(Woolf & Pfleger, 2003). Currently no disease-modifying treatment is available, other 
than pain relief and joint replacement for end-stage disease. As highlighted in the OARSI 
white paper (OARSI, 2016), ‘Osteoarthritis: A Serious Disease’, submitted to the U.S. 
Food and Drug Administration, and previously highlighted by Nüesch et al. (Nüesch et 
al., 2011), individuals with OA are at increased risk of death highlighting the need to 
develop successful therapies to delay disease progression and manage symptoms such 
as pain.  According to the Global Burden of Disease 2010 study, OA was the 11th highest 
contributor to disability amongst nearly 300 diseases studied (Cross et al., 2014). 
 
1.6.4. OA diagnosis 
Despite its high prevalence, OA can be very difficult to diagnose (Martel-Pelletier et al., 
2016) especially in its early stages. Clinical diagnosis of OA is based on history and 
symptoms; pain being the most common reason for which patients seek medical 
attention (Glyn-Jones et al., 2015). Specific diagnostic criteria have been developed for 
the knee (Altman et al., 1986; Wu et al., 2005), hand (Altman et al., 1990) and hip 
(Altman et al., 1991) OA. While no specific diagnostic criteria have been developed for 
other sites affected with OA, such as spine or big toe, diagnosis is usually based on 
symptoms and imaging (Martel-Pelletier et al., 2016).  
Pain is the primary reason for patients to seek medical attention, however, it usually 
develops in advanced stages of the disease which offers little room for targeted 
prevention (Glyn-Jones et al., 2015). Interestingly, in a large number of patients 
experiencing pain radiological changes are not always present and conversely 
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radiological changes are not commonly accompanied by pain (Litwic et al., 2013; 
Nieuwenhuijse & Nelissen, 2015).This poor correlation could be explained by lack of 
nociceptive innervation in some of the joint structures or simply due to variability in 
pain response which is very complex and individual-specific (Litwic et al., 2013). It is also 
possible that plain radiographs are not sensitive enough to detect all relevant changes 
associated with OA.  
 
1.6.5. OA pathogenesis 
Historically, OA was considered a disease of articular cartilage, however it is now 
recognized as a disease of the whole joint, affecting all of its tissues and subsequently 
leading to joint failure (Martel-Pelletier et al., 2016; Van Der Kraan et al., 2016). The 
pathogenesis of OA is due to multiple risk factors, with biomechanics, inflammation, 
biochemical mediators and bone response all contributing to this process (Birrell et al., 
2011).  
In sections to follow I will describe the key changes in cartilage, subchondral bone and 
synovium observed in OA.  
Cartilage  
Damage to articular cartilage is one of the key features of OA. In healthy joints the 
composition and architecture of cartilage is successfully maintained by chondrocytes, 
however in joints affected by OA the cartilage matrix undergoes substantial alterations 
(Martel-Pelletier et al., 2016). Histologically cartilage appears rough owing to the 
development of fibrillations and fissures on its surface. As OA progresses, cartilage 
becomes fragmented exposing the underlying bone. In addition, the zone of calcified 
cartilage extends and the tidemark (which separates articular from underlying calcified 
cartilage) duplicates. These changes are accompanied by vascular invasion of the bone 
and calcified cartilage. As a result, new bone is formed in a process resembling that of 




During OA, both anabolic and catabolic activities in cartilage are increased. In early 
disease stages, chondrocytes proliferate and synthesise matrix molecules in order to 
preserve matrix integrity. With time, the ECM becomes disrupted and proteoglycans 
depleted leading to erosion which marks irreversible damage to the cartilage. This 
makes the cartilage particularly susceptible to external insults and stimuli (Man & 
Mologhianu, 2014; Martel-Pelletier et al., 2016).  
In healthy joints chondrocytes are metabolically inactive and their activity is limited to 
low-turnover repair, however during OA they become metabolically active (Goldring & 
Otero, 2011). In OA cartilage chondrocytes proliferate and become hypertrophic, form 
clusters and produce inflammatory response proteins including cytokines (i.e. 
interleukin (IL) 1, IL-6, IL-15 and tumour necrosis factor (TNF)) and matrix degrading 
enzymes (such as metalloproteinases and a disintegrin and metalloproteinase with 
thrombospondin-like motifs 4 (ADAMTS4), ADAMTS5, MMP1, MMP3, MMP13) (Goldring 
& Otero, 2011; Man & Mologhianu, 2014; Martel-Pelletier et al., 2016).  
 
Subchondral bone  
Substantial changes affecting the cortical bone plate and the trabecular bone which lies 
underneath are also seen in OA. These include changes to the cortical plate (increase in 
volume and thickness), changes in the architecture of trabecular bone, changes in bone 
mass, development of bone cysts and osteophytes and presence of bone marrow lesions 
(BMLs). These changes are thought to be the result of an imbalance between osteoclast 
and osteoblast activity. Increased matrix production is thought to result in thickening of 
the subchondral bone plate. BMLs, which can be imaged using MRI, are thought to 
localise in regions with severe cartilage damage. Subchondral bone cysts are thought to 
develop in regions previously occupied by BMLs and form by a process of EO. 
Osteophytes are bony outgrowths on the margins of joints and are thought to support 
joint stability rather than contribute to OA progression (Loeser, 2010; Man & 






Inflammation of the synovium (also known as synovitis) is another feature of OA and can 
be present even in early disease stages. It is characterised by synovial hyperplasia, 
fibrosis and release of inflammatory mediators and degrading enzymes by synoviocytes  
(Loeser, 2010; Man & Mologhianu, 2014; Martel-Pelletier et al., 2016). The degree of 
synovitis varies between patients and disease stage and previous studies found that the 
presence of synovitis in early OA was associated with disease progression (Loeser, 
2010). 
 
1.6.6. OA epidemiology 
1.6.6.1. Prevalence and incidence  
OA is the most common form of arthritis affecting 10% of men and 18% of women over 
the age of 60 years and an estimated 240 million people worldwide (Nelson, 2018). The 
prevalence of OA increases with age in both men and women (Martel-Pelletier et al., 
2016) and the risk of hand, hip and knee OA is higher in women compared with men 
(Lanyon et al., 2003; Oliveria et al., 1995; Palazzo et al., 2016) with similar prevalence 
reported in European and American data (Martel-Pelletier et al., 2016). Hand OA is less 
frequent in Native Americans and African-Americans compared with white Americans 
and the prevalence of primary RHOA in studies from Europe and North America is higher 
than the prevalence reported in studies from Asia and Africa (Johnson & Hunter, 2014) 
which could be explained by differences in pelvic morphology (Martel-Pelletier et al., 
2016).  
The incidence of OA at all sites declines approximately at the age of 80 years, a finding 
consistently reported in previous studies (Oliveria et al., 1995; Prieto-Alhambra et al., 
2014). Some discrepancies in reported prevalence and incidence rates of OA exist which 
are likely due to high variability in case definition (i.e. radiographic or symptomatic OA) 




1.6.6.2. OA risk factors 
A number of risk factors for OA have been identified and these will be discussed in more 
detail below. These include modifiable and non-modifiable risk factors, some of which 
act through altered or increased biomechanical stress (such as altered hip shape).  
 
 Age and sex 
Age is a well-recognized risk factor for OA, however the exact mechanisms underlying 
the relationship between age and OA risk remain to be fully elucidated. The likely 
contributors include oxidative stress, decrease in cartilage volume and sarcopenia. 
Moreover, the ability to respond to stress and injury declines with age resulting in tissue 
damage  (Jordan et al., 2007; Litwic et al., 2013). 
The risk of hand, hip and knee OA is higher in women with significant increase around 
the time of menopause (Litwic et al., 2013) suggesting a potential role of oestrogen in 
the development of OA, however the evidence from clinical and epidemiological studies 
is inconclusive (Johnson & Hunter, 2014; Litwic et al., 2013).  
 
 Obesity 
Obesity represents one of the strongest and most-recognised risk factors for OA 
(Johnson & Hunter, 2014; Vina & Kwoh, 2018) and using a Mendelian randomization 
(MR) approach, a recent study of the UK Biobank confirmed  the causal role of increased 
body mass index (BMI) and other obesity related traits on the risk of OA (Zengini et al., 
2018). In 2012, in a meta-analysis of observational studies, Jiang et al. reported a clear 
dose-response relationship between BMI and knee OA with 35% increase in knee OA 
risk for every 5-unit increase in BMI (Jiang et al., 2012). Conversely, in the Framingham 
study, a reduction in body weight was associated with a decreased risk of knee OA 
development (Felson et al., 1992), a finding also supported by a 2007 meta-analysis of 
randomised controlled trials (Christensen et al., 2007).  
While the relationship between obesity and knee OA is much stronger than that for hip 
OA, the evidence supports the role of excess weight in the risk of both (Johnson & 
21 
 
Hunter, 2014; Vina & Kwoh, 2018) and a recent prospective study from Spain reported 
increased risk of knee, hip, and hand OA in obese subjects (Reyes et al., 2016). 
 
 Nutritional factors 
Previous studies explored the relationship between a number of nutritional factors and 
OA. The role of vitamin D, known for its role in cartilage and bone metabolism, is 
conflicting. Previous studies reported an association between low/moderate levels of 
vitamin D and increased risk of incident hip OA and progression of knee OA (Johnson & 
Hunter, 2014). However, in a previous randomized placebo-controlled, double-blind 
clinical trial, 2 year supplementation with vitamin D in patients with symptomatic knee 
OA did not impact on pain or cartilage volume loss (McAlindon et al., 2013). In the 
Osteoarthritis Initiative (OI) study, total dietary fibre intake was associated with reduced 
risk of symptomatic knee OA, but not with radiographic knee OA (RKOA) (Dai et al., 
2017). In terms of antioxidant intake, Li et al. found no evidence of an association 
between carotenoid, vitamin E, and selenium intake with the prevalence of RKOA (H. Li 
et al., 2016). Similarly, in The Malmö Diet and Cancer cohort, a prospective population-
based study, dietary intake of vitamin E and β–carotene had no protective effect on 
severe knee and hip OA (Engstrom et al., 2009).  
 
 Occupation and physical activity  
Physically demanding occupations, especially those involving repetitive activities, have 
been found to be associated with an increased risk of OA. For example, individuals with 
occupations requiring squatting or kneeling have been found to be at an increased risk 
of knee OA compared with individuals in non-manual occupations (Johnson & Hunter, 
2014; Vina & Kwoh, 2018). Moreover, individuals in occupations involving prolonged 
standing (Johnson & Hunter, 2014) and heavy lifting (Bergmann et al., 2017) have been 
found to have increased risk of hip OA.  
The evidence regarding physical activity (PA) and risk of OA is conflicting. On one hand, 
previous studies showed a relationship between recreational running and decreased risk 
of knee and hip OA (Alentorn-Geli et al., 2017), on the other hand others found 
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increased prevalence of knee OA (Driban et al., 2017) and increased incidence of hip OA 
(Vigdorchik et al., 2017) in footballers. While it appears that the type and intensity of PA 
is important, the underlying joint health also needs to be considered. For example, 
previous study in patients with established OA found association between vigorous PA 
and increased risk of knee replacement surgery (Y. Wang et al., 2010), whereas study in 
healthy individuals showed beneficial effect of vigorous PA on knee cartilage (Racunica 
et al., 2007).  
It appears that habitual levels of PA do not increase the risk of radiographic or 
symptomatic OA, as opposed to high levels of PA (Neogi & Zhang, 2013). Overall, the 
evidence suggests beneficial effect of PA in reducing the risk of OA (particularly in the 
absence of injury (Litwic et al., 2013)), however clear relationship between elite impact 
sports and future risk of both hip and knee OA have been shown, which might be 
explained by higher risk of injury which is common in high impact and elite sports (Vina 
& Kwoh, 2018). 
 
 Joint injury 
The knee is one of the most commonly injured joints. Rupture of the anterior cruciate 
ligament, meniscal tears and damage to the articular cartilage following injury have 
been found to be associated with increased risk of knee OA, OA changes and functional 
impairment present as early as 10 years following the injury (Vina & Kwoh, 2018). 
Moreover, in a population-based case-control study in England, previous hip injury 
(sustained as a result of a fall, road traffic accident or sports injury) was found to be 
associated with a 4-fold increase in the risk of hip OA (Cyrus Cooper et al., 1998).  
 
 Muscle strength/ weakness 
Previous observational evidence showed a relationship between muscle weakness and 
OA. However, it is possible that muscle weakness might occur as a result of OA itself, 




 Leg-length inequality 
Leg-length inequality (LLI) which leads to altered joint mechanics and results in 
abnormal joint loading is also thought to contribute to increased risk of OA (Murray & 
Azari, 2015). In the Johnston County OA Project, individuals with LLI (≥2cm) were found 
to be at increased risk of prevalent RKOA (Golightly et al., 2007). Similarly, Harvey et al. 
reported association between LLI (≥ 1cm) and higher risk of prevalent radiographic and 
symptomatic knee OA (Harvey et al., 2010). Likewise, in the Multicentre Osteoarthritis 
Study and the OI study, LLI was found to be associated with increased odds of 
radiographic hip OA (RHOA) (Kim et al., 2018). 
 
1.6.7. Hip morphology and OA  
As demonstrated, OA is a complex disorder with many risk factors contributing to its 
development. It has been suggested that hip shape, which forms the primary focus of 
this thesis, is one of the most important risk factors for the development of hip OA 
(Murphy et al., 2016). While severe hip abnormalities have been linked to early onset 
hip OA, more subtle changes in hip morphology are also thought to play an important 
role in the pathogenesis of hip OA (Murphy et al., 2016). Hip shape abnormalities such 
as acetabular dysplasia (AD), and pincer- and cam-type femoroacetabular impingement 
(FAI) deformities are thought to contribute to altered joint biomechanics and thus 
abnormal distribution of loads within the hip joint leading to excessive contact stress on 
the cartilage, its degeneration and consequently hip OA (Harris-Hayes & Royer, 2011). 
As well as alterations in joint shape, soft tissue changes can also contribute to altered 
biomechanics suggesting that ligament laxity precedes bone and cartilage changes 
(Quasnichka et al., 2006). It is important to bear in mind that as well as being associated 
with the development of hip OA, changes in hip morphology can also be the result of 
the OA process itself (Faber et al., 2017; Resnick, 1976) making it difficult to distinguish 
changes causing OA from those resulting from it.  
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1.6.7.1. Acetabular dysplasia 
The most striking evidence, confirming the role of altered joint shape in OA 
development, comes from studies in individuals with developmental dysplasia of the hip 
(DDH), one of the most common developmental skeletal disorders. DDH is characterized 
by insufficient acetabular coverage of the femoral head with varying degrees of severity 
ranging from mild dysplastic acetabular change to complete hip dislocation 
(Hatzikotoulas et al., 2018). It is most commonly diagnosed in the first few months of life 
and if left untreated is thought to be the most common cause of early onset hip OA 
(Khanna & Beaulé, 2014; Pun, 2016). The incidence of DDH ranges between 1 (Lee & 
Eberson, 2006) to 3.6 (Hatzikotoulas et al., 2018) per 1000 live births, with higher 
incidence observed for female gender, positive family history or breech presentation 
(Abbassi, 1998) illustrating both, strong genetic and environmental components in DDH 
development. In a recent genome-wide association study (GWAS), Hatzikotoulas et al. 
identified a robustly replicating association between genetic locus at GDF5 and DDH 
case status (Hatzikotoulas et al., 2018). In addition, GDF5 is known to be associated with 
OA risk (Zengini et al., 2016).  
While DDH can result in severe hip abnormalities, the relationship between milder 
forms of AD and risk of hip OA have also been explored. It is important to bear in mind 
that while DDH represents AD most commonly diagnosed in early life, adolescent onset 
dysplasia has also been reported in the literature. While this could simply represent 
delayed diagnosis of DDH, AD can develop without prior history of DDH (Pun, 2016) and 
is thought to develop due to delayed and insufficient ossification at the acetabular 
socket (Pun, 2016). According to previous studies, of patients with hip OA, between 25-
40% cases can be attributed to subtle AD (Khanna & Beaulé, 2014). OA is thought to 
develop as a result of unequal distribution of shear forces in the hip joint due to 
decreased femoroacetabular contact surface in shallow acetabulum. With time, both 
the acetabular labrum and articular cartilage degenerate eventually leading to joint 
failure (Murphy et al., 2016). The most common measurement used to assess AD in 
studies is the lateral centre edge angle (CEA) of Wiberg (Chaganti & Lane, 2011). The 
thresholds defining dysplasia reported in studies vary, with values ranging from ≤ 20° to 
≤ 30° (Harris-Hayes & Royer, 2011; Khanna & Beaulé, 2014). 
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1.6.7.2. Femoroacetabular impingement 
Previous studies in adults have reported an association between FAI and hip OA 
(Resnick, 1976). Childhood hip disorders, such as Legg–Calvé–Perthes' disease (LCPD) 
and slipped capital femoral epiphysis (SCFE), which are associated with FAI, are also 
though to contribute to hip OA in later life (Froberg et al., 2011; Harris-Hayes & Royer, 
2011; Khanna & Beaulé, 2014). In general, two patterns of FAI can be distinguished: cam 
and pincer FAI (Figure 1.5). Pincer FAI represents a deepened acetabulum and excessive 
acetabular coverage resulting in abnormal contact between the femoral head-neck 
junction and the acetabular labrum (Khanna & Beaulé, 2014). It is often quantified using 
CEA with different thresholds being reported in studies (CEA ≥40° (Chung et al., 2010),  
CEA≥45° (Gosvig et al., 2010) or no defined cut off value (Ecker et al., 2007)). Other 
methods used to assess pincer FAI reported in the literature include the crossover sign, 
coxa profunda (both assessed on radiographs) or global acetabular retroversion 
(assessed on CT scans) (Harris-Hayes & Royer, 2011). In a previous population-based 
survey in individuals from the Copenhagen Osteoarthritis Substudy, Gosvig et al. 
reported a risk ratio of 2.4 for the development of hip OA in individuals with a deepened 
acetabulum (Gosvig et al., 2010). Cam FAI, also referred to as pistol grip deformity, can 
be characterized by aspherical femoral head and additional bone growth at the 
anterolateral aspect of the femoral-head neck junction (Khanna & Beaulé, 2014; Murphy 
et al., 2016). Unlike pincer FAI, which is more common in women, cam FAI is five times 
more likely to be found in men (Khanna & Beaulé, 2014). Assessment of cam FAI in 
studies commonly relies on the alpha angle, with varying thresholds being reported 
(>50° (Ecker et al., 2007) or >62.5° (Pollard et al., 2013)), while other measures include 
anterior offset ratios (Pollard et al., 2013) or visual inspection (Harris-Hayes & Royer, 
2011). A number of studies have found an association between cam deformity and hip 
OA (Doherty et al., 2008; Khanna & Beaulé, 2014; Pollard et al., 2013). For example, 
Doherty et al. reported that cases with symptomatic RHOA were nearly seven times 





Figure 1.5 Schematic diagram showing pincer and cam femoroacetabular 
impingement.  
Image publicly available at  
https://www.orthobullets.com  
 
1.6.8. Genetics of OA  
OA is a complex disease with a strong genetic component, inherited in non-Mendelian 
fashion (Salter et al., 2014; Warner & Valdes, 2016). According to previous studies, 
between 30-65% of OA risk is determined genetically (Vina & Kwoh, 2018). The evidence 
for genetic influences on OA comes from family and twin studies, linkage and candidate 
gene studies and most recently large scale GWASes. These studies enabled identification 
of several variants, implicated in OA development and progression, each exerting a 
modest effect on disease risk.  
1.6.8.1. Heritability  
The earliest evidence for genetic involvement in OA was reported in 1940s by Stecher 
(Stecher, 1941) who studied familial clustering of Heberden’s nodes in hands. A number 
of studies followed and confirmed clustering of hand, knee, hip ad spine OA within 
families (Spector & MacGregor, 2004). Classic twin studies (where concordance between 
identical and non-identical twin-pairs are compared) were then used to estimate 
heritability of OA, defined as the proportion of the total variability in a trait that is 
explained by the genetic variation. Based on these studies, heritability estimates for 
Image removed due to copyright reasons. 
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radiographic hand and knee OA range between 39% and 65%, and ~60% for RHOA 
(Salter et al., 2014).  
1.6.8.2. Candidate gene studies, linkage studies, GWAS studies 
In order to improve our understanding of the genetic architecture of OA, further 
approaches have been undertaken to identify novel genetic variants associated with this 
trait. Linkage studies scan large number of genetic markers in the genome to firstly, 
identify the patterns that they are inherited in families and secondly, to localize disease 
loci on the genome. Previous studies implicated several chromosomal regions with 
linkages to OA, such as 2q31-32, 4q 12-21, 6p/6q, 14q32.11, 16p and Col 9A1 amongst 
others (Loughlin et al., 2000; Mustafa et al., 2000; Spector & MacGregor, 2004; Valdes & 
Spector, 2010). 
Candidate gene studies, which take a hypothesis-driven approach and test the 
associations between biologically relevant variants and the disease of interest, identified 
important loci for OA susceptibility in genes including GDF5, ASPN, FRZB and PTGS2 
(Warner & Valdes, 2016). However, one of the limitations of this approach is the fact 
that only a small portion of the genome can be studied at any time, thus other 
important genes are likely to be overlooked. Moreover, this approach requires good 
prior knowledge and many findings failed to be replicated because the initial evidence 
was weak (Panoutsopoulou & Zeggini, 2013). Nevertheless, rs143383 in GDF5 is an 
example of successfully identified and replicated locus, which was found to be strongly 
associated with hip OA in Asians and knee OA in Europeans (Panoutsopoulou & Zeggini, 
2013). GDF5 is a member of the transforming growth factor β (TNF-β) superfamily and 
plays an important role in the development, maintenance and repair of bone and 
cartilage (Cornelis et al., 2011; Panoutsopoulou & Zeggini, 2013).  
A more recent method used to identify genetic variants associated with OA includes 
GWAS which offer a hypothesis-free approach and simultaneously tests for associations 
between millions of single nucleotide polymorphisms (SNPs) with a trait of interest. 
Previous GWAS studies identified 21 loci associated with hand, hip and/or knee OA 
(defined radiographically, on self-report or as end-stage disease requiring joint 
replacement) (Cibrián Uhalte et al., 2017) and a recent GWAS in the UK Biobank in 
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30,727 OA cases  identified a further nine novel loci, which together account for 26% of 
variance in OA (Zengini et al., 2018). Despite large collaborative efforts only modest 
number of loci, with moderate-to small effects, have been identified (compared with 
other complex traits, i.e. ~70 GWAS loci have been identified to date for type 2 diabetes 
(X. Sun et al., 2014)). This could be partially explained by OA heterogeneity and variation 
in case definition amongst studies (ranging from self-reported to radiographically 
defined OA). Nevertheless, these studies support the complex and heterogenous nature 
of OA with identified SNPs being site-specific and sex-specific. For example, an intronic 
SNP rs4836732 within the ASTN2 gene has been found to be strongly associated with 
THR in females (Zeggini et al., 2012). Another variant, rs12982744 in DOT1L, showed 
stronger association with hip OA in males, compared with females (Castaño-Betancourt 
et al., 2012). A number of other potentially relevant SNPs have been identified and 
previously reviewed in the literature, and these include variants involved in the Wnt 
signalling pathway, synthesis and remodelling of ECM components, or regulation of 
proteins involved in inflammatory and immune responses (Panoutsopoulou & Zeggini, 
2013).   
1.6.8.3. OA-associated endophenotypes and genetics of hip shape 
Although previous GWASes of OA have identified a number of important variants 
associated with OA, these studies have largely focused on radiographic, severe OA as 
defined by joint replacement or self-reported OA. It has been recognized that studying 
OA-related endophenotypes is likely to increase the power of genetic studies and 
further improve our understanding of OA pathogenesis (Kerkhof et al., 2011).   
One of the first successful examples of genetic discovery when studying OA 
endophenotypes was the DOTL1 locus found to be associated with radiographic joint 
space width (which was used as a proxy for cartilage thickness) and this finding was 
subsequently replicated in a large hip OA case-control study (Panoutsopoulou & Zeggini, 
2013). Other studies identified associations between variants in the LRCH1 and 
maximal joint space narrowing (JSN) (Panoutsopoulou et al., 2016), whereas Castaño-
Betancourt reported associations between four novel variants (TGFA, PIK3R1, FGFR3 
and TREH) and minimal JSN (Castaño-Betancourt et al., 2016). Furthermore, using 
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Statistical Shape Modelling (SSM), Linder et al. (Lindner et al., 2015) and Baird et al. 
(Baird et al., 2018) reported associations between previously established OA loci and the 
shape of the proximal femur.  
 
1.6.9. OA management 
There are currently no disease modifying interventions for OA, but number of 
treatments are available to manage symptoms. The primary reason for which patients 
with OA seek medical attention is pain which constitutes the primary target of 
treatment. OA should be managed on a case by case basis and management will often 
consist of a combination of non-pharmacological and pharmacological interventions 
(David J Hunter & Felson, 2006). In the following sections I will describe the non-
pharmacological and pharmacological strategies for the management of OA along with 
its surgical management.  
 Non-pharmacological interventions 
Weight loss, in overweight and obese individuals, comprises one of the most important 
interventions for OA. While it is thought to reduce the risk of developing OA, by as much 
as 50% in case of knee OA (Felson et al., 1992), in already established knee OA, weight 
loss is strongly associated with reduction in pain and improved function (D J Hunter et 
al., 2015). Although not as robust as for knee OA, there is some evidence suggesting 
benefit in patients with hip OA, as demonstrated by improvement in self-reported 
physical function in patients involved in exercise and weight loss programmes (Paans et 
al., 2013). Nevertheless, both NICE (NICE, 2008) and OARSI (W. Zhang et al., 2008) 
guidelines recommend weight loss in patients with both hip and knee OA. Alongside 
weight loss, interventions such as health education, self-management, exercise (low 
impact sports such as swimming, cycling, rowing) and strength training are often 
recommended in the management of both knee and hip OA (Aresti et al., 2016; Bennell 
et al., 2012; Martel-Pelletier et al., 2016).   
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 Pharmacological interventions    
There are currently no pharmaceutical therapies that can prevent, reverse or slow down 
the progression of OA. In terms of pain management, a number of topical, oral and 
injectable pharmacological treatments are available. Paracetamol and non-steroidal 
anti-inflammatory drugs (NSAIDs) are often recommended as the first-line treatment 
options (Martel-Pelletier et al., 2016). However, many patients still suffer with 
persistent pain despite being on treatment (Martel-Pelletier et al., 2016). Second-line 
treatment options include opioids (when paracetamol and NSAIDs are either ineffective 
or contraindicated) or intra-articular injections. While opioids are associated with a 
number of side effects (including considerable toxicity), intra-articular injections are 
thought to offer only short-term benefit in both, knee and hip OA (Aresti et al., 2016; 
Bennell et al., 2012). 
Joint surgery 
While a combination of pharmacological and non-pharmacological interventions forms 
the mainstay of OA management, knee and hip replacement surgery is often considered 
in patients with severe disease characterized by persistent moderate to severe pain, 
limited function and reduced quality of life, provided conservative management is 
ineffective and radiographic disease is present (Aresti et al., 2016; Bennell et al., 2012; 
Litwic et al., 2013).  
Total hip replacement (THR) is a commonly performed and successful procedure 
worldwide (Aresti et al., 2016) and according to the National Joint Registry for England, 
Wales, Northern Ireland and the Isle of Man (NJR) data, the probability of hip revision at 
14 years is 7.27% . The reason for revision depends on the period of follow up; revisions 
due to aseptic loosening of the prosthesis become the most common reason at longer 
follow up (Aresti et al., 2016; Kandala et al., 2015) and smoking and obesity are 
associated with increased postoperative and prosthesis related complications (Aresti et 
al., 2016). 
Although not as common as hip replacement, knee replacement surgery is also thought 
to be highly successful with about 80% of patients reporting reduction in pain (Bennell 
et al., 2012). In younger patients, with predominantly unicompartmental OA, knee 
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osteotomy may be used in order to re-align tibia and correct abnormal joint 
biomechanics (Katz et al., 2010).  
 
Novel/emerging therapies 
Several candidate pathways and processes have been identified as potential treatment 
targets. These include chondrocyte autophagy, reduction of reactive oxygen species 
production, modulation of growth factor signalling to prevent cartilage anabolism and 
degradation, and nociceptive signalling (M. M.-G. Sun et al., 2017). In addition, gene 
therapy targeting knee OA, which has been approved in South Korea, is due to undergo 
phase III clinical trials in the USA  (C. H. Evans et al., 2018a, 2018b). 
 
1.7. Osteoporosis 
The inverse relationship between osteoporosis (OP) and OA is well-recognized (Jan 
Dequeker et al., 2003; Im & Kim, 2014). While they are different diseases in terms of risk 
factors and genetics, it is thought that bone metabolism plays a crucial role in the 
pathophysiology of both (Geusens & van den Bergh, 2016). Furthermore, hip shape is 
related to both disorders, having previously been found to be associated with hip 
fracture (Alonso et al., 2000; Gnudi et al., 1999) and the development of hip OA (Baker-
LePain & Lane, 2010). 
1.7.1. Definition and burden of OP 
OP is a complex age-related disease characterized by low BMD and deterioration of 
bone microarchitecture leading to increased bone fragility and increased risk of fracture 
(Consensus Development Conference, 1993). OP usually arises due to imbalance 
between bone formation and resorption. It is often asymptomatic and does not 
manifest clinically until fracture occurs. It affects almost 1 in 2 women and 1 in 5 men 
over the age of 50 years (Curtis et al., 2015).  
Osteoporotic fractures most commonly affect the hip, forearm and spine with the 
highest mortality, morbidity and economic burden attributed to hip fractures. Following 
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hip fracture, in previously independent individuals, about half require long-term care 
and assistance with day to day living (WHO, 2003). In the UK, the estimated cost 
associated with osteoporotic fracture is approximately £3 billion per year (Curtis et al., 
2015) and about 90% of hospital costs associated with osteoporotic fracture are due to 
those of hip (WHO, 2003).  
1.7.2. OP diagnosis 
OP has no warning signs and is most commonly diagnosed when patients present with 
low trauma fracture. Low BMD (with a T-score of <= -2.5), one of the strongest risk 
factors for fracture, is also indicative of OP. Dual energy x-ray absorptiometry (DXA) of 
either lumbar spine (LS) or proximal femur is used clinically in the assessment of BMD 
(Schuiling et al., 2011). An online fracture risk assessment tool (FRAX), which uses 
combination of risk factors for OP (described in detail in section 1.7.4.1) with or without 
BMD measurement, is often used to estimate 10-year probability of major osteoporotic 
or hip fracture in men and women (Kanis et al., 2008). 
1.7.3. OP pathogenesis  
OP is a multifactorial disease with complex pathogenesis. Low BMD is one of the key 
contributors to osteoporotic fracture and factors contributing to OP pathogenesis 
include those influencing the attainment of peak bone mass in early adulthood and 
factors accelerating bone loss in later life. Factors negatively affecting peak bone mass 
gain, which largely determines BMD in later life, include poor nutrition, physical 
inactivity and paediatric disorders (e.g. growth hormone deficiency). Once peak bone 
mass has been achieved it begins to gradually decline with age, with considerable bone 
loss observed around the age of 65 and 50 years in men and women, respectively 
(Rizzoli & Bonjour, 1999; WHO, 2003). At menopause, bone turnover increases, due to 
oestrogen deficiency, causing imbalance between bone formation and resorption. 
Mechanisms involved include release of cytokines (such as TNFs and ILs) which stimulate 
osteoclast activity. In men, the likely contributors to OP are low rates of bone formation 
(due to decline in the levels of gonadal hormone) rather than increase in bone 
resorption (WHO, 2003).  
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While the inverse relationship between BMD and fracture is well-established, reduced 
bone strength at macro- and microarchitectural levels is also though to influence 
fracture susceptibility. As described below (section 1.7.4.1, hip morphology and 
geometry), a range of measures of hip geometry derived from hip DXA scans have 
been found to be related to hip fracture risk (Gregory & Aspden, 2008). Furthermore, 
techniques assessing bone strength such as finite element analysis on DXA scans (Luo 
et al., 2011) and cortical thickness mapping applied to CT scans (K. E. S. Poole et al., 
2012) are examples of other tools used in fracture prediction.  
1.7.4. OP epidemiology 
1.7.4.1. Risk factors 
 Clinical risk factors 
Several risk factors for OP have been identified and these include low BMI, prior history 
of low trauma fracture, parental history of hip fracture, use of oral glucocorticoids, 
rheumatoid arthritis, diabetes, untreated hyperthyroidism, hypogonadism or premature 
menopause (before the age of 45 years), chronic liver disease, current smoking and 
alcohol intake of 3 or more units per day (Curtis et al., 2015; WHO, 2003). 
 Bone mineral density  
Previous studies have shown consistent inverse associations between BMD and fracture 
with a 1.5 to 3-fold increase in fracture risk for each SD decrease in BMD. For example, a 
meta-analysis showed a 2.6-fold increase in hip fracture risk for every 1 SD decrease in 
hip BMD (Holroyd et al., 2008). BMD is one of the best predictors of osteoporotic 
fracture and peak bone mass, which is achieved in adolescence, is the main predictor of 
BMD in later life (Lane, 2006). However, it is important to bear in mind that fractures do 
occur in individuals with BMD above the osteoporotic threshold and conversely in 
individuals with low BMD, fractures are more likely but might not occur (Nguyen et al., 




 Hip morphology and geometry 
While BMD is one of the most important predictors of fracture, a number of geometrical 
measures to assess hip morphology have been used in studies in relation to fracture. 
These include femoral neck width (FNW), Hip Axis Length (HAL) and NSA (Boese et al., 
2016; Leslie et al., 2015).  
Previous studies found greater NSA in both men and women with fracture, association 
between higher NSA with hip fracture risk, and a number of studies reported 
relationship between wider FNW in men and women with fracture, although some 
studies found the opposite reporting associations with narrower FNW and fracture (for a 
review of studies please refer to (Gregory & Aspden, 2008)). Similarly, in a recent meta-
analysis higher HAL, NSA and FNW were associated with the risk of FN fractures (Fajar et 
al., 2018).  
Hip geometrical measurements can be obtained using hip structural analysis (HSA), a 
standardized software applied to hip DXA scans (Beck, 2007). The advantage of HSA 
includes the automated generation of hip geometrical indices; however, these 
parameters are often correlated with each other (therefore not independent) and with 
measures of body size (Gregory et al., 2004; Michelotti & Clark, 1999).  
1.7.5. Genetics of OP  
As previously mentioned, genetic factors play an important role in OP and fracture risk 
and between 50-85% of variance in BMD, which comprises one of the strongest 
predictors of fracture, is thought to be determined genetically (Estrada et al., 2012). In 
addition to BMD, previous studies exploring genetic influences on bone phenotypes 
looked at hip geometry (Hsu & Kiel, 2012), bone ultrasound measures (Kemp et al., 
2017) and fracture risk (Tran et al., 2013). Previous studies reported significant 
heritability of fractures with 2-fold increase in fracture risk (independent of BMD) in 
those individuals with a parental history of hip fracture (Zmuda et al., 2006). Both 
candidate gene and genome-wide searches have been performed and here, I will focus 
on the findings from the most recent GWASes.  
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The largest to date meta-analysis of DXA derived phenotypes, based on 17 GWASes, 
identified 56 loci associated with FN and LS BMD (Estrada et al., 2012). These included 
variants implicated in pathways with relevance to bone such as Wnt, MSC 
differentiation, EO and RANK-RANKL-OPG pathways. In addition, 14 BMD-associated 
loci were also found to be associated with fracture risk. In a recent GWAS of BMD, 
estimated by quantitative heel ultrasound, in 142,487 participants from the UK Biobank 
study, 153 novel loci explaining 12% of phenotypic variance in BMD have been identified 
of which several were rare variants with large effects (Kemp et al., 2017). In addition, 
this study provided evidence for the causal role of GPC6 locus (which encodes glypican 6 
protein) in BMD and the pathophysiology of OP, a potential novel drug target for OP.   
1.7.6. OP management  
Non-pharmacological interventions in the management of OP consist of falls prevention, 
which are important in the pathogenesis of fracture, and lifestyle interventions such as 
adequate calcium intake and vitamin D levels, regular exercise, smoking cessation and 
reducing alcohol intake (K. E. S. Poole & Compston, 2006).  
A wide range of pharmacological interventions for OP are currently available. 
Bisphosphonates, which deactivate osteoclasts and thus inhibit bone resorption, are 
commonly prescribed to treat glucocorticoid induced or postmenopausal OP (Curtis et 
al., 2015; K. E. S. Poole & Compston, 2006). Denosumab is a human monoclonal 
antibody which binds to receptor activator of nuclear factor kappa B ligand (RANKL) 
expressed on the surface of osteoblasts. By binding to RANKL, denosumab blocks the 
formation and activation of bone resorbing osteoclasts and previous studies have 
showed a substantial reduction in vertebral and hip fractures following treatment with 
denosumab. Teriparatide which is a parathyroid hormone analogue, increases bone 
formation and has been shown to substantially reduce the incidence of new vertebral 
fractures. Other treatments such as strontium ranelate, which increases bone strength, 
and raloxifene (selective oestrogen receptor modulator), which has antiresorptive 
effects on bone, are also available (Curtis et al., 2015).  
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1.8. Relationship between osteoporosis and osteoarthritis 
OA and OP rarely coexist and the inverse relationship between OP and OA was first 
reported by Foss and Byers in 1972 (Foss & Byers, 1972) who studied patients with 
osteoporotic fractures and noted that OA was almost never present in individuals with 
upper femoral fractures, and patients with hip OA had higher than normal BMD. Since 
then, a number of epidemiological studies reported inverse relationship between OP 
(defined as low FN BMD) and radiographically defined OA (C Cooper et al., 1991) as well 
as an association between higher BMD and increased risk of incident and prevalent OA 
(Allen & Golightly, 2015; Hardcastle et al., 2015a; Vina & Kwoh, 2018). In terms of the 
relationship between fracture risk and OA the evidence is conflicting and likely reflects 
heterogeneity in OA case definition. Previous studies reported either protective effect of 
self-reported (J Dequeker & Johnell, 1993) and physician diagnosed (Vestergaard et al., 
2009) OA on fracture risk, while others reported no association between OA 
(radiographic and self-reported) and vertebral, nonvertebral or hip fractures (Nigel K 
Arden et al., 1999; G. Jones et al., 1995). Others yet reported an increased risk of 
fracture in cases with RHOA compared with controls (N K Arden et al., 1996) and an 
association between self-reported OA and increased risk of fracture in postmenopausal 
women (Prieto-Alhambra et al., 2013), a finding likely to be explained by increased risk 
of falls (Lane & Nevitt, 2002; Prieto-Alhambra et al., 2013). Finally, studies in individuals 
with extremely high bone mass showed higher prevalence of joint replacement 
(Hardcastle et al., 2013) and radiographic knee and hip OA (Hardcastle et al., 2015a; 
Hardcastle et al., 2014) in these individuals compared with general population controls. 
The exact mechanisms underlying the OA-OP relationship are not fully understood. 
However, the likely mechanisms contributing to this relationship include a shared 
relationship with hip shape (Baker-LePain & Lane, 2010) or increased bone remodelling 
and bone loss in early stages of OA as well as slow remodelling and subchondral 
sclerosis in the late stages of OA which could both contribute to OA pathogenesis (Burr 
& Gallant, 2012). Important signalling pathways potentially implicated in OA include 




While there is strong epidemiological evidence of an inverse relationship between OP 
and OA and a clear relationship between higher BMD and OA, the mechanisms 
underlying this relationship are not fully understood. One explanation for this 
relationship could be due to shared genetic factors. Previous studies showed 30% 
overlap between genes involved in bone metabolism and those influencing OA (Williams 
& Spector, 2006). For example, previous studies reported associations between BMD 
SNPs with knee (Yerges‐Armstrong et al., 2014) and hip OA (Yerges-Armstrong et al., 
2014). In addition, Hackinger et al. undertook the first systematic overlap analysis of OA 
and BMD and identified 143 variants associated with OA and BMD, a number of which 
had known relevance to bone (Hackinger et al., 2017). 
1.9. Statistical Shape Model (SSM) 
As discussed above, altered hip shape plays an important role in both, hip fracture and 
hip OA (Baker-LePain & Lane, 2010; Gregory et al., 2004), possibly via altered 
biomechanics. While the majority of studies investigating relationships with hip shape 
relied on individual geometrical measures, given the limitations associated with these 
measures, Gregory et al. (Gregory et al., 2004) were the first to introduce SSM as a 
means of capturing the global shape of the proximal femur using Principal Component 
Analysis (PCA). Since then this method has been applied to radiographs to investigate 
associations with incident hip fracture (Baker‐LePain et al., 2011), incident RHOA (An et 
al., 2016) and to predict THR in OA cases as shown by Gregory et al. (Gregory et al., 
2007) and Agricola (Agricola et al., 2015).  
Despite lower resolution, when compared with standard radiographs, DXA images have 
been successfully used to quantify hip shape with SSM in previous studies (Faber et al., 
2017; Pavlova et al., 2017). For example, to investigate the relationships with prevalent 
RHOA and symptomatic hip OA in MrOS (Faber et al., 2017) and to describe the variation 
in hip shape and its correlations with spine shape in the MRC National Survey of Health 
and Development (NSHD) cohort (Pavlova et al., 2017). In the largest SSM study to date, 
nearly 20,000 DXA images were used to identify novel genetic determinants of hip shape 
(D. A. Baird et al., 2017) and a previous study which also used SSM, explored 
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relationships between known OA loci and hip shape (Baird et al., 2018). It is worth 
noting that compared with radiographs, DXA images are quick to perform and produce 
very low doses of radiation and are thus readily available. As well as being widely 
available, hip DXA scans were successfully used in previous studies which explored the 
relationship between hip shape (derived from SSM) and radiographic and clinical hip OA 
(Faber et al., 2017; Waarsing et al., 2010). Whilst older DXA devices may produce images 
of lower resolution, making it difficult to identify specific OA features, such as 
osteophytes, the resolution of images obtained with newer DXA scanners is comparable 
to radiographs (Yoshida et al., 2015). Given the many advantages of SSM this method 
was used to quantify hip shape in this thesis and the method will be described in more 
detail in Chapter 2.  
1.10. Hypotheses and aims to be addressed in thesis 
OA is a complex disorder with several risk factors contributing to its development. 
Abnormal hip morphology has been recognized as an important risk factor for hip OA. 
Alongside severe skeletal disorders such as DDH, a growing body of evidence suggests 
that more subtle changes in joint morphology play important role in the development of 
hip OA (Baker-LePain & Lane, 2010). Whereas hip geometry is known to be related to 
hip fracture, proximal femur shape measured with SSM is also thought to contribute 
(Baker‐LePain et al., 2011) and this in turn may contribute to the known reciprocal 
relationship between OA and osteoporotic fracture.  
With the majority of studies investigating the association between joint shape and OA in 
older adults and the lack of longitudinal data with sufficient follow up, it is difficult to 
distinguish shape changes that are the direct result of OA from those that lead to OA 
development. While it is clear that joint shape can be altered by OA processes (Resnick, 
1976), as discussed in section 1.6.7, it has been recognized that abnormalities in hip 
morphology can also cause hip OA. While on one extreme DDH is known to be 
associated with early-onset OA it is being increasingly recognized that subtle changes in 
hip structure and geometry are present in up to 90% of cases with primary hip OA 
(Khanna & Beaulé, 2014). For example, Lynch et al. reported that variation in hip shape 
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at baseline (as measured by SSM) was associated with incident RHOA after 8 years 
follow up in elderly women (Lynch et al., 2009). While it is likely that variation in hip 
shape contributed to the development of hip OA in this cohort, little is known when 
these changes develop and how variation in hip morphology is shaped throughout life.   
Despite the great body of evidence suggesting that subtle architectural changes in hip 
morphology predate the onset of hip OA, the development of hip shape and factors 
influencing this process remain poorly understood (Khanna & Beaulé, 2014).  
 
1.10.1. Knowledge gaps to be addressed in this thesis 
Despite the well-established relationship between hip shape and OA, little is known 
about how hip shape develops in childhood and adolescence, which I aim to address by 
describing sex differences in hip shape at age 14 and 18 (Chapter 3), and its associations 
with pubertal timing (Chapter 4).  
While the inverse relationship between hip fracture and hip OA may in part reflect 
associations with BMD, relationships with hip shape could also contribute. In addition, 
BMD and hip shape could be influenced by common pathways, as supported by findings 
from the recent hip shape GWAS which identified a number of loci previously found to 
be related to BMD (D. A. Baird et al., 2017). Therefore, a further aim of my thesis is to 
explore previously unknown relationships between BMD and hip shape (Chapters 5 and 
6). Given the genetic influences on BMD which are well recognised, this opens up the 
possibility of using methods such as MR to explore shared genetic mechanisms between 
BMD and hip shape, which I also aimed to apply. 
In terms of genetic influences on hip shape, previous studies explored the effect of hip 
morphology in mediating the risk of OA (Lindner et al., 2015), and one previous study 
explored genetic influences on hip shape in adult cohorts (D. A. Baird et al., 2017). So 
far, however, no research has been found that explored the genetic influences on hip 





1.10.2. Summary and aims of this PhD  
Despite many studies investigating the role of hip morphology in the development of OA 
many questions remain unanswered. Little is known about the development of hip 
shape in adolescence and it is not clear what factors influence this process. This thesis 
aims to provide the first characterisation of hip shape development across adolescence 
as assessed by SSM, based on application to hip DXA scans obtained from ALSPAC 
offspring at age 14 and 18.  
This thesis is composed of eight chapters. The first Chapter introduces the background 
and aims of this thesis. The second Chapter is concerned with the methodology, 
whereas Chapters 3 – 7 are the main results chapters (see Figure 1.6 for overview of 
relationships to be explored during this PhD). The final Chapter draws upon the entire 
thesis summarizing the key findings, discussing the strengths and limitations of this 
research and considerations for future. 
 
The specific aims of my research are 
- To apply previously developed SSM methodology and adult reference SSM 
template to hip DXA scans obtained in adolescents at age 14 and 18 (Chapter 2)   
- To examine differences in hip shape between age 14 and 18 and describe sex 
differences in hip shape at these time points. Also, to determine whether sex 
differences at age 14 and 18 are explained by those in body size (Chapter 3) 
- To examine the relationship between pubertal timing (using measures of height 
tempo) and hip shape at age 14 and 18 (Chapter 4) 
- To investigate cross-sectional associations between hip BMD and hip shape in 
adolescents, and to explore the extent to which common genetic pathways 
underlie both BMD and hip shape in this group (Chapter 5) 
- To investigate cross-sectional associations between hip BMD and hip shape in 
adult women, and to explore the extent to which common genetic pathways 
underlie both BMD and hip shape in this group (Chapter 6) 
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- To identify genetic variants associated with hip shape in adolescents and to 
determine if genetic variants associated with adult hip shape have similar effects 
on hip shape in adolescence. Finally, to determine if OA associated variants are 




Figure 1.6 Overview of PhD content indicating relationships to be explored during this PhD. Abbreviations: BMD (bone mineral density).
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CHAPTER 2.  METHODS  
 
In this chapter, I will describe the data and methodology that were used to quantify the 
shape of proximal femur. Sections 2.1 and 2.2 will describe ALSPAC cohort and data 
used throughout this thesis. Section 2.3 of this chapter will introduce Statistical Shape 
Modelling and the technical steps involved in this process. Section 2.4 will describe steps 
undertaken to apply Statistical Shape Model (SSM) to data from ALSPAC adolescents 
and model checking. Section 2.5 will describe how external adult reference SSM was 
applied to ALSPAC data. Finally, Section 2.6 will describe the statistical methods that 




2.1. Cohort description 
2.1.1. ALSPAC cohort 
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a birth cohort which 
was initially established to investigate factors influencing child health and development. 
All pregnant women resident in the county of Avon, South West of England, with 
expected delivery date between 1st April 1991 and 31st December 1992 were eligible to 
participate. A total of 14,541 pregnancies were initially enrolled (for details see 
www.alspac.bris.ac.uk), of these 68 have no known birth outcome, 195 were twin, 3 
were triplet and 1 was quadruplet; accounting for 14,676 known foetuses. This resulted 
in 14,062 live births of whom 13,988 were alive at 1 year of age.  
In addition to the initial enrolment that took place between 1991 and 1992, further 
recruitment took place when the children were on average 7 years old, and another 
from age 8 onwards to which eligible children and those not initially enrolled were also 
invited. This resulted in a total of 15,247 pregnancies enrolled (Boyd et al., 2012). Since 
recruitment these children have been followed up at regular intervals; questionnaire 
and clinical assessment data have been collected. Moreover, additional data on siblings, 
mothers and their partners, have also been collected. 
The ALSPAC cohort provides a unique opportunity to investigate the environmental and 
genetic influences on hip shape in adolescence due to the wide range of data which has 
been collected, including genome-wide genotyping data. Since recruitment these 
children underwent repeated DXA scans, which enabled me to quantify hip shape at two 
time points and investigate a range of environmental and genetic influences on hip 
shape in adolescence.  
2.1.2. Ethical approval 
Written informed consent was collected for all participants in line with the Declaration 
of Helsinki (Rickham, 1964). Ethical approval for the study was obtained from the 
ALSPAC Ethics and Law Committee and the Local Research Ethics Committees (North 
Somerset & South Bristol Research Ethics Committee: 08/H0106/96). The current 
project, B2325, has been approved by the ALSPAC executive committee. 
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2.2. Data 
2.2.1. Outcome – hip shape 
2.2.1.1. ALSPAC offspring  
The majority of data that contribute to this thesis were collected during two separate 
assessment clinics. These included Teen Focus (TF) 2 and TF 4 clinics. TF 2 was carried 
out between January 2005 and September 2006. The target age for attendance was 13.5 
years (mean age at attendance was 13.8 years, range 12.5 – 15.1 years). Of 11,351 
individuals invited to TF 2 clinic, 6,147 attended. TF 4 clinic started in December 2008 
and was completed by early to mid-2011. The target age for attendance was 17.5 years 
(mean age at attendance was 17.8 years, range 16.2 – 19.8 years).  Of 10,101 individuals 
invited to TF 4 clinic, 5,217 attended.  
In order to quantify the shape of proximal femur all hip DXA images collected during 
these clinics were securely sent to collaborators in Aberdeen for image processing and 
subsequent upload in Shape software (University of Aberdeen, UK). Data generated in 
Shape was then linked with other ALSPAC variables and all analyses were performed in 
singletons. The section below describes the data that were available to quantify hip 
shape at each time point.   
 
1. Hip shape at age 13.8 years 
A total of 6,162 images were available to align in Shape (please note that some 
participants underwent repeat DXA scans to assess data precision, hence the number of 
images that were uploaded into Shape is higher than the number of participants who 
attended the clinic). Of those, 268 were excluded due to poor image quality, 171 were 
duplicate scans (either from twins, siblings or repeat scans) and 1,255 were not aligned 
due to time constraints (data restricted to include individuals who had both, genetic 
data and DXA image acquired at TF 4 clinic) (see Table 2.1 for more details). The final 
dataset, and hence final Statistical Shape Model (SSM) was based on 4,468 images.  
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2. Hip shape at age 17.8 years 
A total of 4,746 images were available to align in Shape (Table 2.2). Of those, 333 were 
excluded; 218 due to image anomalies, 115 were duplicate scans (either from twins, 
siblings or repeat scans). The final dataset was based on 4,413 images. 
 
2.2.1.2. ALSPAC mothers’ 
Hip DXA data were also collected during the Focus on Mothers 1 (FoM1) research clinic. 
This clinic was held between 2008 and 2011, ~16 – 20 years postpartum. All eligible 
women (i.e., still engaged with the study; alive with known contact details and who had 
not withdrawn their consent) were invited to take part. Of 11,264 women invited, 4,834 
attended. 
A total of 4,631 hip DXA images were available for marking up in Shape and of those 28 
were excluded due to image anomalies leaving a total of 4,603 images available for 
subsequent analysis (Table 2.3). Hip morphology was quantified in the same way as 
adolescent images (see section 2.3 of this chapter) and adult reference SSM (described 
in Chapter 2, section 2.5) was then applied to enable direct comparison between 
adolescent and adult results. 
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Table 2.1; ALSPAC offspring hip shape data at age 14 
*Due to delay in image acquisition and given the time constrains, half way through 
image alignment it was decided to restrict alignment of the remaining images to those 
who had both, genetic data and DXA image acquired at TF 4 clinic. 
  
 Table 2.2; ALSPAC offspring hip shape data at age 18 
Description N 
Total number of images uploaded in shape 6,162 
Excluded twins, sibs and re-invites 171 
Excluded images without genetic or TF4 data  1,255* 
Excluded images due to poor image quality 268 
  
Total hips aligned  4,468 
     Of those, with genetic data  3,929 
     Of those, with TF4 data 3,188 
Description N 
Total number of images uploaded in shape 4,746 
Excluded twins, sibs and re-invites 115 
Excluded images due to poor image quality 218 
  
Total hips aligned 4,413 




Table 2.3; ALSPAC mothers’ hip shape data 
 
2.2.2. Exposure and covariate data  
2.2.2.1. ALSPAC offspring  
 Age at clinic attendance  
Participant age was calculated as the difference between the date of attendance and 
date of birth for both TF2 and TF4.  
 Sex  
Data on sex were obtained from hospital birth records.  
 Anthropometry 
Total body (TB) lean and fat mass (kg) along with total hip and femoral neck (FN) bone 
mineral density (BMD) (g/cm2) were measured using DXA scans, performed using a GE 
Lunar Prodigy (Madison, WI, USA). Scans were analysed according to the manufacturers’ 
standard scanning and positioning protocols.  
Height was assessed at the time of the DXA scan. It was measured to the nearest 0.1 cm 
using a Harpender stadiometer with shoes removed.  
 Age at peak height velocity (aPHV) 
aPHV was estimated from serial height measurements collected during assessment 
clinics (from age 5 to 20 years). These clinics encompassed ‘children in focus clinics’ (CIF) 
to which a random 10% subsample of children were invited between the age 2 and 5 
Description N 
Total number of images uploaded in shape 4,631 
Excluded images due to poor image quality 28 
  
Total hips aligned 4,603 
    Of those, with genetic data 3,111 
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years annual clinics in late childhood (between age 7 and 13 years), three further 
assessment clinics in adolescence (ages 13, 15 and 17 years). This method is described in 
more detail in Chapter 4. 
 Tanner stage assessment  
Pubertal status in ALSPAC offspring has been assessed via sex-specific questionnaires, 
which were repeatedly sent out to participants (between ages 8 - 17 years). See Table 
2.4 for details regarding the frequency at which Tanner questionnaires were sent out 
and the frequency of responses. These questionnaires consisted of a set of line drawings 
representative of the Tanner stages, as described by Marshall and Tanner (Marshall & 
Tanner, 1969, 1970), for breast size (sent to females only), genitalia (sent to males only) 
and pubic hair development (sent to both, males and females). Tanner stage categories 
are on a scale 1 to 5, with 1 indicating pre-adolescent stage prior to puberty onset, and 
stage 5 indicating mature adult stage.  
During the course of pubertal assessment an issue with genital stage assessment in 
males was noticed, whereby males went backwards in genital stage when the data was 
assessed longitudinally. Therefore, pubertal status based on pubic hair development 
only was used in this thesis in order to aid comparability between males and females.   
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Table 2.4; Number of puberty questionnaires sent to ALSPAC  participants and number 
of questionnaires returned 






 N N 
8 11,414 6,192 
9 11,000 7,020 
10 10,450 6,348 
11 10,312 6,054 
13 10,143 5,801 
14 9,947 4,938 
15   5,149* 4,637 
16 9,534 4,553 
17 9,357 4,177 
*please note that the questionnaires were only sent to study children who made an 
appointment for Teen Focus 3 and Teen Focus Express assessment clinics 
 
2.2.2.2. ALSPAC mothers  
 Age at clinic attendance  
Mothers’ age was calculated as the difference between the date of clinic attendance 
and date of birth.  
 Anthropometry 
Total body (TB) lean and fat mass (kg) along with total hip and femoral neck (FN) BMD 
(g/cm2) were measured using DXA scans, performed using a GE Lunar Prodigy (Madison, 
WI, USA). Scans were analysed according to the manufacturers’ standard scanning and 
positioning protocols.  
Height was assessed at a time of the DXA scan. It was measured to the nearest 0.1 cm 
using a Harpender stadiometer with shoes removed.  
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2.2.3. Genotyping and imputation 
Information regarding genotyping and imputation was taken from the ALSPAC data 
description as previously referred to in other studies (H. J. Jones et al., 2016; Taylor et 
al., 2018).  
A total of 9,912 ALSPAC children were genotyped using the Illumina HumanHap550 
quad genome-wide SNP genotyping platform (Illumina Inc., San Diego, CA, USA) by 
23andMe subcontracting the Wellcome Trust Sanger Institute, Cambridge, UK and the 
Laboratory Corporation of America, Burlington, NC, USA. PLINK v1.07 was used for 
quality control (Purcell et al., 2007) and individuals were excluded on the basis of gender 
mismatches, minimal or excessive heterozygosity, disproportionate levels of individual 
missingness (>3%), evidence of cryptic relatedness (>10% of alleles identical by descent 
(IBD)), and being of non-European ancestry (assessed by multidimensional scaling 
analysis seeded with HapMap2 individuals). SNPs with a minor allele frequency of <1% 
and call rate of <95% were removed and only SNPs that passed an exact test of Hardy–
Weinberg equilibrium (HWE) (P>5×10−7) were included in the analysis. 
ALSPAC mothers were genotyped using the Illumina human660W-quad array at Centre 
National de Génotypage (CNG) and genotypes were called with Illumina GenomeStudio. 
PLINK (v1.07) was used to carry out quality control measures on an initial set of 10,015 
subjects and 557,124 directly genotyped SNPs. SNPs were removed if they displayed 
more than 5% missingness or a Hardy-Weinberg equilibrium p value of less than 1.0e-
06. Additionally, SNPs with a minor allele frequency of less than 1% were removed. 
Samples were excluded if they displayed more than 5% missingness, had indeterminate 
X chromosome heterozygosity or extreme autosomal heterozygosity. Samples showing 
evidence of population stratification were identified by multidimensional scaling of 
genome-wide identity by state pairwise distances using the four HapMap populations as 
a reference, and then excluded. Cryptic relatedness was assessed using an IBD estimate 
of more than 0.125 which is expected to correspond to roughly 12.5% alleles shared IBD 
or a relatedness at the first cousin level. Related subjects that passed all other quality 
control thresholds were retained during subsequent phasing and imputation. 9,048 
subjects and 526,688 SNPs passed these quality control filters. 
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A total of 477,482 SNP genotypes in common between the sample of ALPSAC mothers 
and children were combined. SNPs with genotype missingness >1% were removed. Data 
imputation was performed using Impute2 v2.2.2 software against the 1000 genomes 
reference panel (phase 1, version 3) using 2186 haplotypes from all populations 
(haplotype release date Dec 2013), which resulted in 28,699,419 SNPs available for 
analysis. A total of 8,237 unrelated children and 8,196 mothers with available genotype 
data were available for analysis.   
 
2.3. Defining and quantifying proximal femur shape 
2.3.1. Statistical Shape Modelling 
Bones are complex objects with considerable variation observed between individuals 
which can be attributed to anatomical differences, environmental and genetic 
influences or be a consequence of a disease process. Traditionally these differences 
have been assessed by measuring lengths and angles e.g. femoral neck width or neck-
shaft angle, which have been described in more detail in the previous chapter (Chapter 
1, section 1.7.4.1). However, it has been recognized that single geometrical 
measurements are often correlated with measures of body size and often highly 
correlated with other geometrical indices. On the other hand, Statistical Shape Analysis 
provides the means for capturing global shape of an object as opposed to a single 
geometrical measurement and can often represent a combination of several different 
aspects of proximal femur shape (such as variation in femoral neck along with variation 
in femoral head). It uses a set of landmark points to describe an outline of an object. 
This concept was validated by Cootes et al. (Cootes et al., 1995) who built on previous 
work by Kass et al. (Kass et al., 1988). This approach is used to study, describe and 
compare variations in anatomical shapes within and across different groups and it has 
been successfully applied to quantify variation in proximal femur shape and predict risk 
of fracture (Baker‐LePain et al., 2011) and progression to THR (Gregory et al., 2007) as 
described in Chapter 1, section 1.9.  
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2.3.2. Definition of shape 
According to Dryden & Mardia (Dryden & Mardia, 1998) shape can be defined as "all the 
geometrical information that remains when location, scale and rotational effects are 
filtered out from an object”. In other words, an objects’ shape is invariant under 
Euclidean transformation which preserves its angles and distances. In order to precisely 
describe shape, a set of points (referred to as landmarks) are identified and located 
around the object. A landmark can be defined as “a point of correspondence on each 
object that matches between and within populations”(Dryden & Mardia, 1998). These 
consist of points that are placed at easily identifiable anatomical features of an object at 
biologically meaningful locations (anatomical landmarks), points with mathematical or 
geometrical properties i.e. at a point of high curvature (mathematical landmarks), and 
the remaining points which are placed between anatomical or mathematical landmarks 
(pseudo-landmarks) (Dryden & Mardia, 1998; Stegmann & Gomez, 2002).  
2.3.3. Analytical steps involved in Statistical Shape Modelling 
Figure 2.1 shows all landmark points that were used to mark up each hip DXA image in 
Shape software (University of Aberdeen). Shape mapped points to each image, and 
these were then manually re-aligned where necessary. The initial model consisted of 58 
landmark points to outline the shape of proximal femur including the acetabular sourcil 
and lesser trochanter. Key landmark points, shown in red, were placed at easily 
identifiable features and the remaining points, were evenly spaced between them 
(Figure 2.1). Table 2.5 describes the anatomical positions of each of the key landmark 
points which are shown in Figure 2.2. 
Following placement of landmark points, Procrustes analysis was used to estimate the 
mean shape. The aim of this step is to first, remove any translational, rotational and 
scaling information and then align each image as closely as possible. After completing 
the alignment, PCA was performed to build the Statistical Shape Model (SSM). PCA, 
which was first introduced by Hotelling in 1933 (Hotelling, 1933), is a method for data 
dimensionality reduction, producing a set of orthogonal modes of variation known as 
principal components. Principal components of hip shape, generated by SSM, are 
referred to as hip shape modes (HSMs) throughout this thesis, which together explain 
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100% of variance in the data set. The modes are ordered according to the amount of 
variance explained: the first mode accounts for the largest amount of variance with 
subsequent modes accounting for less. Each HSM has a mean of zero and unit standard 
deviation (SD), and each image and consequently individual is assigned a set of values 
for each HSM which describes the number of SDs away from the mean shape. 
Images of poor quality and those with missing key anatomical features (i.e. features 
required for placement of all landmark points, as shown in Figure 2.1) were excluded 
from the analysis. Any outliers (images with scores above or below 4 SDs) were checked, 
re-aligned where necessary and Procrustes analysis and PCA were then repeated. For 
more details on Procrustes analysis and PCA please refer to Dryden and Mardia (Dryden 
& Mardia, 1998).  
 
 




Figure 2.2 Key landmark points. Please note that point 2 (placed on femoral shaft; image A) often maps to point 46 (indicating inferior lesser 
trochanter; image B). By modelling points 2 and 46 separately, the overlap between the femoral shaft and the lesser trochanter can be 
visualized as well as the differences  between greater and lesser trochanter that can overlap the shaft on 2D images as exemplified on 
image C.  
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Table 2.5; Description of the key landmark points shown in red in Figure 2.2 
Point number Anatomical feature 
2 Medial femoral shaft meets inferior lesser trochanter (often maps to 
same position as point 46, depending on orientation) 
4 Medial femoral shaft meets superior lesser trochanter  
9 Change in curvature: lateral inferior curvature of femoral head at 
point where it meets femoral neck 
10 Change in curvature: medial inferior curvature of the femoral head 
23 Change in curvature: superior lateral femoral head curvature 
25 Change in curvature: inferior lateral femoral head where meets the 
superior femoral neck 
29 Inferior greater trochanter slope where it meets superior femoral 
neck 
31 Medial superior greater trochanter 
38 Inferior lateral greater trochanter 
43 Lateral femoral shaft 
46 Inferior lesser trochanter (often maps to point 2) 
51 Acetabular sourcil medial end (end of brightest line) 
56 Acetabular sourcil lateral end  




2.4. Building the Statistical Shape Model in ALSPAC children  
All images uploaded in Shape were aligned by a single person (MF) followed by 
Procrustes analysis and PCA. Initial model checking (as described in section 2.4.1) and 
reproducibility (section 2.4.2) were then performed.   
2.4.1. Model checking (effect of hip abduction and adduction on hip shape mode 
scores) 
During hip shape alignment, it became apparent that numerous hip DXA images had a 
degree of abduction and adduction (see Figure 2.3 and Figure 2.4 for examples). It has 
been suggested that positioning errors during DXA image acquisition may introduce 
small bias with regards to BMD measurement. For example, a previous study by 
Lekamwasam et al. reported that external leg rotation by 10° compared with 
standardized positioning was associated with an increase in femoral neck, trochanter 
and Ward’s area BMD. Whereas, 10° internal leg rotation was associated with a 
decrease in BMD measurements (Lekamwasam et al., 2003). On the other hand, Ozer et 
al. found no effect of subtle abduction or adduction on the measurement of BMD (Ozer 
et al., 2010). However, it is unlikely that positioning errors that were observed in ALSPAC 
would bias hip shape results as these should be accounted for during Procrustes 
analysis. 
To assess the impact of the positioning errors on the overall model performance and 
further inform image exclusion criteria when building the final SSM model, abduction 
and adduction errors were assessed. These errors were assessed visually, based on the 
assumption that DXA images were acquired according to the manufacturer's standard 
scanning and positioning protocols. During DXA scan acquisition, the body of a scanned 
participant should be positioned straight and cantered on the scanning table. Subject’s 
leg is rotated inward, and the foot is placed against a positioning device and secured 
with a strap. If necessary, the leg is adjusted so that the shaft of the femur is parallel to 
the edge of the table. If these steps are followed correctly, femoral shaft on the DXA 
image will appear parallel to the edge of the image. Following visual assessment, each 
image was marked for abduction/adduction. It needs to be noted that the assessment 
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was subjective (an approach used previously when examining the effect of positioning 
errors on BMD measurements (McKiernan & Washington, 2005)) and could therefore be 
less accurate compared with a quantitative assessment of abduction/adduction. Each 
image was coded in Shape according to the positioning error (see Figure 2.3 and Figure 
2.4 for examples of incorrectly vs. correctly (Figure 2.5) positioned hips). The codes were 
as follows: 1a – slight abduction, 1b – severe abduction, 2a – slight adduction, 2b – 
severe adduction. All coded images were then excluded to check the impact on model 
performance and two SSMs were built. The first SSM was based on all DXA images (only 
excluding images with poor image quality or missing hip components as outlined in 
section 2.2.1.1 of this chapter). The second SSM excluded images as outlined above and 
all abducted and adducted hips regardless of the degree of rotation. Scores for the top 
ten HSMs from each model were cross-correlated. 
 
The proportion of images with positioning errors was 19% and 12% for images collected 
during TF 2 and TF 4 clinics, respectively (Table 2.6). Variance explained by the first ten 
HSMs (based on TF 4 data) in the model based on all images vs model based on 
exclusions was very similar, 83.6 vs 82.2% respectively (Table 2.7).  
 
 
Figure 2.3 Example of hip abduction on DXA images. Left hand side represents lower 




Figure 2.4 Example of hip adduction on DXA image. Left hand side represents lower 
degree of adduction. Right hand side represents higher degree of adduction 
 
  
Figure 2.5 Example of correctly positioned hip 
 
Table 2.8 shows cross-correlations between the top ten HSMs for SSM based on all 
images vs. SSM with exclusions. As demonstrated, correlations for the first eight HSMs 
were very high (correlation coefficient >= 0.95). HSM10 from the model based on all 
images correlated well with HSM9 based on model with exclusions. Correlations 
between HSM10 based on SSM with all images vs. HSM10 based on SSM with exclusions 
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was very weak (correlation coefficient = 0.36). It appears that the variation in HSM10 
based on SSM with exclusions is captured by both HSM9 and HSM10 based on SSM with 
all images included. It is worth noting that variance explained by the latter modes, from 
mode 9 onwards, is very small (less than 3%). These results are in-keeping with a 
previous study where the effect of rotation on hip shape measurement was assessed 
and the authors concluded that rotation not exceeding a few degrees had little impact 
on variation in hip shape measurement (Pavlova et al., 2017).  
Given the high concordance between HSM scores based on these two SSMs, only scans 
with anomalies (such as poor image quality or missing features from the image) were 
subsequently excluded when building SSMs. Consequently, the impact of subtle 
positioning errors was not assessed in mothers’ data. 
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Table 2.6; Number of hips with positioning errors 
* Number of images after excluding images of poor quality only (N= 218) 
 
Table 2.7; Percentage of hip shape variation at age 18 (TF 4) explained by the top 10 
HSMs in SSMs based on all images vs. SSM which excluded hips with positioning errors 
 SSM based on all images SSM with exclusions 
HSM % variance 
1 29.7 29.3 
2 16.5 16.5 
3 10.0 9.3 
4 7.3 7.4 
5 5.1 4.8 
6 3.8 4.2 
7 3.5 3.2 
8 3.0 2.7 
9 2.6 2.5 
10 2.2 2.4 
Total variance 83.6 82.2 
 
 Age 14  
(TF 2) 





% of total 
images* 
(N= 4,528) 
No. of images with slightly 
abducted hip (1a) 
331 7.4 206 4.5 
No. of images with severely 
abducted hip (1b) 
345 7.7 109 2.4 
No. of images with slightly 
adducted hip (2a) 
154 3.4 172 3.8 
No. of images with severely 
adducted hip (2b) 
39 0.9 44 0.9 
Total 869 19 531 11.7 
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Table 2.8; Cross-correlations between the top ten HSMs based on SSM built on all images vs. SSM built after excluding images with 
positioning errors 
 HSM1_ex HSM2_ex HSM3_ex HSM4_ex HSM5_ex HSM6_ex HSM7_ex HSM8_ex HSM9_ex HSM10_ex 
HSM1 1 -0.01 0 -0.01 0.01 0 0 0 0 0 
HSM2 0.02 1 0 0.02 0 0 0 0 0 0 
HSM3 0 0.01 -0.98 -0.21 0.04 0.03 -0.01 0 0.01 0 
HSM4 0.04 -0.04 -0.27 0.95 -0.1 -0.03 0.02 0 -0.01 0.01 
HSM5 -0.03 0 0.03 0.17 0.98 -0.02 0.01 -0.01 0.02 -0.03 
HSM6 -0.04 0.01 0.07 0.09 0.03 0.97 -0.07 -0.02 0.05 0.05 
HSM7 0 0.01 -0.01 -0.06 -0.01 0.11 0.99 -0.03 -0.07 0.02 
HSM8 0.01 0 -0.01 0.01 0.02 0.08 0.01 0.99 -0.09 -0.04 
HSM9 -0.04 0.02 0.02 0 0.01 -0.31 0.13 0.2 0.63 0.35 
HSM10 -0.01 0 -0.01 -0.04 0.08 -0.13 -0.05 0.01 -0.82 0.36 
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2.4.2. Repeatability and reproducibility of point placement 
Data from the TF4 (which I aligned in Shape first) was used to assess repeatability and 
reproducibility of point placement as part of the SSM method described above.  
From a total of 4,746 hip DXA scans collected during TF 4 clinic which were available in 
Shape, a set of 100 images were randomly selected and marked 2 months after 
completing the initial point placement. The same set of images was also marked by a 
second marker (DB). Intra- (within-) and inter-observer (between-observer) repeatability 
of manual point placement was measured as the difference in pixels between 
coordinates of 58 points using Matlab version R2015a. The intra- and inter-observer 
reliability assessed by mean point-to-point repeatability was 1.22 and 1.78 pixels, 
respectively. Compared with results from another study using High Bone Mass cohort 
based on radiographic images, the mean inter-observer reliability (images marked by AJ 
and DB) was 1.56 pixels. Given the higher resolution of X-ray images, the inter-rater 
error was comparable with our result (based on DXA images). A cut off median point-to-
point difference of less than or equal to 3 has previously been considered as accurate 
(Faber et al., 2017) .  
The mean intra-observer point-to-point repeatability values ranged from 0.61 to 2.18 
pixels (Figure 2.6). The highest values: 2.18, 1.97 and 1.65 were recorded for points 51, 
52 and 53 respectively, which are placed at the medial end of acetabular sourcil. The 
mean inter-observer repeatability values ranged from 0.96 to 2.92 pixels. Figure 2.7 
shows points with inter-observer repeatability scores higher than 2 pixels (points 0, 21, 
24 -27, 31, 32, 42 -46), of those majority were pseudo-landmarks which are placed 
between key landmark points.  
The above results are based on the 58-point model that was available at the beginning 
of my PhD. However, this was subsequently modified by the Aberdeen group to a 53-
point model due to high variability in points placed at the acetabular overhang (point 
57), and medial and lateral femoral shaft (points 0, 1, 44 and 45), which also scored high 
when assessing inter-observer repeatability for TF 4 images. My subsequent analyses 
were also based on this modified 53-point model.  
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Before alignment of the offspring data, I marked up a set of 100 hip images (not from 
ALSPAC cohort) to ensure that accuracy of point placement was maintained. Please note 
that subsequent repeatability and reproducibility of point placement was only 




Figure 2.6 Intra-observer repeatability assessed by mean point-to-point repeatability showing mean and median differences in pixels for 





Figure 2.7 Inter-observer repeatability assessed by mean point-to-point repeatability showing mean and median differences in pixels for 




2.4.3. SSMs in ALSPAC offspring  
Initially, I generated HSMs using the included data as its own reference which gives 
modes with mean = 0 and SD = 1. Similarly to previously published literature (Baird et 
al., 2018; Faber et al., 2017; Pavlova et al., 2017) the first 10 modes, which together 
explained 85% and 84% of variance at age 14 and 18 respectively, were selected. In 
addition, higher modes (>10) can often be regarded as noise as each subsequent mode 
explained less than 2% of variance at both time points.  
Figure 2.8 and Figure 2.9 show variation in hip shape described by the top ten HSMs 
based on images collected at age 14. 
Figure 2.10 and Figure 2.11 show variation in hip shape described by the top ten HSMs 















Figure 2.10 Variation in hip shape described by modes 1 - 5 at age 18 (SSM based on age 18 images) 
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Figure 2.11 Variation in hip shape described by modes 6 - 10 at age 18 (SSM based on age 18 images)  
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2.5. Applying external reference SSM to adolescent HSMs 
2.5.1. Building and applying scores from adult reference Statistical Shape Model 
One of the limitations of SSM is the lack of comparability of HSMs with other cohorts, 
since each SSM is unique to that particular set of images. This issue is relevant to my 
research where I intend to compare hip shape between adolescents of different ages, 
and adolescent hip shape to that of adults. One way of overcoming this limitation is to 
apply a set of pre-defined HSMs, previously obtained from a reference population. I 
decided to apply this approach, based on a reference set generated from a GWAS meta-
analysis of hip shape from five cohorts, derived from the same points template to that 
used to examine adolescent hip shape as part of my thesis. This included the ALSPAC 
mothers’ cohort (Fraser et al., 2013), Framingham (Hannan et al., 2000), Osteoporotic 
fractures in men study (MrOS) (Blank et al., 2005), the study of Osteoporotic Fractures 
(SOF) (Cummings et al., 1990) and Twins UK (Moayyeri et al., 2013; Spector & Williams, 
2006) resulting in a total of 19,379 images (Table 2.9). These were aligned in Shape and 
SSM was built as described previously, in section 2.3.3. Briefly, the reference model was 
built using PCA which allows any new image (set of points) to be used and (after 
Procrustes analysis) the eigen vectors can be used to calculate the mode scores for any 
model (without adding the new image to the reference model or changing it in any 
way). 
Table 2.9; Cohorts contributing to the adult reference Statistical Shape Model 
Cohort N Gender Mean age (SD) of 
participants 
ALSPAC mothers 4,603 Females 47.9 (4.3) 
Framingham 3,088 Males and females 63.3 (11.0) 
MrOS 5,924 Males 74.0 (6.0) 
SOF 1,715 Females  72.8 (4.6) 
Twins UK 4,049 Males and females 52.5 (13.5) 
Total 19,379   
Abbreviations: ALSPAC (Avon Longitudinal Study of Parents and Children), MrOS 
(Osteoporotic fractures in men study), SOF (Study of Osteoporotic Fractures). 
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2.5.2. Comparing adolescent HSM scores with HSM scores based on adult reference 
SSM 
In order to compare the current SSM based on adolescent images (included as its own 
reference) with the SSM after applying scores from the combined adult reference 
model, the first ten HSMs were cross-correlated and means and SDs were calculated.  
 Mean HSM scores 
Compared to mean = 0 and SD = 1 when using the data as its own reference, when using 
the combined adult reference, means for the first ten HSMs ranged from -1.14 to 2.26 at 
age 14 and from -1.5 to 2.42 at age 18, whereas SDs ranged from 0.42 to 0.97 at age 14 
and from 0.41 to 0.91 at age 18 (Table 2.10). When the adult reference SSM was applied 
to ALSPAC mothers’ images, means for modes 2-9 were close to 0 (ranging from -0.35 to 
0.34) and SDs were close to 1 (ranging from 0.8 to 1), whereas mean and SD HSM1 score 
were 1.45 and 0.5 respectively. These differences, in means and SDs, could be due to sex 
and/or age differences (i.e. mothers were on average 48 years old, therefore much 
closely resembling the ages of cohorts included in the reference model as opposed to 
ALSPAC offspring). The deviation away from the mean was particularly noted for HSM1, 
in the case of both ALSPAC offspring and mothers, which is likely to reflect scanner 
differences between ALSPAC and other cohorts in the adult reference set. Different pixel 
spacing in the Lunar Prodigy scanner (used to acquire DXA scans in ALSPAC) relative to 
other scanners alters the aspect ratio (ratio between image height and width) and 
therefore HSM1 reflects these differences. An attempt was made to correct for these 
differences; however some residual differences still remain. What is more, compared 
with the other modes, SD for HSM1 appears to be artefactually lowered as the 
contribution of scanner differences is excluded when looking at a single cohort. In 
addition, whilst using adult reference SSM is an added advantage, the source of data for 
limitations of positioning for DXA needs to be carefully considered. For example, to what 
extent the variation in lesser trochanter size and position represents anatomical 
variation as opposed to subject positioning during image acquisition, is currently 
unknown. Whilst in adolescents, rotation of lesser trochanter might reflect a tendency 
towards joint hypermobility, in older adults, particularly those with hip pain, the degree 
of hip rotation required for DXA positioning may be limited.   
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When using adolescent data as its own reference, the percentage of variance explained 
by the first ten HSMs was 85% and 84% at age 14 and 18, respectively and 81% in 
ALSPAC mothers (Table 2.11). The variance explained by the first ten modes in the adult 
reference model was 86%. It is important to note that one limitation of this approach is 
the fact that I was unable to calculate the exact variance explained in the adolescent 
and mothers’ data after applying the adult reference SSM (also discussed in Chapter 8, 
section 8.4).  
 Cross-correlations 
The majority of modes based on age 14 images correlated well with HSM scores based 
on the reference SSM (Table 2.12). For example, HSM1 scores based on the adolescent 
dataset correlated well with HSM2 scores based on the reference dataset. Variation in 
shape at age 14 described by the top ten modes is presented in Figure 2.8 and Figure 
2.9, and the variation in shape after applying the adult reference model at both time 
points is presented in Figure 2.12 and Figure 2.13. Although the modes do not directly 
correlate with each other (i.e. HSM1 does not strongly correlate with HSM1 based on 
adult reference SSM; HSM2 does not strongly correlate with HSM2 based on the adult 
reference set and so on), both HSM1 and HSM2 based on the reference SSM describe 
variation in the same aspects of hip shape, namely greater and lesser trochanters, FNW 
and femoral head size (especially in the inferior aspect proximal to lesser trochanter). 
Furthermore, HSM2 correlated well with HSM1 based on the reference SSM and both 
modes describe variation in femoral head (particularly at the superior aspect proximal to 
greater trochanter), greater and lesser trochanters and FNW. Table 2.14 shows the 
summary of key morphological features described by the top ten HSMs based on the 
combined adult reference model. 
At age 18, the majority of modes correlated well with the adult reference HSM scores, 
except modes 6 and 10 (Table 2.13). Variation in shape at age 18 described by the top 
ten modes is presented in Figure 2.10 and Figure 2.11, and Figure 2.12 and Figure 2.13 
show the variation in shape after applying adult reference model scores. In terms of 
correlations, HSM1 correlated well with HSM2 based on the reference SSM. HSM3 
(Figure 2.10) correlated with both HSM3 and HSM4 based on the reference SSM (Figure 
2.12); the common variation described by HSM3 and HSM4 based on the reference SSM 
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included variation in lesser trochanter and acetabular coverage, while the common 
variation between HSM3 and HSM4 based on the reference SSM was clearly related to 
superolateral aspect of femoral head.   
As expected, slight differences between the mean adolescent shape and adult shape 
were observed (i.e. particularly with regards to the shape of greater trochanter as it 
appeared more pointed in the children compared with adults, and the inferior lateral 
greater trochanter which was more pronounced in adults compared with adolescents). 
However, the majority of modes correlated well with HSM scores based on the adult 
reference SSM and the modes which correlated well with each other described variation 
in the same aspects of shape.  
In addition, when referring to mode scores based on adult reference SSM, the features 
described by each HSM are the same at both adolescent time points and in ALSPAC 
mothers (please refer to Supplementary Table 10.1.1 in Appendix 1 for detailed 
description of the variation described by the top ten HSMs based on the adult reference 
SSM). This is important particularly when comparing the influence of various exposures 
on specific aspects of shape across different time points. Therefore, HSM scores based 






Table 2.10; Mean HSM scores for the top ten HSMs based on ALSPAC adolescent and 
mothers’ images, after applying adult reference model (compared with mean=0 and 
SD=1 when data from each time point included as its own reference) 
 
Age 14 Age 18 Mothers 
HSM Mean (SD) Mean (SD) Mean (SD) 
1 2.26 (0.42) 2.42 (0.41) 1.45 (0.53) 
2 0.57 (0.76) 0.23 (0.85) -0.01 (0.90) 
3 -0.19 (0.68) 0.10 (0.66) -0.31 (0.92) 
4 0.87 (0.68) 0.36 (0.73) 0.32 (0.77) 
5 -1.14 (0.79) -1.50 (0.84) -0.35 (0.94) 
6 0.27 (0.68) 0.27 (0.86) -0.01 (1.00) 
7 -0.25 (0.63) 0.02 (0.70) -0.14 (0.87) 
8 0.39 (0.97) 0.02 (0.91) 0.06 (0.95) 
9 0.22 (0.76) -0.21 (0.91) 0.34 (0.95) 
10 -1.09 (0.59) -1.04 (0.77) 0.11 (0.92) 
 
Table 2.11; Percentage of variance explained by the first ten HSMs by different SSMs 
 
% variance explained 
HSM Age 14 Age 18 Mothers Adult reference SSM 
1 28.9 29.7 25.2 42.1 
2 19.1 16.5 15.5 13.4 
3 9.2 10.0 12.5 8.5 
4 7.1 7.3 6.8 6.1 
5 6.3 5.1 5.0 4.1 
6 5.9 3.8 4.7 3.4 
7 2.9 3.5 3.8 2.6 
8 2.4 3.0 3.2 2.5 
9 1.8 2.6 2.3 1.8 
10 1.8 2.2 1.8 1.5 
total 85.4 83.6 80.7 86.1 
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Table 2.12; Correlations between first ten HSMs at age 14 vs. the adult reference model  
 
HSM1_14 HSM2_14 HSM3_14 HSM4_14 HSM5_14 HSM6_14 HSM7_14 HSM8_14 HSM9_14 HSM10_14 
ref_HSM1_14 -0.62 -0.76 0.09 0.14 0.03 0.09 -0.03 0.01 0.02 0.02 
ref_HSM2_14 -0.85 0.43 -0.27 -0.01 -0.09 0.08 -0.10 0.03 0.00 0.00 
ref_HSM3_14 -0.50 0.46 0.50 0.22 0.48 -0.09 0.05 -0.07 0.01 -0.06 
ref_HSM4_14 -0.22 0.15 0.67 -0.43 -0.37 0.39 0.05 -0.03 0.01 -0.03 
ref_HSM5_14 -0.63 -0.20 0.06 -0.05 -0.34 -0.56 0.32 -0.02 -0.06 0.00 
ref_HSM6_14 0.11 0.25 -0.34 0.42 -0.02 0.45 0.60 0.12 0.14 -0.04 
ref_HSM7_14 -0.18 -0.09 0.20 -0.42 0.37 0.17 0.20 0.59 -0.25 0.18 
ref_HSM8_14 0.22 0.33 0.43 0.60 -0.47 -0.06 -0.15 0.19 0.00 0.04 
ref_HSM9_14 -0.26 0.36 0.09 -0.57 0.06 -0.42 0.07 0.21 0.25 0.12 
ref_HSM10_14 0.21 -0.02 -0.14 0.08 0.004 -0.15 -0.12 0.07 -0.70 0.08 




Table 2.13; Correlations between top ten HSMs at age 18 vs. the adult reference model 
 
HSM1_18 HSM2_18 HSM3_18 HSM4_18 HSM5_18 HSM6_18 HSM7_18 HSM8_18 HSM9_18 HSM10_18 
ref_HSM1_18 0.50 -0.85 -0.01 0.16 -0.04 -0.04 -0.02 0.07 -0.04 0.02 
ref_HSM2_18 0.89 0.38 0.20 0.13 -0.02 -0.04 -0.07 0.05 -0.01 0.02 
ref_HSM3_18 0.57 0.05 -0.65 0.13 0.36 0.22 0.03 -0.10 0.21 -0.03 
ref_HSM4_18 0.31 0.20 -0.77 -0.13 -0.29 -0.35 0.10 0.03 -0.16 0.00 
ref_HSM5_18 0.66 -0.26 0.18 -0.31 -0.33 0.28 0.32 -0.20 0.04 -0.11 
ref_HSM6_18 -0.33 0.24 0.12 0.73 -0.11 -0.04 0.49 0.05 -0.02 -0.07 
ref_HSM7_18 0.20 0.03 -0.27 -0.16 0.38 0.25 0.21 0.57 -0.35 -0.19 
ref_HSM8_18 -0.27 0.14 -0.37 0.27 -0.63 0.35 -0.33 0.12 0.09 -0.06 
ref_HSM9_18 0.33 0.29 0.07 -0.65 -0.08 0.19 0.24 0.27 -0.01 0.11 
ref_HSM10_18 -0.11 -0.03 0.14 0.07 0.07 0.38 -0.33 -0.06 -0.61 -0.36 
Abbreviations: HSM (Hip shape Mode), ref_HSM (standardized Hip Shape Mode, based on SSM to which scores from an adult reference 










Figure 2.13 Variation in hip shape at ages 14 and 18 described by modes 6 -10, based on adult reference SSM 
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Table 2.14; Summary of the key morphological features described by the top ten HSMs 
based on combined adult reference model 
HSM Variation described by each mode 
1 Femoral head (most pronounced in the medial aspect, also superolateral 
and inferolateral aspects), FNW, greater and lesser trochanters 
2 Femoral head (inferolateral and superior aspects), FNW, greater and lesser 
trochanters, neck-shaft angle 
3 Femoral head (inferolateral aspect, cam-type deformity), FNW, lesser 
trochanter 
4 Femoral head (superolateral and medial aspects), FNW, lesser trochanter 
5 Femoral head (inferolateral aspect), FNW, greater and lesser trochanters, 
femoral shaft width 
6 Femoral head (superior aspect), FNW  
7 Femoral head (medial and inferolateral aspect), femoral shaft width and 
lesser trochanter 
8 Femoral head (superior and medial aspects), FNW, greater and lesser 
trochanters, femoral shaft width 
9 Femoral head (superolateral and inferolateral aspects), lesser trochanter  
10 Lesser trochanter  
 Abbreviations: HSM (Hip shape Mode), FNW (femoral neck width) 
82 
 
2.5.3. Checking independence of standardized HSMs 
One of the potential issues that may arise after applying an external reference data set 
to another set of data is that previously independent HSMs might no longer be 
independent of each other. The greater the differences between the original data and 
the reference dataset, including different scanners used to acquire the data or 
differences in age between the cohorts, the greater the potential for modes not being 
independent of one another. To explore if this is likely to have an important impact on 
the results, I aimed to quantify the extent of this loss of independence. After applying 
SSM based on the combined adult reference model to adolescent data Matrix Spectral 
Decomposition was performed using the matSpD tool 
(https://gump.qimr.edu.au/general/daleN/matSpD/) to compute the number of 
independent modes.  
The top ten HSMs based on adult reference SSM at both time points were first 
correlated (Table 2.15 and Table 2.16) and tested for the number of independent 
variables (HSMs) using matSpD. The results showed close to ten (9.6) independent 
variables for both time points suggesting that the loss of independence is unlikely to 
materially affect the results. Therefore, given the advantages of using an external 
reference model (such as direct comparison between time points, as discussed 
previously in section 2.5.1), I decided to use the results generated for the top ten HSMs 
using the adult reference template, to use as outcomes throughout this thesis.  
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Table 2.15; Correlation matrix for the top ten standardized HSM scores at age 14 to assess the number of independent variables using 
matrix Spectral Decomposition (matSpD) which showed strong evidence for nearly all variables (9.6) to be independent 
 
HSM1 HSM2 HSM3 HSM4 HSM5 HSM6 HSM7 HSM8 HSM9 HSM10 
HSM1 1 0.1853 0.0371 0.0375 0.4698 -0.198 0.1578 -0.272 -0.2019 -0.1227 
HSM2 0.1853 1 0.4216 0.131 0.3872 0.0883 0.054 -0.118 0.3098 -0.1471 
HSM3 0.0371 0.4216 1 0.2081 0.1451 -0.0381 0.1772 0.144 0.2597 -0.1564 
HSM4 0.0375 0.131 0.2081 1 0.0924 -0.1778 0.248 0.1602 0.2208 -0.2277 
HSM5 0.4698 0.3872 0.1451 0.0924 1 -0.2271 0.0095 -0.0648 0.3164 -0.0647 
HSM6 -0.198 0.0883 -0.0381 -0.1778 -0.2271 1 -0.0972 0.1324 -0.2759 -0.0347 
HSM7 0.1578 0.054 0.1772 0.248 0.0095 -0.0972 1 -0.3302 0.2572 0.0019 
HSM8 -0.272 -0.118 0.144 0.1602 -0.0648 0.1324 -0.3302 1 -0.191 0.0862 
HSM9 -0.2019 0.3098 0.2597 0.2208 0.3164 -0.2759 0.2572 -0.191 1 -0.1126 
HSM10 -0.1227 -0.1471 -0.1564 -0.2277 -0.0647 -0.0347 0.0019 0.0862 -0.1126 1 
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Table 2.16; Correlation matrix for the top ten standardized HSM scores at age 18 to assess the number of independent variables using 
matrix Spectral Decomposition (matSpD) which showed strong evidence for nearly all variables (9.6) to be independent 
 
HSM1 HSM2 HSM3 HSM4 HSM5 HSM6 HSM7 HSM8 HSM9 HSM10 
HSM1 1 0.141 0.2264 -0.0047 0.4621 -0.2515 0.0537 -0.1779 -0.1618 -0.0226 
HSM2 0.141 1 0.3793 0.1983 0.4458 -0.1167 0.1083 -0.1985 0.3159 -0.0712 
HSM3 0.2264 0.3793 1 0.4535 0.1827 -0.1872 0.3169 -0.0169 0.0756 -0.1303 
HSM4 -0.0047 0.1983 0.4535 1 0.0864 -0.1524 0.1849 0.204 0.1695 -0.2213 
HSM5 0.4621 0.4458 0.1827 0.0864 1 -0.3191 0.0347 -0.1862 0.4001 -0.0575 
HSM6 -0.2515 -0.1167 -0.1872 -0.1524 -0.3191 1 -0.1257 0.1897 -0.3383 -0.0189 
HSM7 0.0537 0.1083 0.3169 0.1849 0.0347 -0.1257 1 -0.1477 0.2756 0.1138 
HSM8 -0.1779 -0.1985 -0.0169 0.204 -0.1862 0.1897 -0.1477 1 -0.1628 0.1194 
HSM9 -0.1618 0.3159 0.0756 0.1695 0.4001 -0.3383 0.2756 -0.1628 1 -0.0967 
HSM10 -0.0226 -0.0712 -0.1303 -0.2213 -0.0575 -0.0189 0.1138 0.1194 -0.0967 1 
       
85 
 
2.6. Statistical methods  
This section describes general statistical methods used in several chapters, more 
detailed methods description, where necessary, are included in relevant chapters. All 
analyses were carried out in Stata versions 14.0 and 15.0 (StataCorp, College Station, TX, 
USA), unless otherwise stated. 
2.6.1. Data checking and descriptive statistics 
Although ALSPAC data was cleaned and checked prior to data release, each variable was 
checked for plausibility, for example by checking minimum and maximum values, with 
any implausible values set to missing. Distributions of continuous variables were 
assessed by plotting histograms. Descriptive statistics are presented as means and SDs. 
Frequency statistics for categorical variables are presented as percentages.  
2.6.2. Regression analysis 
Observational associations between exposures of interest and the top ten HSMs were 
investigated using linear regression. As discussed below, adjustment for confounders 
was based on previous literature. For a variable to be a confounder it must be 
associated with the outcome and with the exposure, in addition it must not lie on the 
causal path from the exposure to outcome (Suttorp et al., 2014). While possible to 
assess statistically, these assumptions should be based on prior knowledge rather than 
the strength of statistical associations. Age, height, lean and fat mass were considered 
to be a priori confounders for analyses carried out in Chapters 3, 5 and 6, whereas 
analysis in Chapter 4 adjusted for fat mass index (FMI). Given the sex differences in hip 
shape described in Chapter 3, analyses in Chapters 4-6 were additionally adjusted for 
sex.  
Age is an important determinant of hip shape and a previous study describing femoral 
morphology in Spanish adolescents showed that the size and shape of the femur varied 
with age in both, males and females (Pujol et al., 2014; Pujol et al., 2016). Therefore, age 
was also adjusted for except in studies of puberty effects as described in Chapter 4. 
The role of mechanical loading in the developing skeleton is well-recognized (Frost, 
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1987; Moro et al., 1996) and body size, in particular higher body weight, is thought to 
increase the strain placed on the bone thus stimulating bone remodelling (Timpson et 
al., 2009). Previous studies showed that adjustment for height and weight partially 
explained differences in hip geometry in individuals over 20 years of age (Looker et al., 
2001), and higher BMI was associated with femoral morphology (as measured by alpha 
angle, head-neck offset, tilt angle, epiphyseal angle, and epiphyseal extension on CT 
images) in adolescents aged 15 +/- 1.95 years (Novais et al., 2018). While body size 
(weight and height) is thought to influence the development of the skeleton, the effects 
of body weight are more accurately explored by examining distinct influences of fat and 
lean mass (Ho-Pham et al., 2014) and previous studies reported that sex differences in 
hip geometry attenuated following adjustment for height, lean and fat mass (Forwood 
et al., 2004; Sayers et al., 2010).  
Previous studies suggest that fat mass or BMI affect the onset of puberty in males and 
females (Kaplowitz, 2008), therefore analyses in Chapter 4 adjusted for FMI 
(independent of height) (for more details please refer to Chapter 4, section 4.2.2.3).  
All analyses were restricted to individuals who had complete data on the outcome, 
exposure and covariates. Overall, children attending TF 2 and TF 4 clinics were more 
likely to be white and of female sex compared with those who did not attend (Table 2.17 
and Table 2.18). Please note that the number of individuals included in each of the 
analyses in the results chapters varies. This is due to sources of data available for each 
participant. For example, in Chapter 4, which looked at the relationship between age at 
peak height velocity (aPHV) and hip shape, fewer participants had complete data on the 
exposure as estimation of aPHV required repeated height measurements compared 
with i.e. BMD measurement which was assessed at a time of a DXA scan. Figure 2.14 
shows participants included in the ALSPAC study and numbers of participants which 
were included in the analyses in the results chapters.   




Table 2.17; A comparison of characteristics between adolescents who did and did not 
participate in the TF 2 assessment clinic 
 
1Chi-square test for categorical variables to assess the null hypothesis of no difference in 





 Table 2.18; A comparison of characteristics between adolescents who did and did not 
participate in the TF 4 assessment clinic 
 
 1Chi-square test for categorical variables to assess the null hypothesis of no difference 









Mean (SD) for continuous variables and prevalence 
n(%) for categorical variables 
Subjects with no data 
available N =  8,551 
Attended TF 2 clinic 
N =  6,133 
 
N N(%) N N(%) P-val1  
Child sex Male  8,551   4,525 (52.9) 6,133 3,011 (49.1) <0.001 









Mean (SD) for continuous variables and prevalence 
n(%) for categorical variables 
Subjects with no data 
available N =   9,469 
Attended TF 4 clinic 
N = 5,215 
 
N N(%) N N(%) P-val1  
Child sex Male  9,469 5,260 (55.6) 5,215 2,276 (43.6) <0.001 




Figure 2.14 Flow chart of participants included in the ALSPAC study and number of participants included in each analysis chapter
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2.6.3. Testing for interaction  
The likelihood-ratio test was used to test for interaction with sex (in Chapters 4 and 5) 
and if there was evidence of an interaction, the analysis was further stratified by sex. 
2.6.4. P value threshold 
A Bonferroni corrected p value threshold of 0.005 (0.05/10 outcomes) was applied to all 
cross-sectional results. 
2.6.5. Mendelian randomization (MR) analysis 
MR is an instrumental variable (IV) analysis which uses genetic variants to infer causality 
between a given exposure (X) and an outcome (Y), as illustrated in Figure 2.15 (Davey 
Smith & Ebrahim, 2003; Davey Smith & Hemani, 2014; Lawlor et al., 2008; Wehby et al., 
2008). The MR concept relies on the fact that genetic variants are randomly distributed 
in the population and are inherited independently of potential environmental 
confounders and other genetic variants. MR is often compared to randomized 
controlled trials where participants are divided into groups to which treatment is 
randomly allocated thus ensuring balanced distribution of known and unknown 
confounders between these groups which therefore limits the issues of confounding and 
reverse causality (Davey Smith & Hemani, 2014; Lawlor et al., 2008). In the MR setting, 
to be a valid IV, a genetic variant must satisfy the following assumptions:  
1) it must be associated with the exposure, 
2) it must not be associated with any confounders, and 
3) it must not directly influence the outcome, except through the exposure of 
interest. 
An exposure refers to any risk factor which can influence an outcome such as a 
biomarker, an anthropometric measure or any other risk factor, whereas the outcome is 
most commonly disease (Burgess & Thompson, 2015; Davey Smith & Ebrahim, 2003). 
MR is most commonly used to assess a causal effect of a modifiable exposure on an 
outcome and thus inform disease prevention strategies. In cases where IV assumptions 
are not plausible, a MR framework can be used to test if similar causal mechanisms 
underlie two different traits (as described previously by Burgess et al. (Burgess et al., 
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2016a)). In this thesis, MR analysis was used in the latter context, i.e. to investigate the 
extent to which BMD and hip shape share genetic influences. One-sample MR (whereby 
data on exposure, outcome and the genetic instrument all come from one sample (D. M. 
Evans & Davey Smith, 2015)) was used in ALSPAC offspring (Chapter 5) and a two-
sample MR approach (which relies on summary statistics data from two independent, 
and often publicly available, GWASes (D. M. Evans & Davey Smith, 2015)) was used in 
ALSPAC mothers (Chapter 6).  
Conventionally, MR uses instruments constructed from SNPs reaching genome-wide 
significance. Given that for many complex traits, the heritability (defined as the 
proportion of variance in a trait explained by the genetic variation (Mayhew & Meyre, 
2017)) is distributed across many variants with small effects, utilising information on all 
SNPs (including those not reaching genome-wide significance) can also be used to 
explore shared genetic basis of complex traits (B. Bulik-Sullivan et al., 2015). For 
example, LD score regression, can be used for the estimation of SNP-based heritability 
and genetic correlation between different phenotypes (Visscher et al., 2017; Zheng et 
al., 2017). However, methods to estimate SNP-based heritability require larger sample 
size (B. Bulik-Sullivan et al., 2015) compared with methods which utilise individual level 
data (as in one-sample MR). 
 
 




2.6.6. Composite hip shape figures  
After association analysis, in order to illustrate the overall effect of a particular exposure 
on hip shape, composite HSM figures were plotted to represent an overall contribution 
to hip shape variation by all modes showing evidence of an association with that 
exposure. As summarised in Table 2.14, the first nine modes all describe variation in the 
shape of the femoral head (Figure 2.12 and Figure 2.13) (although different aspects of 
femoral head such as superolateral, inferomedial or superior) coupled with variation in 
either greater and lesser trochanters and/or FNW. For factors like age, which affects 
multiple HSMs, interpretation of the results can be challenging. Therefore, I aimed to 
model the overall effect on hip shape by combining all modes associated with a given 
exposure. This was achieved by simultaneously entering coefficients from the linear 
regression analysis into Shape software, for all modes showing evidence for an 
association with that exposure, thus combining the effect of a single exposure across hip 
shape components.  
In order to aid visualisation of the overall effect on hip shape, all coefficients entered 
into Shape were multiplied by a factor of 2 (as in Chapter 3), or where necessary due to 
small effect sizes, by a factor of 10 (Chapter 5 and Chapter 6). Figure 2.16 shows 









CHAPTER 3.  AGE AND SEX 
DIFFERENCES IN HIP SHAPE  
 
3.1. Introduction and chapter aims   
In general, the incidence of hand, hip and knee OA is higher in women compared with 
men, especially after the age of 50 years (Litwic et al., 2013; Prieto-Alhambra et al., 
2014). One explanation for this could be due to varying levels of hormones, in particular 
the rapid decrease of oestrogen around the time of menopause in women (Nevitt et al., 
1996; Wluka et al., 2000). Another explanation for the differences in OA incidence might 
be due to differences in anatomical features including those present earlier in life. For 
example, one study, investigating joint space changes according to age and sex in 
asymptomatic hip joints (free from pain), found that minimum hip joint space is smaller 
in women compared with men (Lanyon et al., 2003). As described in the introduction 
chapter, as well as being risk factors for OA, age and gender are also related to hip 
fracture. It has been estimated that almost one in two women and one in five men over 
the age of 50 years are at risk of fracture (Curtis et al., 2016). Previous research has 
indicated that variation in hip morphology established early in life, including hip 
geometrical indices, could account for these differences (Hind et al., 2012; F. Zhang et 
al., 2010).  
Previous studies suggest that sexual dimorphism in hip geometry emerge around the 
time of puberty (Sayers et al., 2010). However, certain limitations when investigating 
relationships with individual geometrical measurements must be considered, such as 
high correlations with other geometrical indices and body size measurements (Gregory 
& Aspden, 2008). Therefore, in this chapter, I will characterise sex differences in hip 
shape, quantified by SSM, in peri-pubertal children and adolescents from the ALSPAC 
cohort, including whether any differences observed are independent of those in body 
size.  
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The aims of this chapter are  
(i) To examine differences in hip shape between age 14 and 18 
(ii) To explore sex differences in hip shape at ages 14 and 18 
(iii) To determine whether sex differences at age 14 and 18 are explained by 




Data were obtained from TF 2 and TF 4 clinics when the participants were on average 14 
and 18 years old, respectively. The study population for the current analyses comprised 
individuals with complete outcome and covariate data from each assessment clinic. For 
more details regarding data collection and cleaning, please refer to the methods chapter 
(Chapter 2).  
3.2.2. Measures  
3.2.2.1. Outcome 
To quantify the shape of proximal femur, DXA images collected at TF 2 and TF 4 clinics 
were used. Images were analysed in Shape and to allow comparison between the time 
points, scores from a consistent external adult reference SSM were applied to each data 
set (see Chapter 2 for details). The first ten HSMs were used as outcomes.  
3.2.2.2. Exposure and covariate data 
Age was calculated as the difference between the date of clinic attendance and date of 
birth. Sex was available from hospital records. As previously described in Chapter 2, 
section 2.6.2, age, height, lean and fat mass, were considered as potential confounders.   
3.2.3. Statistical analysis  
The differences in mean HSM scores between age 14 and 18 were assessed by paired t-
test (results expressed as mean difference in HSM scores (SD)). Linear regression was 
used to explore sex differences in the top ten HSMs at each time point. The differences 
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in mean HSM scores between males and females were explored in unadjusted analysis 
(model 1), and in adjusted analysis controlling for age at clinic attendance, height, lean 
and fat mass (model 2).  
I hypothesised that age and body size might confound the relationship between sex and 
hip shape, hence univariate associations between each confounder and the top ten 
HSMs were also explored.  
To illustrate the overall sex differences in hip shape at each time point, coefficients from 
linear regression were simultaneously entered into Shape software, for all modes 
showing evidence for sex differences (p<0.005). 
 
3.3. Results 
3.3.1.  Participant characteristics  
Of 11,351 children invited to the TF 2 clinic, 6,147 attended, and of those 4,428 had 
complete data on outcome and covariates. Participant recruitment has been described 
previously (Chapter 2, section 2.2.1.1). Table 3.1 shows the characteristics of TF 2 
participants. Their mean (SD) age was 13.8 (0.2) years. Boys were taller and had more 
lean mass compared with girls, whereas girls had higher fat mass compared with boys.   
 
A total of 10,101 individuals were invited to the TF 4 clinic, of whom 5,217 attended and 
of those 4,369 individuals had complete data on outcome and covariates. Table 3.1 
shows participant characteristics. Mean (SD) age at clinic attendance was 17.8 (0.4) 
years, and similarly to TF 2 boys were taller and had more lean mass, while girls had 
more fat mass compared with boys. 
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Table 3.1; Characteristics of participants who attended TF 2 and TF 4 assessment clinics 
 
 Age 14 Age 18 
  
N Mean (SD) p for sex diff* N Mean (SD) p for sex diff* 
Age Combined 4,428 13.8 (0.2) 0.36 4,369 17.8 (0.4) 0.59 
 
Male 2,117 13.8 (0.2) 
 
1,931 17.8 (0.4) 
 
 
Female 2,311 13.8 (0.2) 
 
2,438 17.8 (0.4) 
 
Height (cm) Combined 4,428 163.4 (7.6) <0.0001 4,369 171.2 (9.2) <0.0001 
 
Male 2,117 165.0 (8.7) 
 
1,931 178.7 (6.6) 
 
 
Female 2,311 162.0 (6.2) 
 
2,438 165.2 (6.2) 
 
Fat mass (kg) Combined 4,428 13.9 (8.0) <0.0001 4,369 18.4 (10.5) <0.0001 
 
Male 2,117 11.2 (7.7) 
 
1,931 14.1 (10.0) 
 
 
Female 2,311 16.4 (7.5) 
 
2,438 21.8 (9.6) 
 
Lean mass (kg) Combined 4,428 38.0 (6.4) <0.0001 4,369 45.7 (9.9) <0.0001 
 
Male 2,117 41.0 (7.2) 
 
1,931 55.2 (6.1) 
 
 
Female 2,311 35.2 (4.0) 
 
2,438 38.1 (4.3) 
 
*Unpaired t-test to assess the null hypothesis of no difference in distributions between males and females at each time point
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3.3.2. Differences in hip shape between age 14 and 18 
A total of 3,188 individuals had complete outcome data available for both time points. 
In gender combined analysis, all HSMs, except HSM6, showed differences in mean HSMs 
scores between age 14 and 18 (Table 3.2). Whereas in sex stratified analysis, the results 
showed strong evidence for differences in mean HSM scores between the time points 
for all modes tested, with slightly weaker evidence for HSM10 (Table 3.3). In males, the 
largest difference was seen for HSM2, HSM5, HSM8 and HSM9 (with mean differences 
in mode scores ranging between 0.57 – 0.67 SDs between age 14 and 18). In females, 
the largest difference was seen for HSM4 scores, with a decrease of 0.55 SDs between 
the time points. The direction of change in HSM scores was consistent in both sexes, 
except for HSM6 which increased with age in males (representing narrower FNW and 
smaller femoral head) but decreased in females (representing wider FNW and larger 
femoral head). As highlighted in the methods chapter (section 2.5.2, Table 2.14), the 
first nine modes all reflect variation in femoral head (with each mode describing 
variation in different aspects of femoral head) along with a combination of either 
variation in greater and lesser trochanters, femoral shaft or changes in FNW which 
makes interpretation of these results challenging given the number of modes affected.
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Table 3.2; Differences in mean HSM scores, between age 14 and 18, for the top ten 
HSMs based on adolescent images, after applying the combined adult reference model 
(N= 3,188) 
 AGE 14 Age 18 AGE 18 – AGE 14 
 
Mode  
(% of variation) 
Mean (SD) Mean (SD) Mean diff. (SD) *P 
1 (42%) 2.26 (0.41) 2.41 (0.42) 0.15 (0.27) < 0.001 
2 (13%) 0.58 (0.75) 0.24 (0.84) -0.34 (0.57) < 0.001 
3 (8.5%) -0.22 (0.69) 0.10 (0.65) 0.32 (0.74) < 0.001 
4 (6.1%) 0.87 (0.68) 0.36 (0.72) -0.52 (0.66) < 0.001 
5 (4.1%) -1.14 (0.79) -1.50 (0.85) -0.36 (0.72) < 0.001 
6 (3.4%) 0.25 (0.67) 0.26 (0.86) 0.01 (0.80) 0.533 
7 (2.6%) -0.25 (0.62) 0.03 (0.69) 0.28 (0.65) < 0.001 
8 (2.5%) 0.36 (0.96) 0.00 (0.91) -0.35 (0.89) < 0.001 
9 (1.8%) 0.23 (0.77) -0.21 (0.90) -0.44 (0.88) < 0.001 
10 (1.5%) -1.09 (0.58) -1.04 (0.78) 0.06 (0.82) < 0.001 
Total = 85.5%     
*Paired t-test to assess the null hypothesis of no difference in mean HSM scores 




Table 3.3; Differences in mean HSM scores between age 14 and age 18 after applying the combined adult reference model, stratified by 
sex 
 
Males N = 1,426 Females N=1,762 
 
Age 14 Age 18 Age 18 – Age 14 
 
Age 14 Age 18 Age 18 – Age 14 
 
HSM Mean (SD) Mean (SD) Mean diff (SD) *p Mean (SD) Mean (SD) Mean diff (SD) *p 
1 2.20 (0.43) 2.40 (0.44) 0.21 (0.28) 6.15x10-136 2.32 (0.39) 2.42 (0.40) 0.10 (0.25) 6.74x10-60 
2 0.55 (0.76) -0.02 (0.78) -0.57 (0.57) 2.77x10-220 0.60 (0.75) 0.46 (0.83) -0.14 (0.50) 1.64x10-32 
3 -0.12 (0.70) 0.02 (0.64) 0.14 (0.75) 1.14x10-11 -0.30 (0.67) 0.16 (0.66) 0.46 (0.69) 5.06x10-145 
4 0.74 (0.69) 0.27 (0.71) -0.47 (0.68) 1.71x10-122 0.98 (0.65) 0.43 (0.73) -0.55 (0.65) 5.04x10-212 
5 -1.05 (0.80) -1.72 (0.77) -0.67 (0.69) 2.05x10-206 -1.21 (0.78) -1.33 (0.87) -0.12 (0.65) 1.89x10-14 
6 0.33 (0.71) 0.60 (0.84) 0.27 (0.78) 8.1x10-37 0.19 (0.62) -0.01 (0.77) -0.20 (0.75) 4.86x10-28 
7 -0.34 (0.61) 0.02 (0.64) 0.36 (0.66) 4.71x10-83 -0.18 (0.62) 0.03 (0.73) 0.21 (0.64) 1.69x10-41 
8 0.73 (0.94) 0.13 (0.92) -0.60 (0.98) 5.49x10-100 0.05 (0.86) -0.10 (0.88) -0.15 (0.76) 4.29x10-17 
9 0.16 (0.76) -0.48 (0.76) -0.64 (0.84) 2.09x10-145 0.29 (0.77) 0.02 (0.94) -0.27 (0.89) 5.61x10-36 
10 -1.08 (0.58) -1.01 (0.77) 0.07 (0.83) 0.001 -1.10 (0.57) -1.06 (0.79) 0.05 (0.81) 0.015 





3.3.3. Univariate associations between confounders and hip shape 
Supplementary Table 10.2.1 in Appendix 2 shows associations between age at clinic 
attendance and the top ten HSMs at both time points. At age 14, there was strong 
evidence for associations between age and HSM1 and HSM8, and weaker evidence for 
associations with HSM3, HSM6 and HSM7. At age 18, there was strong evidence for an 
association with HSM6 and no evidence to suggest associations with other modes.  
Supplementary Table 10.2.2 in Appendix 2 shows associations between height and the 
top ten HSMs. At age 14, there was strong evidence for associations with all modes 
except HSM6. Whereas, by age 18 there was evidence for associations with HSM2, 
HSM4, HSM5, HSM6 and HSM9, with consistent direction of effect across the time 
points.  
There was strong evidence for an association between lean mass and hip shape with the 
majority of modes, except for little evidence of an association with HSM7 at age 14, and 
HSM1 at age 18. The direction of effect was consistent across the time points, apart 
from mode 8 which was positively related to lean mass at age 14 and negatively at age 
18 (Supplementary Table 10.2.3 in Appendix 2). 
Finally, fat mass was associated with most modes across the time points, other than 
little evidence for associations with HSM5, HSM7 and HSM9 at age 14 and HSM4 at age 
18. The direction of effect was consistent across time points (Supplementary Table 
10.2.4 in Appendix 2).  
3.3.4. Sex differences in hip shape 
 Age 14 
In unadjusted analysis, all modes, except HSM10, showed some evidence for sex 
differences (Table 3.4). Following adjustment for age, height, lean and fat mass 
associations with HSM4 and HSM7 remained unchanged, HSM2 and HSM6 results were 
attenuated towards the null (and there was no longer evidence of an association), while 
several associations (HSM1, HSM3, HSM5 and HSM8) were strengthened. Interestingly, 
in unadjusted analysis the difference between mean male and female HSM9 scores was 
0.12 (positive coefficient indicating higher mean score in females compared with males). 
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Following adjustment for age and body size (model 2), the difference in mean HSM9 
score switched to negative (mean score in females being now lower than that in males) 
(Table 3.4).  
The proportion of variance explained in HSMs by sex alone ranged from <0.5 – 14%, 
while the variance in HSMs predicted from sex, age, height, lean and fat mass ranged 
from 3 – 22%, with the largest variance accounted for in HSM8 (R2= 0.22, models 2 and 
3).  
The combined effect of sex on hip shape at age 14 is shown in Figure 3.1. In the 
unadjusted model, females had smaller femoral heads (in the superolateral and 
inferomedial aspects) and lesser trochanter compared with males. In addition, 
differences in femoral neck length and greater trochanter size were also observed. After 
controlling for age and body size differences in femoral head size became more 
pronounced (smaller femoral head in females in the superolateral and inferomedial 
aspects), while the differences in the size of lesser trochanter were less marked. 
Moreover, the difference in femoral neck length and greater trochanter size also 
became more pronounced.  
 
 Age 18 
In unadjusted analysis, there was strong evidence for sex differences in all modes except 
HSM1 and HSM7 (Table 3.5). Following adjustment for age, height, lean and fat mass 
(model 2) associations of sex with HSM2, HSM5, HSM6 and HSM9 were partially 
attenuated, while the association with HSM10 was strengthened. Adjustment for age 
and body size had little or no impact on HSM3, HSM4 and HSM8 results.  
Compared with age 14 results, sex along with other covariates explained less variance in 
hip shape. Sex alone explained between <1 -12% of variance and the addition of further 
predictors slightly increased the strength of the association which ranged between <1-
13% (model 2). The highest proportion of variance in hip shape explained by sex along 
with the predictors was observed for HSM2 (R2=0.13) and HSM6 (R2=13).  
The combined effect of sex on hip shape at age 18 is shown in Figure 3.2. In unadjusted 
model, females had narrower FNW, smaller lesser trochanters and wider femoral shafts. 
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In addition, the medial part of the femoral head appeared larger in females compared 
with males. Following adjustment for age and body size, differences in the femoral head 
and femoral shaft were considerably attenuated, whilst smaller lesser trochanters and 
slightly narrower FNW in females were still present.   
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Table 3.4; Differences in hip shape mode scores between males and females (age 14) 
 
Model 1 Model 2 
HSM β (95% CI) p R2 β (95% CI) p R2 
1 0.13 (0.11,0.15) 3.7x10-25 0.02 0.19 (0.16,0.22) 1.1x10-32 0.05 
2 0.06 (0.01,0.10) 0.013 1.4 x10-3 -0.04 (-0.09,0.02) 0.163 0.09 
3 -0.19 (-0.23,-0.15) 1.7x10-21 0.02 -0.35 (-0.40,-0.30) 5.6x10-46 0.11 
4 0.22 (0.18,0.26) 4.8x10-28 0.03 0.18 (0.13,0.23) 1.1x10-12 0.03 
5 -0.18 (-0.23,-0.14) 6.1x10-15 0.01 -0.34 (-0.39,-0.28) 4.5x10-30 0.06 
6 -0.14 (-0.18,-0.10) 9.8x10-12 0.01 -0.03 (-0.08,0.02) 0.210 0.03 
7 0.18 (0.15,0.22) 3.3x10-22 0.02 0.23 (0.19,0.28) 2.2x10-23 0.05 
8 -0.73 (-0.78,-0.67) 7.2x10-148 0.14 -0.87 (-0.93,-0.80) 2.3x10-145 0.22 
9 0.12 (0.08,0.17) 1.5x10-7 0.01 -0.08 (-0.14,-0.03) 0.004 0.05 
10 -0.01 (-0.04,0.03) 0.737 2.6 x10-5 -0.02 (-0.06,0.03) 0.478 0.03 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows mean difference in HSM scores between males and females 
(N=4,428) and 95% CIs, p value and r squared (R2). Positive beta coefficients indicate higher mean HSM scores in females, compared with 
males. Model 1: unadjusted, model 2: adjusted for age, height, lean and fat mass. 
104 
 
Table 3.5; Differences in hip shape mode scores between males and females (age 18) 
 
Model 1 Model 2 
HSM β (95% CI) p R2 β (95% CI) p R2 
1 0.02 (-0.003,0.05) 0.084 0.001 0.09 (0.03,0.14) 0.001 0.005 
2 0.48 (0.43,0.52) 1.4x10-78 0.08 0.41 (0.31,0.51) 3.8x10-16 0.13 
3 0.13 (0.09,0.17) 5.1x10-11 0.01 0.17 (0.09,0.25) 4.6x10-5 0.05 
4 0.15 (0.11,0.20) 5.1x10-12 0.01 0.19 (0.10,0.28) 5.7x10-5 0.01 
5 0.39 (0.34,0.44) 5.7x10-53 0.05 0.29 (0.19,0.39) 3.4x10-8 0.06 
6 -0.60 (-0.65,-0.55) 6.9x10-124 0.12 -0.53 (-0.63,-0.43) 1.2x10-24 0.13 
7 0.003 (-0.04,0.04) 0.872 0 -0.09 (-0.18,-0.01) 0.036 0.04 
8 -0.25 (-0.31,-0.20) 7.4x10-20 0.02 -0.31 (-0.42,-0.20) 4.5x10-8 0.05 
9 0.49 (0.43,0.54) 2.0x10-72 0.07 0.33 (0.22,0.44) 4.8x10-9 0.08 
10 -0.07 (-0.11,-0.02) 0.004 0.002 -0.16 (-0.25,-0.06) 0.001 0.06 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows mean 
difference in HSM scores between males and females (N=4,369) and 95% CIs, p value 
and r squared (R2). Positive beta coefficients indicate higher mean HSM scores in 
females, compared with males. Model 1: unadjusted, model 2: adjusted for age, height, 






Figure 3.1 Sex differences in hip shape at age 14 based on the difference in mean HSM scores. Sex beta coefficients (for all modes with 




Figure 3.2 Sex differences in hip shape at age 18 based on the difference in mean HSM scores. Sex beta coefficients (for all modes with 
p<0.005) magnified 4-fold were modelled in Shape to represent the average overall hip shape between males and females. 
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3.4. Discussion  
In this chapter, I examined age and sex differences in hip shape in a cohort of ALSPAC 
adolescents. In gender stratified analysis, there was strong evidence for differences in 
mean HSM scores between age 14 and 18 for several HSMs with consistent effects 
observed across sexes, except HSM6 (which reflects variation in femoral head size and 
FNW) which increased with age in boys but decreased with age in girls. It needs to be 
noted that the observed differences are unlikely to represent longitudinal change at the 
individual patient level. Previous evidence suggests that skeletal maturation is related to 
changes in hip morphology and the following chapter will further explore the effect of 
the pubertal growth marker of tempo on hip shape.  
Having described the differences in HSM scores between age 14 and 18, I went on to 
explore sex differences at each time point. Several modes showed evidence for sex 
differences. Previous studies revealed sex differences in various aspects of hip 
morphology, including greater FNW (Sayers et al., 2010) and hip joint space in boys 
(Wegener et al., 2017). However, it has been suggested that sexual dimorphism in hip 
morphology can be largely explained by the differences in body size, due to high 
correlations between hip geometric indices and those of body size (Arsuaga & Carretero, 
1994). Employing SSM enables identification of independent hip shape components 
which can be related to either exposures of interest or relevant disease outcomes.  
At age 14, the majority of modes showed strong evidence for sex differences. Of the 
modes which were associated with sex following age and body size adjustment, the 
majority represent variation in femoral head along with other morphological features of 
the hip. As highlighted previously (Chapter 2, section 2.6.6), this is challenging to 
interpret, and therefore the combined effect of sex on hip shape was modelled. As 
expected, females had smaller femoral head and lesser trochanter compared with 
males. In addition, differences in femoral neck length and greater trochanter were also 
observed. Following adjustment for age and body size these differences became more 
pronounced, indicating that age and body size may confound these associations.  
At age 18, several associations between sex and HSMs were also observed and the 
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majority of these were attenuated following adjustment for age and body size. What is 
more, the combined effect of sex on hip shape was mainly reflected by narrower FNW, 
smaller lesser trochanter, wider femoral shaft and larger femoral head in the medial 
aspect in females compared with males. Most of these differences attenuated following 
adjustment for age and body size, however differences in FNW and lesser trochanter 
remained.  
This is the first time SSM has been applied to describe variation in hip shape in a cohort 
of adolescents. One previous cross-sectional study in adults from the Medical Research 
Council (MRC) National Survey of Health and Development (NSHD) (mean age 63 years), 
which also used SSM, reported sex differences in hip shape in older adults (Pavlova et 
al., 2017). Consistent with the findings at age 18, men in the NSHD cohort had greater 
FNW compared with women. The authors also observed flattening of femoral head and 
greater acetabular coverage in women, a finding which was not observed in this study. 
Both increased acetabular coverage (Harris-Hayes & Royer, 2011) and flattening of 
femoral head (Doherty et al., 2008) have been previously found to be risk factors for OA. 
Given the average age of study participants it is likely that some of the shape features 
identified in the NSHD cohort might be the result of OA associated changes.  
The relationship between FNW with hip OA and fracture have been investigated 
previously. In a previous prospective population-based study investigating the role of 
hip geometry in prediction of RHOA, a wider femoral neck was associated with higher 
risk of incident hip OA (Castaño‐Betancourt et al., 2013b). In terms of the associations 
with hip fracture, the evidence is conflicting. While some studies reported associations 
between wider neck and hip fracture in males and females (Alonso et al., 2000; Karlsson 
et al., 1996), others reported the opposite in men (Ego Seeman et al., 2001) and women 
(Ahlborg et al., 2005). Others yet, found that the association between femoral neck 
diameter and trochanteric hip fracture fully attenuated following adjustment for age, 
height, weight and BMD (Duboeuf et al., 1997).  
The relationship between femoral head morphology and hip OA has been widely 
investigated (Baker-LePain & Lane, 2010). For example, pistol grip deformity (Doherty et 
al., 2008) as well as cam-type deformities (Heijboer et al., 2012) are both well-
established risk factors for hip OA. In this study, sex differences in hip shape observed at 
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age 14, amongst other features, reflect variation in femoral head size. Interestingly boys 
had a larger femoral head in the superolateral and inferomedial aspects, which may 
contribute to risk of hip OA in later life. For example, a previous study investigating 
radiographic patterns of OA in older men and women (mean age 66 years) found clear 
associations of male gender with superolateral osteoarthritis while females showed a 
tendency to more medial patterns (Ledingham et al., 1992).  
Standardization of HSM scores, by applying adult reference SSM, allows comparison 
between time points and will enable future comparisons with other cohorts. Although 
sex differences observed here were relatively small, SSM enables global assessment of 
hip morphology and might be more sensitive at picking up subtle anatomical variations, 
compared with more traditional approaches.  
 Conclusions  
In summary, several aspects of hip shape were related to age and sex. In terms of sex 
differences assessed at age 14, these mainly comprised of smaller femoral head and 
lesser trochanter in females and variation in femoral neck length and greater trochanter 
and these differences became more pronounced after adjustment for age and body size. 
At age 18, the differences in femoral head and femoral shaft were explained by those in 
body size, while differences including narrower FNW and lesser trochanter in females 
compared with males remained. These results demonstrate that sex differences in 
several components of hip shape can be discerned in childhood and adolescence. These 
are largely independent of sex differences in body size and could play a yet 
unrecognized role in predisposing to hip OA or fracture in later life.  
 
In this chapter I found evidence for differences in mean HSM scores between age 14 and 
18 years and sex differences in hip shape at both time points, however to what extent 
these differences could be explained by other factors, such as timing of pubertal growth 
will be explored in Chapter 4. In addition, having observed age and sex differences in hip 
shape, analyses in subsequent chapters will be adjusted for age and sex along with other 




CHAPTER 4.  INFLUENCE OF 
PUBERTAL GROWTH ON HIP 
SHAPE  
 
4.1. Introduction and chapter aims  
This chapter builds on the previous chapter which examined age and sex differences in 
hip shape. Having found differences in hip shape between age 14 and 18, this chapter 
will explore the relationship between pubertal timing and hip shape.  
Puberty is described as a period of rapid growth and is thought to be a critical period for 
bone development (Kuh et al., 2016; Q. Wang et al., 2015). Furthermore, the timing of 
puberty has been linked to a number of important health outcomes later in life (Day et 
al., 2015). For example, in the UK Biobank study, early menarche was associated with an 
increased risk of OA and reduced risk of OP (Day et al., 2015). On the other hand, in the 
MRC NSHD cohort later puberty was associated with lower aBMD at the hip and spine in 
men and women, which in turn confers the risk of fracture (Kuh et al., 2016). However, 
the exact mechanisms contributing to the risk of OA and OP in later life are not fully 
understood. While the relationship between hip shape and risk of hip fracture and OA 
are well-established, factors influencing hip shape including critical periods for shape 
development remain to be elucidated. Previous studies suggest that sex differences in 
bone geometry emerge around the time of puberty (Sayers et al., 2010). However, it is 
unclear whether other aspects of hip structure, including hip shape, are also related to 
puberty. 
 Pubertal assessment  
One of the hallmarks of puberty onset is a rapid growth spurt accompanied by the 
development of secondary sexual characteristics (Rogol et al., 2002). Various methods 
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to assess an individuals’ pubertal status exist and these include recalled age at 
menarche or age at voice breaking, Tanner staging assessment (most commonly 
assessed via questionnaire), age at take-off or aPHV (J. Baird et al., 2017; Dhiman et al., 
2015; Sherar et al., 2010). Due to its complexity, puberty assessment is challenging, and 
the assessment methods suffer from a number of limitations. While age at menarche or 
age at voice breaking are easy and relatively cheap to assess they are prone to recall 
bias (Kindblom et al., 2006). The agreement between self-reported vs. clinically assessed 
Tanner stage can range from as little as 43% to 81% (J. Baird et al., 2017). Age at take-off 
(indicating the start of pubertal growth spurt (Di Giovanni et al., 2017)) and aPHV 
provide objective assessment of pubertal timing, and are free from recall bias, but 
require frequent height measurements. An added advantage of using aPHV is that it 
enables alignment of individuals on the same developmental scale (Kuh et al., 2016) 
which is important when comparing pubertal effects between males and females 
(Bundak et al., 2007; Demirjian et al., 1985; Dhiman et al., 2015; Granados et al., 2015). 
Given the limitations of conventional methods and high frequency of height 
measurements available in ALSPAC, height tempo (which corresponds to aPHV)  was 
estimated, in order to explore the relationship between puberty and hip shape. The aim 
of this chapter was: 
i)  to examine the relationship between pubertal timing (using measures of height 
tempo) and hip shape at age 14 and 18 in ALSPAC cohort   
 
4.2. Methods 
4.2.1. Subjects  
Data were obtained from ALSPAC TF 2 and TF 4 clinics when the participants were on 
average 14 and 18 years old, respectively. The study population for current analyses 
comprised individuals with complete outcome and covariate data from each assessment 
clinic. Details regarding data collection have been described in more detail in Chapter 2.  
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4.2.2. Measures  
4.2.2.1. Outcome  
To quantify the shape of proximal femur, DXA images collected at TF 2 and TF 4 clinics 
were used. Images were analysed in Shape and to allow comparison between the time 
points scores from a consistent external adult reference SSM were applied to each data 
set (see Chapter 2 for details). Top ten HSMs were used as outcomes, for details see 
Chapter 2. 
4.2.2.2. Exposures 
 Growth tempo (equivalent to age at peak height velocity)  
Age at peak height velocity (aPHV) was estimated using SuperImposition by Translation 
and Rotation (SITAR) mixed effects growth curve analysis. This is a shape-invariant 
growth curve model consisting of a mean growth curve along with three 
transformations (size, tempo and velocity) to describe how each individual differs from 
the mean curve (see Figure 4.1 for model illustration). The three SITAR parameters are 
size, reflecting up/down shift relative to height; tempo (corresponding to aPHV), 
reflecting left/right shift (on the age scale) (with negative values indicating early puberty 
and positive late puberty), and velocity reflecting stretching/shrinking of the age scale 
and hence describing differences in the rate at which individuals pass through puberty. 
Size (cm) is a random intercept relative to the spline curve intercept, tempo (years) 
reflects the timing of the growth process and corresponds to aPHV, and velocity (years) 
reflects the rate at which ‘time’ passes for individuals. Details describing the method 
have been described previously (Cole et al., 2010).  
While aPHV and tempo both measure the timing of pubertal growth spurt (Pearson's 
correlation coefficient between tempo and aPHV was 0.9946 and 0.9971 in males and 
females, respectively), aPHV is measured from individual growth curves whereas tempo, 
is a random effect from a single analysis and much easier to estimate (Cole et al., 2010). 
Given the range of estimates for aPHV (10.8 – 16.6 years in males and 9.0 – 14.6 years in 
females) and tempo (-2.7 – 2.7 in males and -3.0 – 3.0 in females) and considering the 
age at TF 2 attendance (mean age was 13.8 years), for a substantial number of boys, 
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aPHV occurred after attending this clinic, therefore tempo, instead of aPHV, was used in 




Figure 4.1 Illustration of the SITAR model for height in puberty. The solid line is the 
mean growth curve; size (α) corresponds to vertical or height shift in the curve (the 
short-dashed lines in red);  tempo (β) corresponds to a horizontal or age shift (the 
long-dashed lines in purple) and velocity (γ) corresponds to a shrinking–stretching of 
the age scale (the dot-dashed line in green).  
Figure credit to (Cole et al., 2010). 
 
Data sources 
Height measurements collected during assessment clinics between age 5 and 20 years 




These included  
(i) Children in Focus data – 10% sample were measured regularly in a clinic setting 
at 10 equally spaced intervals from 4 months to 61 months of age (for this 
analysis measurements were restricted to those taken from age 5 onwards),  
(ii) assessment clinics in childhood (around age 7, 8, 9, 10, 11 and 12 years), 
(iii) assessment clinics in adolescence (ages 13, 15 and 17 years). 
 
These data were further restricted to only include individuals with at least one 
measurement for the following time periods: 5 to 10 years, 10 to 15 years and 15 to 20 
years.   
Data analysis 
The height data was analysed for males and females separately using SITAR model with 
5 degrees of freedom (Cole et al., 2010). Optimal degrees of freedom value, which 
indicates the number of parameters that are free to vary in the model, was chosen to 
minimise the Bayesian Information Criterion (BIC)(Schwarz, 1978). The model was fitted 
using sitar package in R version 3.4.1. 
After fitting the initial model, the data were checked and points with velocity exceeding 
4 SDs and standardized residuals exceeding 4 in absolute value were removed.  
For details regarding estimation of aPHV in ALSPAC please refer to a data note (available 
in Appendix 3 and published online (Frysz et al., 2018)). 
 
 Tanner stage  
Self-reported Tanner stage assessed when the children were approximately 13 years old 
was used in this analysis. To aid comparability between the sexes only data relating to 
pubic hair development was used. Tanner stages were combined to indicate early/pre-
pubertal (Tanner stage I+II), mid- (Tanner III), and advanced (Tanner IV+V) pubertal 
stages. For more details regarding data collection and pubertal assessment please refer 
to Chapter 2. 
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4.2.2.3. Confounding variables 
Previous studies suggest that fat mass or BMI affect the onset of puberty in males and 
females (Kaplowitz, 2008). To adjust for the effect of fat mass, fat mass index (FMI) 
(independent of height) was calculated for each time point, as described previously 
(Wells & Cole, 2002). Briefly, fat mass and height were log transformed. Log 
transformed fat mass was then regressed on log height, separately for males and 
females. Subsequently fat mass was regressed on height raised to the appropriate 
power (value corresponding to regression coefficient of log fat mass on log height) and 
the residuals were used to adjust for FMI in the following analyses. In addition, to 
estimate the relationship between tempo and hip shape independent of sex and the 
remaining SITAR parameters (size and velocity), an additional model adjusting for these 
covariates was run.  
4.2.3. Statistical analysis  
SITAR parameters (estimated in R) were exported into Stata and merged with outcome 
and covariate data. Multivariable linear regression was used to examine cross-sectional 
associations between growth tempo and the top ten HSMs at age 14 and 18, adjusting 
for sex (model 1) and additionally for FMI (model 2). Sensitivity analyses additionally 
adjusting for the remaining SITAR parameters, size and velocity of height, were also 
performed (model 3). In addition, associations between Tanner stage and the top ten 
HSMs at age 14 were explored and compared with tempo results. Sex differences were 
explored by comparing regression coefficients and their 95% CIs in gender stratified 
analysis and by formally testing for evidence of statistical interaction using likelihood-
ratio tests.  
Given the strong association between tempo and hip shape at age 14 (but not at age 
18), tempo was further split into quintiles to explore the relationships between tempo 
quintiles and hip shape in males and females separately. Tempo was sorted in ascending 
order and split into five equal groups using xtile command in Stata version 14.0. 
To illustrate the overall relationship between pubertal timing and hip shape at each time 
point, sex-stratified coefficients from adjusted linear regression models corresponding 
to 10th and 90th percentiles of tempo (each beta coefficient was multiplied by a value 
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corresponding to 10th and 90th percentile of tempo to represent the differences 
between early vs. late maturers) were simultaneously entered into Shape software, for 
all modes showing evidence of an association with growth tempo (p<0.005).  
4.3. Results  
4.3.1. Assessment of puberty 
 SITAR results 
A total of 18,095 height measurements for 2,688 males, and 21,942 measurements for 
3,019 females were available for analysis. Mean (SD) aPHV was 13.5 (0.9) years for 
males and 11.8 (0.8) years for females (see Supplementary Figure 10.3.1 and 
Supplementary Figure 10.3.2 in Appendix 3). The SITAR model explained 98.5% and 
98.7% of variance in the height data set in males and females, respectively. 
 Tanner stage  
The Tanner stage questionnaire was completed at an average age of 13.2 years. 
Complete outcome, Tanner stage and confounder data were available for 3,003 
individuals (1,364 were male and 1,639 were female). Table 4.4 shows age distribution 
by Tanner stage. Compared with males, females were more advanced in puberty as 
demonstrated by a higher proportion of females in advanced pubertal stages and a 
small proportion of females in pre-pubertal stages (i.e. 35%, 28% and 38% of males vs. 
16%, 23% and 60.5% of females in early, mid and late pubertal stages, respectively). 
 
4.3.2. Study participant characteristics  
Of individuals who attended the TF 2 clinic (mean age at attendance 13.8 years), 
complete outcome and covariate data were available for 1,797 males and 2,030 
females. Males who attended the assessment clinic were taller, had higher total body 
lean mass and lower total body fat mass compared with females (Table 4.1). 
Of those who attended the TF 4 clinic (mean age at attendance 17.8 years), a total of 
1,597 males and 1,910 females had complete data. Similarly, to TF 2 results, males were 
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taller and heavier, had higher lean mass content and lower fat mass content compared 
with females (Table 4.1). 
The target age for TF 2 clinic recruitment was 13.5 years. Although there was no 
difference with regards to the age at clinic attendance (males and females attended at a 
mean age of 13.8 years) it is clear that males and females were at distinct pubertal 
stages, as reflected by the differences in mean aPHV (Table 4.1), time since achieving 
PHV when attending the clinic (Table 4.2) and Tanner stage category distributions (Table 
4.4). As shown in Table 4.2, based on sex, tempo quintiles 1 and 2 indicate early 
maturers (they reached their aPHV earlier compared with the mean aPHV), quintile 3 
indicates average maturers (those around mean aPHV) and quintiles 4 and 5 indicate 
late maturers (they reached their aPHV later compared with the mean aPHV). For 
example, females in the first quintile of tempo achieved their PHV at least 3 years prior 
to attending the clinic compared with an average of 1.5 years for males in this quintile. 
In addition, 729 males achieved their PHV after attending the clinic compared with only 
22 females. 
At the time of TF 4 clinic attendance (the target age for attendance was 17.5 years) 
similar differences in terms of time since achieving PHV were observed for males and 
females (Table 4.3). For example, females in the first quintile of tempo achieved their 
PHV an average 7 years prior to attending the clinic compared with an average of 5.4 
years in males. 
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 Table 4.1; Descriptive statistics of ALSPAC study participants 
  Age 14 (TF 2) Age 18 (TF 4) 
    N Mean (SD) p for sex 
diff*  
N Mean (SD) p for sex 
diff*  
Age at clinic 
attendance  
M&F 3,827 13.8 (0.2) 0.077 3,507 17.7 (0.4) 0.612 
M  1,797 13.8 (0.2)  1,597 17.7 (0.4)  




M&F 3,827 163.6 (7.5) <0.0001 3,507 171.6 (9.2) <0.001 
M  1,797 165.0 (8.5)   1,597 178.8 (6.5)  
F 2,030 162.0 (6.2)   1,910 165.5 (6.1)  
Weight (kg) M&F 3,827 54.6 (10.9) 0.675 3,507 67.1 (13.4) <0.001 
M  1,797 54.8 (11.5)   1,597 72.5 (13.3)  
F 2,030 54.5 (10.4)   1,910 62.5 (11.7)  
Lean mass 
(kg) 
M&F 3,827 38.1 (6.4) <0.0001 3,507 45.9 (9.9) <0.001 
M  1,797 41.2 (7.1)   1,597 55.2 (6.1)  




M&F 3,827 13.9 (8.0) <0.0001 3,507 18.0 (10.3) <0.001 
M  1,797 11.1 (7.6)   1,597 14.1 (10.1)  




M&F 3,827 0.03 (0.8) 0.999 3,507 0.01 (0.8) 0.999 
M  1,797 0.02 (0.8)   1,597 -0.02 (0.8)  




M&F 3,827 12.6 (1.2) <0.0001 3,507 12.6 (1.2) <0.001 
M  1797 13.5 (0.9)   1597 13.5 (0.9)  
F 2030 11.8 (0.8)   1910 11.8 (0.8)  
* Unpaired t-test to assess the null hypothesis of no difference in distributions between 
males and females at each time point. **Tempo corresponds to the timing of pubertal 
growth spurt (and thus aPHV) in each individual compared with the mean. Geometrically 
it indicates subject-specific left-right shift or translation in the spline curve. Negative 
values indicate early puberty, and positive values indicate late puberty.  
Abbreviations: M (males), F (females), aPHV (age at peak height velocity).
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Table 4.2; Mean aPHV and years since aPHV by quintiles of tempo stratified by gender, 
in children who attended TF 2 clinic (mean age at attendance 13.8 years) 
 Males (N= 1,797) Females (N=2,030) 
  
aPHV years since 
aPHV 
 




N Mean (SD) Mean (SD) N Mean (SD) Mean (SD) 
1 360 12.4 (0.38) 1.5 (0.42) 406 10.7 (0.35) 3.1 (0.38) 
2 359 13.1 (0.17) 0.8 (0.24) 406 11.4 (0.14) 2.4 (0.24) 
3 360 13.6 (0.17) 0.2 (0.25) 406 11.8 (0.14) 2.0 (0.23) 
4 359 14.0 (0.16) -0.2 (0.27) 406 12.3 (0.16) 1.6 (0.29) 
5 359 14.8 (0.47) -0.9 (0.51) 406 13.0 (0.39) 0.8 (0.43) 
Abbreviations: aPHV (age at peak height velocity), years since aPHV (difference between 
age at peak height velocity and age at clinic attendance)  
 
Table 4.3; Mean aPHV and years since aPHV by quintiles of tempo stratified by gender, 
in children who attended TF 4 clinic (mean age at attendance 17.7 years) 
 
Males (N=1,597) Females (N=1,910) 
  
aPHV years since 
aPHV 
 aPHV years since aPHV 
Tempo 
quintile 
N Mean(SD) Mean(SD) N Mean(SD) Mean(SD) 
1 320 12.3 (0.37) 5.4 (0.49) 382 10.7 (0.35) 7.1 (0.49) 
2 319 13.0 (0.17) 4.7 (0.40) 382 11.4 (0.14) 6.4 (0.39) 
3 320 13.5 (0.17) 4.2 (0.40) 382 11.8 (0.14) 5.9 (0.33) 
4 319 13.9 (0.16) 3.8 (0.39) 382 12.3 (0.16) 5.5 (0.41) 
5 319 14.7 (0.52) 3.0 (0.63) 382 13.0 (0.39) 4.8 (0.55) 
Abbreviations: aPHV (age at peak height velocity), years since aPHV (difference between 




Table 4.4; Age distribution by pubertal status for 3,003 individuals with complete 
outcome, Tanner stage and covariate data at age 14 
 
Males (N= 1,367) Females (N=1,639) 
Tanner stage N (%) Mean age (SD) N (%) Mean age (SD) 
I + II 472 (34.6) 13.8 (0.19) 269 (16.4) 13.8 (0.19) 
III 378 (27.7) 13.8 (0.18) 379 (23.1) 13.8 (0.20) 
IV + V 514 (37.7) 13.8 (0.19) 991 (60.5) 13.8 (0.18) 
Results shown for individuals with complete outcome, covariate and Tanner stage data  
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Table 4.5; Number of individuals in each Tanner stage category (assessed at a mean age of 13.2 years) per quintile of tempo 
 
Males (N= 1,226) Females (N= 1,495) 
Tanner stage Tanner stage 
Tempo quintiles 
 
I + II III IV + V N I + II III IV + V N 
1 N (%) 18 (7.2) 33 (13.2) 199 (79.6) 250 3 (1.0) 22 (7.1) 284 (91.9) 309 
2 N (%) 38 (15.6) 62 (25.4) 144 (59.0) 244 6 (2.5) 49 (20.5) 238 (99.6) 293 
3 N (%) 66 (26.6) 107 (43.1) 75 (30.2) 246 13 (4.2) 89 (28.7) 208 (67.1) 310 
4 N (%) 134 (55.1) 85 (35.0) 24 (9.9) 243 46 (16.3) 108 (38.3) 128 (45.4) 282 
5 N (%) 168 (71.8) 56 (23.9) 10 (4.3) 243 174 (57.8) 82 (27.2) 45 (15.0) 301 
* number of individuals in each tempo quintile restricted to individuals with complete hip shape data age 14, SITAR parameters and Tanner 
stage data assessed at mean age of 13.2 years.
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4.3.3. Relationship between tempo and hip shape 
4.3.3.1. Age 14  
In gender combined analysis (model 1), tempo was associated with the majority of 
HSMs, except for HSM4 (Table 4.6). Following adjustment for FMI (model 2), 
associations were essentially unchanged. After further adjustment for the remaining 
SITAR parameters (size and velocity of growth) (model 3), the results remained 
essentially unchanged, except for the association with HSM6 which attenuated. There 
was strong evidence of interaction by sex (consistent across the models) for all modes 
except HSM6 (Table 4.6).  
In males, in unadjusted analysis there was strong evidence of association of tempo with 
all modes, and some evidence of an association with HSM6 (model 1), and these results 
were essentially unchanged following FMI adjustment (model 2) (Table 4.7). Following 
further adjustment for size and velocity of growth (model 3), HSM4 result attenuated 
slightly and the evidence of an association was weak, while the remaining results were 
unchanged (Table 4.7).  
Compared with males, associations between tempo and HSMs in females were generally 
weaker. There was evidence for an association with a number of modes, including 
HSM2, HSM3, HSM6, HSM8, HSM9 and HSM10 (model 1, Table 4.8). Following 
adjustment for FMI (model 2) associations with HSM2, HSM3 and HSM10 attenuated 
towards the null and there was no longer evidence of an association, the association 
with HSM6 was strengthened, whereas HSM8 and HSM9 results remained unchanged 
(Table 4.8). After additional adjustment for size and velocity of growth (model 3), HSM6 
and HSM8 results remained unchanged, whereas the HSM9 association was 
strengthened, and associations with HSM3 and HSM5 emerged (Table 4.8). 
 
The overall relationship between tempo (early vs. late) and hip shape, independent of 
FMI, was modelled separately for males and females and is shown in Figure 4.2. In 
males, the overall change in hip shape associated with later timing of puberty was 
reflected by slight narrowing of FNW, smaller lesser and greater trochanters and larger 
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femoral head in the superolateral aspect. In females, the overall relationship between 
pubertal timing and hip shape was harder to discern.  
To explore possible non-linear relationship between pubertal timing and hip shape, 
tempo was divided into quintiles; with quintiles 1 and 2 indicating early maturers, 
quintile 3 indicating  average maturers (those around mean aPHV) and quintiles 4 and 5 
indicating late maturers. Unadjusted mean HSM scores and their 95% CIs were plotted 
per each quintile of tempo in males and females separately (Figure 4.3 - Figure 4.7).  
In males, the strongest associations were seen for modes HSM2, HSM3, HSM5, HSM8 
and HSM9 and these results were reflected when modelling the relationship between 
tempo quintiles with these modes, i.e. there was a clear increase in mean HSM scores 
with each quintile of tempo and clear differences in mean HSM scores were particularly 
noted between 1st and 5th (early vs. late maturers) quintiles of tempo as reflected by 
non-overlapping CIs. 
In females, the relationship between tempo and HSM scores was much weaker 
compared with that in males. The strongest association with tempo was observed for 
HSM8, however when looking at the relationship with tempo quintiles no clear pattern 
of change in mean HSM scores per quintile of tempo emerged, and this was similar for 
other modes showing evidence of an association with tempo.  
 Tempo vs. Tanner stage results 
Compared with tempo results, the associations between Tanner stage and HSMs were 
broadly similar. It is important to bear in mind that the direction of beta coefficients was 
in the opposite direction representing the differences in coding of tempo and Tanner 
stage variables. Negative tempo (quintiles 1 and 2) indicates early timing of puberty and 
roughly corresponds to Tanner stages IV and V (with majority of individuals in tempo 
quintiles 1 and 2 being in Tanner stages IV and V, as shown in Table 4.5). On the other 
hand, Tanner stages I and II correspond to the pre-pubertal stage (and thus could 
represent late maturers i.e. individuals who enter puberty later compared with those 
already in Tanner stages IV and V) and, as shown in Table 4.5, the majority of individuals 
in tempo quintile 5 are in Tanner stages I and II.  
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In gender combined analysis, in minimally adjusted model there was evidence for an 
association between Tanner stage and all modes, apart from HSM4 and these results 
were essentially unchanged following adjustment for FMI (model 2) (Table 4.9). As with 
tempo results, there was strong evidence of sex interaction.  
In males, there was evidence for an association between the Tanner stage and the 
majority of modes, apart from HSM6, and adjustment for FMI made little difference to 
these results (Table 4.10). These findings were consistent with those observed for 
tempo, however associations between Tanner stage and hip shape (models 1 and 2) 
were generally weaker. 
In females, similarly to tempo results, the association between Tanner stage and hip 
shape were weaker compared with the results in males. There was some evidence of 
association between Tanner stage with most modes (apart from HSM2, HSM3 and 
HSM4) and following adjustment for FMI, associations with HSM1 and HSM7 were 
attenuated towards the null and there was no longer evidence of an association, 
association with HSM8 was slightly attenuated whereas the remining results remained 
unchanged (Table 4.11). In contrast to tempo results, there was some evidence to 
suggest association between Tanner stage with HSM5 and HSM10 independent of FMI. 
125 
 
Table 4.6; Associations between tempo and the top ten HSMs in ALSPAC adolescents at age 14 (N=3,827) 
 
Model 1 Model 2 Model 3 
HSM β (95% CI) p p for 
sex-int 
β (95% CI) p p for sex-
int 
β (95% CI) p p for sex-
int 
1 -0.04 (-0.06,-0.03) 1.4x10-8 5.3x10-5 -0.04 (-0.06, -0.03) 3.8x10-8 2.6x10-5 -0.03 (-0.05, -0.00) 0.015 3.8x10-6 
2 0.15 (0.12, 0.18) 4.5x10-25 6.8x10-9 0.13 (0.10, 0.15) 2.6x10-18 9.7x10-15 0.14 (0.10, 0.17) 6.7x10-13 4.3x10-16 
3 0.14 (0.12, 0.17) 9.2x10-28 2x10-13 0.12 (0.10, 0.15) 7.4x10-22 5.0x10-19 0.16 (0.12, 0.19) 2.9x10-20 5.3x10-19 
4 0.02 (-0.00, 0.05) 0.073 0.001 0.02 (-0.00, 0.05) 0.093 0.001 0.02 (-0.02, 0.05) 0.333 2.7x10-4 
5 0.14 (0.11, 0.17) 1.1x10-21 1.9x10-21 0.15 (0.12, 0.18) 4.8x10-24 3.2x10-19 0.19 (0.15, 0.23) 3.9x10-21 3.7x10-20 
6 -0.04 (-0.07,-0.02) 0.001 0.758 -0.06 (-0.08, -0.03) 6.4x10-6 0.385 -0.07 (-0.10, -0.04) 4.0x10-5 0.232 
7 -0.06 (-0.08,-0.03) 2.4x10-6 1.6x10-14 -0.07 (-0.09, -0.04) 1.6x10-8 1.2x10-11 -0.03 (-0.06, 0.00) 0.082 1.2x10-13 
8 0.25 (0.21, 0.28) 7.8x10-48 8.7x10-14 0.23 (0.20, 0.27) 5.3x10-43 1.1x10-16 0.26 (0.21, 0.30) 2.6x10-31 5.2x10-19 
9 0.12 (0.09, 0.15) 7.2x10-16 8.6x10-8 0.12 (0.09, 0.15) 2.0x10-16 2.5x10-7 0.16 (0.12, 0.19) 7.7x10-16 1.5x10-7 
10 0.06 (0.04, 0.08) 6.4x10-8 0.038 0.05 (0.03, 0.07) 1.7x10-5 0.001 0.05 (0.02, 0.08) 4.9x10-4 6.7x10-4 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of linear regression analysis between tempo and the 
top ten HSMs in male and female adolescents. Regression coefficients represent SD change in HSM per one-year increase in growth tempo, 
95% CIs and p value. Model 1: adjusted for sex; model 2: model 1 + fat mass index; model 3: model 2 + size and velocity.  
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Table 4.7; Associations between tempo and the top ten HSMs in ALSPAC males at age 14 (N=1,797) 
 
Model 1 Model 2 Model 3 
HSM β (95% CI) p β (95% CI) p β (95% CI) p 
1 -0.08 (-0.10, -0.06) 1.2x10-10 -0.08 (-0.10, -0.06) 1.1x10-10 -0.06 (-0.09, -0.02) 4.0x10-4 
2 0.24 (0.20, 0.28) 2.8x10-29 0.24 (0.20, 0.28) 9.8x10-31 0.24 (0.19, 0.30) 4.3x10-20 
3 0.24 (0.21, 0.28) 1.6x10-36 0.25 (0.21, 0.28) 9.2x10-38 0.24 (0.19, 0.29) 1.4x10-23 
4 0.07 (0.03, 0.11) 4.2x10-4 0.07 (0.03, 0.11) 4.4x10-4 0.05 (0.00, 0.10) 0.045 
5 0.30 (0.26, 0.34) 3.0x10-41 0.30 (0.26, 0.34) 3.4x10-41 0.30 (0.25, 0.36) 8.6x10-28 
6 -0.05 (-0.09, -0.01) 0.020 -0.05 (-0.09, -0.01) 0.025 -0.07 (-0.12, -0.01) 0.013 
7 -0.16 (-0.19, -0.12) 3.0x10-19 -0.15 (-0.19, -0.12) 4.3x10-19 -0.10 (-0.14, -0.06) 1.9x10-6 
8 0.38 (0.33, 0.43) 1.6x10-49 0.38 (0.33, 0.43) 4.1x10-50 0.36 (0.30, 0.42) 9.0x10-30 
9 0.20 (0.16, 0.24) 1.2x10-21 0.20 (0.16, 0.24) 1.2x10-21 0.21 (0.16, 0.26) 5.4x10-15 
10 0.09 (0.05, 0.12) 4.4x10-7 0.09 (0.06, 0.12) 2.0x10-7 0.10 (0.05, 0.14) 7.6x10-6 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of linear regression analysis between tempo and the 
top ten HSMs in male adolescents. Results are SD change in HSM per one-year increase in growth tempo, 95% CIs and p value. Model 1: 




Table 4.8; Associations between tempo and the top ten HSMs in ALSPAC females at age 14 (N=2,030)    
 
Model 1 Model 2 Model 3 
HSM β (95% CI) p β (95% CI) p β (95% CI) p 
1 -0.02 (-0.04, 0.00) 0.109 -0.01 (-0.03, 0.01) 0.196 0.00 (-0.03, 0.03) 0.898 
2 0.07 (0.04, 0.11) 1.2x10-4 0.01 (-0.02, 0.05) 0.476 0.03 (-0.02, 0.09) 0.208 
3 0.06 (0.02, 0.09) 0.001 0.01 (-0.02, 0.05) 0.498 0.08 (0.03, 0.12) 0.001 
4 -0.01 (-0.05, 0.02) 0.379 -0.03 (-0.06, 0.01) 0.126 -0.02 (-0.07, 0.02) 0.338 
5 0.02 (-0.02, 0.06) 0.416 0.04 (-0.00, 0.08) 0.052 0.09 (0.04, 0.15) 8.8x10-4 
6 -0.04 (-0.07, -0.01) 0.012 -0.07 (-0.10, -0.03) 6.1x10-5 -0.08 (-0.13, -0.04) 3.1x10-4 
7 0.03 (-0.01, 0.06) 0.109 0.01 (-0.02, 0.04) 0.498 0.04 (-0.01, 0.08) 0.085 
8 0.13 (0.09, 0.18) 1.3x10-9 0.10 (0.05, 0.14) 1.6x10-5 0.17 (0.11, 0.23) 6.0x10-8 
9 0.05 (0.01, 0.09) 0.017 0.06 (0.02, 0.10) 0.006 0.12 (0.07, 0.18) 1.1x10-5 
10 0.04 (0.01, 0.07) 0.007 0.02 (-0.01, 0.05) 0.303 0.01 (-0.03, 0.05) 0.614 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of linear regression analysis between tempo and the 
top ten HSMs in female adolescents. Results are unit change in HSM per one-year increase in growth tempo, 95% CIs and p value. Model 1: 




Figure 4.2 The overall difference in hip shape at age 14 between early vs. late matures (changes in hip shape associated with unit 
change in tempo) based on adjusted beta coefficients. Beta coefficients were scaled to reflect changes in early maturers (10th percentile 




Figure 4.3 Unadjusted mean (and 95% CIs) HSM1 and HSM2 scores per quintile of 
tempo in males and females. Tempo quintiles 1 and 2 indicate those maturing early 
(earlier aPHV), quintile 3 indicates those around mean aPHV and quintiles 4 and 5 




Figure 4.4  Unadjusted mean (and 95% CIs) HSM3 and HSM4 scores per quintile of 
tempo in males and females. Tempo quintiles 1 and 2 indicate those maturing early 
(earlier aPHV), quintile 3 indicates those around mean aPHV and quintiles 4 and 5 
indicate those maturing later (later aPHV). 
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Figure 4.5 Unadjusted mean (and 95% CIs) HSM5 and HSM6 scores per quintile of 
tempo in males and females. Tempo quintiles 1 and 2 indicate those maturing early 
(earlier aPHV), quintile 3 indicates those around mean aPHV and quintiles 4 and 5 
indicate those maturing later (later aPHV). 
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Figure 4.6 Unadjusted mean (and 95% CIs) HSM7 and HSM8 scores per quintile of 
tempo in males and females. Tempo quintiles 1 and 2 indicate those maturing early 
(earlier aPHV), quintile 3 indicates those around mean aPHV and quintiles 4 and 5 
indicate those maturing later (later aPHV). 
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Figure 4.7 Unadjusted mean (and 95% CIs) HSM9 and HSM10 scores per quintile of 
tempo in males and females. Tempo quintiles 1 and 2 indicate those maturing early 
(earlier aPHV), quintile 3 indicates those around mean aPHV and quintiles 4 and 5 










HSM β (95% CI) p p for sex-int β (95% CI) p p for sex-int 
1 0.05 (0.03,0.07) 1.1x10-8 0.007 0.05 (0.03,0.07) 1.3x10-8 0.003 
2 -0.10 (-0.14,-0.07) 3.0x10-9 0.001 -0.10 (-0.13,-0.07) 4.4x10-9 5.1x10-7 
3 -0.11 (-0.14,-0.08) 7.8x10-13 5.6x10-6 -0.11 (-0.14,-0.08) 1.1x10-12 6.5x10-9 
4 -0.02 (-0.05,0.01) 0.158 0.064 -0.02 (-0.05,0.01) 0.159 0.059 
5 -0.14 (-0.17,-0.11) 2.5x10-15 4.2x10-5 -0.14 (-0.18,-0.11) 1.8x10-15 <0.0001 
6 0.04 (0.01,0.08) 0.003 0.362 0.05 (0.02,0.08) 0.003 0.091 
7 0.05 (0.03,0.08) 1.4x10-4 1.1x10-11 0.05 (0.03,0.08) 9.0x10-5 9.2x10-10 
8 -0.23 (-0.27,-0.19) 8.4x10-30 4.8x10-8 -0.23 (-0.27,-0.19) 1.2x10-29 1.6x10-10 
9 -0.12 (-0.15,-0.08) 7.9x10-12 0.114 -0.12 (-0.15,-0.08) 8.1x10-12 0.107 
10 -0.06 (-0.09,-0.03) 4.9x10-6 0.414 -0.06 (-0.09,-0.03) 6.9x10-6 0.940 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows regression coefficients with 95% CIs for linear trend test 
between Tanner stage and the top ten HSMs at age 14 in ALSPAC adolescents. Model 1: adjusted for sex, model 2: adjusted for sex and fat 






Table 4.10; Test for linear trend between Tanner stages and the top ten HSMs in 
ALSPAC males at age 14 (N=1,364) 
 
Model 1 Model 2 
HSM β (95% CI) p β (95% CI) p 
1 0.08 (0.05,0.10) 1.4x10-8 0.08 (0.05,0.11) 5.6x10-9 
2 -0.16 (-0.21,-0.11) 5.8x10-11 -0.18 (-0.23,-0.13) 1.4x10-13 
3 -0.18 (-0.22,-0.13) 2.7x10-16 -0.19 (-0.23,-0.15) 3.3x10-19 
4 -0.05 (-0.09,-0.01) 0.025 -0.05 (-0.09,0.00) 0.031 
5 -0.21 (-0.26,-0.16) 3.7x10-17 -0.21 (-0.26,-0.16) 3.5x10-17 
6 0.03 (-0.01,0.08) 0.177 0.02 (-0.03,0.06) 0.402 
7 0.14 (0.11,0.18) 3.3x10-14 0.14 (0.10,0.17) 9.1x10-13 
8 -0.33 (-0.39,-0.28) 5.1x10-31 -0.35 (-0.40,-0.29) 6.7x10-33 
9 -0.14 (-0.19,-0.10) 1.1x10-9 -0.15 (-0.19,-0.10) 5.2x10-10 
10 -0.05 (-0.09,-0.01) 0.007 -0.06 (-0.10,-0.02) 0.001 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows regression 
coefficients with 95% CIs for linear trend test between Tanner stage and the top ten 
HSMs at age 14 in ALSPAC males. Model 1: unadjusted, model 2: adjusted for fat mass 
index. Analysis based on three Tanner stage categories (I+II, III, IV +V) based on self-
reported pubic hair development.  
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Table 4.11; Test for linear trend between Tanner stages and the top ten HSMs in 
ALSPAC females at age 14 (N=1,639) 
 
Model 1 Model 2 
HSM β (95% CI) p β (95% CI) p 
1 0.03 (0.00,0.05) 0.03 0.02 (0.00,0.05) 0.053 
2 -0.04 (-0.09,0.01) 0.087 -0.01 (-0.06,0.04) 0.725 
3 -0.04 (-0.08,0.00) 0.071 -0.02 (-0.06,0.02) 0.426 
4 0.01 (-0.03,0.05) 0.731 0.01 (-0.03,0.05) 0.612 
5 -0.07 (-0.12,-0.02) 0.008 -0.08 (-0.13,-0.03) 0.002 
6 0.06 (0.02,0.10) 0.004 0.07 (0.03,0.11) 0.001 
7 -0.04 (-0.08,0.00) 0.031 -0.03 (-0.07,0.01) 0.096 
8 -0.12 (-0.17,-0.06) 2.9x10-5 -0.09 (-0.15,-0.04) 0.001 
9 -0.09 (-0.14,-0.04) 3.1x10-4 -0.09 (-0.14,-0.04) 2.3x10-4 
10 -0.07 (-0.11,-0.03) 1.6x10-4 -0.06 (-0.10,-0.02) 0.002 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows regression 
coefficients with 95% CIs for linear trend test between Tanner stage and the top ten 
HSMs at age 14 in ALSPAC females. Model 1: unadjusted, model 2: adjusted for fat mass 
index. Analysis based on three Tanner stage categories (I+II, III, IV +V) based on self-
reported pubic hair development.  
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4.3.3.2. Age 18  
Compared with age 14 results, the associations between tempo and hip shape at age 18 
were much weaker. Although there was some evidence to suggest association between 
tempo and hip shape, the magnitude of effect was much weaker (across all models 
tested) compared with the results at age 14, with coefficients ranging from -0.08 to 
0.08.  
In gender combined analysis, in the minimally adjusted model there was evidence to 
suggest association between tempo with HSM1, HSM2, HSM5, HSM9 and HSM10 and 
following adjustment for FMI (model 2) these results remained unchanged except 
association with HSM2 which fully attenuated (Table 4.12). In addition, the association 
of tempo with HSM10 attenuated slightly, and an association with HSM8 emerged 
although the evidence was weak. After further adjustment for the remaining SITAR 
parameters (model 3), the association with HSM5 attenuated towards the null and there 
was no longer evidence of an association, associations with HSM1 and HSM10 were 
strengthened, the association with HSM9 attenuated slightly, whereas the association 
with HSM8 switched to positive, however the evidence was weak (Table 4.12).  
While there was no evidence to suggest interaction by sex, some differences in the 
effect estimates were observed in gender stratified analysis. There was consistent 
evidence for an association between tempo and HSM9 in both males (Table 4.13) and 
females (Table 4.14) across the models tested, however following full adjustment 
(model 3) the association fully attenuated in females, whereas there was still evidence 
of an association in males. With regards to the remaining modes, different patterns of 
associations were observed between the sexes. There was evidence to suggest an 
association between tempo and HSM10 (model 1) in both sexes, but these results were 
attenuated following adjustment for FMI and there was no longer evidence of an 
association (Table 4.13 and Table 4.14), however while the results were unchanged 
following further adjustment for size and velocity of growth (model 3) in males, an 
association emerged in females.  
In females, additional unadjusted associations between tempo with HSM2 and HSM5 
were seen (model 1) (Table 4.14). Following adjustment for FMI (model 2), the 
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association with HSM2 was attenuated and there was no longer evidence of an 
association, whereas the HSM5 association was strengthened, but the latter was fully 
attenuated following further adjustment for size and velocity (model 3) (Table 4.14).  
When modelling the overall relationship between pubertal timing and hip shape, the 








Table 4.12; Associations between tempo (continuous measure) and the top ten HSMs in ALSPAC adolescents at age 18 (N=3,507) 
 
Model 1 Model 2 Model 3 
HSM β (95% CI) p p for sex-
int 
β (95% CI) p p for 
sex-int 
β (95% CI) p p for sex-int 
1 0.02 (0.00, 0.03) 0.031 0.756 0.02 (0.00, 0.04) 0.014 0.762 0.03 (0.01, 0.05) 0.009 0.784 
2 0.05 (0.02, 0.08) 0.003 0.186 0.00 (-0.03, 0.04) 0.789 0.197 0.03 (-0.01, 0.08) 0.106 0.263 
3 0.00 (-0.02, 0.03) 0.823 0.178 -0.02 (-0.05, 0.00) 0.092 0.159 -0.01 (-0.05, 0.02) 0.413 0.258 
4 -0.00 (-0.03, 0.03) 0.889 0.172 -0.01 (-0.04, 0.02) 0.523 0.168 0.00 (-0.04, 0.04) 0.915 0.176 
5 -0.06 (-0.09, -0.03) 2.6x10-4 0.149 -0.06 (-0.09, -0.03) 2.7x10-4 0.148 -0.00 (-0.05, 0.04) 0.877 0.111 
6 -0.01 (-0.04, 0.02) 0.488 0.670 -0.02 (-0.05, 0.01) 0.235 0.679 -0.04 (-0.08, 0.00) 0.065 0.789 
7 0.01 (-0.01, 0.04) 0.306 0.880 -0.01 (-0.04, 0.02) 0.490 0.847 -0.01 (-0.04, 0.03) 0.784 0.924 
8 -0.01 (-0.04, 0.03) 0.650 0.079 -0.04 (-0.08, -0.01) 0.021 0.068 0.05 (0.00, 0.10) 0.033 0.035 
9 -0.08 (-0.11, -0.05) 3.9x10-6 0.766 -0.07 (-0.11, -0.04) 2.4x10-5 0.761 -0.06 (-0.11, -0.02) 0.008 0.731 
10 0.07 (0.04, 0.10) 5.3x10-6 0.677 0.03 (0.00, 0.06) 0.038 0.627 0.07 (0.03, 0.11) 0.001 0.491 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of linear regression analysis between tempo and the 
top ten HSMs in male and female adolescents. Regression coefficients represent unit change in HSM per one-year increase in growth 




Table 4.13; Associations between tempo (continuous measure) and the top ten hip shape modes in ALSPAC males (N=1,597) 
 
Model 1 Model 2 Model 3 
HSM β (95% CI) p β (95% CI) p β (95% CI) p 
1 0.02 (-0.01, 0.05) 0.119 0.02 (-0.00, 0.05) 0.080 0.03 (-0.00, 0.07) 0.067 
2 0.02 (-0.02, 0.07) 0.333 -0.01 (-0.06, 0.03) 0.613 0.03 (-0.03, 0.09) 0.357 
3 0.02 (-0.02, 0.06) 0.235 0.00 (-0.03, 0.04) 0.831 0.03 (-0.02, 0.08) 0.223 
4 0.02 (-0.02, 0.06) 0.342 0.02 (-0.02, 0.06) 0.352 0.02 (-0.03, 0.08) 0.436 
5 -0.03 (-0.08, 0.01) 0.163 -0.03 (-0.08, 0.01) 0.167 0.03 (-0.03, 0.08) 0.410 
6 -0.02 (-0.07, 0.03) 0.455 -0.03 (-0.08, 0.02) 0.303 -0.01 (-0.08, 0.05) 0.701 
7 0.02 (-0.02, 0.05) 0.396 -0.00 (-0.04, 0.03) 0.841 -0.01 (-0.06, 0.04) 0.740 
8 0.03 (-0.03, 0.08) 0.314 -0.01 (-0.06, 0.05) 0.770 0.10 (0.03, 0.17) 0.005 
9 -0.09 (-0.13, -0.04) 2.4x10-4 -0.08 (-0.13, -0.03) 7.7x10-4 -0.11 (-0.17, -0.05) 5.2x10-4 
10 0.08 (0.03, 0.12) 8.8x10-4 0.04 (-0.01, 0.08) 0.118 0.04 (-0.02, 0.10) 0.219 
Abbreviations: HSM (hip shape mode), CI (confidence interval).Table shows results of linear regression analysis between tempo and the 
top ten HSMs in male adolescents. Results are unit change in HSM per unit increase in exposure, 95% CIs and p value. Model 1: unadjusted; 





Table 4.14; Association between tempo and the top ten HSMs in ALSPAC females at age 18 (N=1,910) 
 Model 1 Model 2 Model 3 
HSM β (95% CI) p β (95% CI) p β (95% CI) p 
1 0.02 (-0.00, 0.04) 0.131 0.02 (-0.00, 0.04) 0.087 0.03 (-0.00, 0.05) 0.074 
2 0.07 (0.02, 0.11) 0.002 0.01 (-0.03, 0.06) 0.513 0.04 (-0.02, 0.09) 0.207 
3 -0.01 (-0.05, 0.02) 0.482 -0.04 (-0.08, -0.01) 0.013 -0.05 (-0.10, -0.01) 0.023 
4 -0.02 (-0.06, 0.02) 0.320 -0.03 (-0.07, 0.00) 0.080 -0.02 (-0.07, 0.03) 0.521 
5 -0.08 (-0.12, -0.04) 4.2x10-4 -0.08 (-0.13, -0.04) 4.2x10-4 -0.02 (-0.08, 0.04) 0.540 
6 -0.01 (-0.05, 0.04) 0.801 -0.01 (-0.06, 0.03) 0.501 -0.07 (-0.13, -0.02) 0.010 
7 0.01 (-0.03, 0.05) 0.524 -0.01 (-0.05, 0.02) 0.450 0.00 (-0.05, 0.05) 0.914 
8 -0.04 (-0.08, 0.01) 0.128 -0.07 (-0.11, -0.02) 0.005 0.01 (-0.05, 0.07) 0.736 
9 -0.08 (-0.12, -0.03) 0.002 -0.07 (-0.12, -0.02) 0.006 -0.01 (-0.08, 0.05) 0.718 
10 0.07 (0.02, 0.11) 0.002 0.03 (-0.01, 0.07) 0.144 0.10 (0.04, 0.15) 5.9x10-4 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of linear regression analysis between tempo and the 
top ten HSMs in female adolescents. Results are unit change in HSM per unit increase in exposure, 95% CIs and p value. Model 1: 




Figure 4.8 The overall difference in hip shape at age 18 between early vs. late matures (changes in hip shape associated with unit 
change in tempo) based on adjusted beta coefficients. Beta coefficients were scaled to reflect changes in early maturers (10th percentile 




 Summary of findings  
In this chapter, I examined the association between pubertal timing (as reflected by 
tempo) and hip shape in ALSPAC adolescents. At age 14, several associations between 
tempo and hip shape were observed, and these were stronger in males compared with 
females. In males, several modes were associated with tempo (unadjusted analysis) and 
clear patterns of association were also observed when modelling the relationship 
between tempo quintiles and hip shape (i.e. relationships appeared to be linear). 
Further adjustment for FMI, size and velocity made little difference to these results. In 
contrast, the associations between tempo and HSMs in females were weaker in terms of 
both strength and magnitude of the effect and no distinct patterns of relationship were 
observed when modelling the relationship between tempo quintiles and hip shape. The 
strongest association was observed for HSM8, and adjustment for FMI, size and velocity 
made little difference to these results. When the overall relationship between pubertal 
timing (early vs. late) and hip shape was modelled, clear differences between males and 
females were observed. In males, later puberty was associated with narrower FNW, 
smaller lesser trochanter and larger superolateral femoral head. Whereas in females, 
the overall relationship between tempo and hip shape was hard to detect. 
At age 18, associations between pubertal timing and hip shape were much weaker 
compared with age 14 results. Tempo was associated with HSM9 in males and this 
association was independent of FMI, size and velocity of growth, while in females there 
was some evidence of an association with HSM2, HSM5 and HSM9, however these 
results were fully attenuated following adjustment for either FMI and/or additional 
adjustment for size and velocity. Interestingly, there was evidence of an association with 
HSM10 which attenuated following FMI adjustment in both males and females, and 
additional adjustment for size and velocity made little difference to these results in 
males, whereas in females these results were strengthened and there was evidence for 
an association. As expected, when modelling the overall relationship between early vs. 
late pubertal timing and hip shape the differences were hard to discern in both males 
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and females. Taken together these results suggest that pubertal timing might not exert 
lasting effects on hip shape.  
 Differences between males and females  
In this chapter, a number of strong relationships between tempo and hip shape at age 
14 were seen in males, but not in females. A possible explanation for these results may 
be due to differences in pubertal stages between males and females during scan 
acquisition. For example, of females in tempo quintile 1 (early maturers) only 3 were in 
Tanner stages I and II while over 90% were in Tanner stages IV and V (Table 4.5). In 
males, the reverse was observed, whereby only 4.3% of individuals in tempo quintile 5 
were in advanced Tanner stages (stages IV and V) (Table 4.5). Given the fact that the 
majority of females had already entered puberty at the time of TF 2 clinic attendance 
(compared with males), part of the effect of pubertal timing on hip shape in females 
may have been missed. While it is well recognized that there is a considerable degree of 
variation in maturity at any specific (chronological) age, this is true both within and 
between the sexes (Cameron, 2015). For example, a previous study estimated mean 
aPHV (SD) of 12.4 (0.14) in females (Marshall & Tanner, 1969) and 14.1 (0.14) in males 
(Marshall & Tanner, 1970), a difference of ~2 years, a finding consistent with estimates 
reported in this study. Another possible explanation for the differences seen between 
males and females could be the fact that changes in hip shape in females are established 
shortly before puberty, consistent with a previous study by Pasco et al., which found no 
relationship between age at menarche and FNW in a cohort of women aged between 
20–30 years (Pasco et al., 1999). Alternatively, changes in hip shape in females might be 
established during the pubertal growth spurt which is shorter compared to males. 
According to Seeman, males have longer pre-pubertal growth, greater growth velocity 
and a much longer duration of pubertal growth spurt compared with females (Ego 
Seeman, 1999).  
 In relation to published literature  
This is the first study to investigate the relationship between the timing of puberty and 
hip shape as quantified using SSM. A number of researchers have investigated the 
relationships between markers of pubertal timing (such as age at menarche, age at voice 
breaking, Tanner stage or aPHV) and musculoskeletal health. These studies have largely 
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focused on either hip geometrical indices (Sayers et al., 2010) including measures of 
bone strength (Šešelj et al., 2012) (which are important predictors for hip OA and/or hip 
fracture in later life) or measures of bone density (Bonjour & Chevalley, 2014; Kuh et al., 
2016). In this study, the overall effect of later puberty on hip shape in males was 
associated with narrower FNW, smaller lesser trochanter and variation in superolateral 
aspect of femoral head. One previous study by Pujol et al. in boys aged between 9 and 
16 years, found that the size of the femoral head and greater and lesser trochanters 
increased with age (Pujol et al., 2016). These findings were partially replicated in this 
study, showing that with maturation (in males post PHV) FNW gets wider and lesser 
trochanter gets larger. However, in this chapter I was also able to describe changes in 
the entire contour of the femoral head, femoral shaft and acetabular sourcil which was 
not explored by the Spanish group due to limitations of their model. In addition, the 
authors did not specifically explore the effect of pubertal timing on hip morphology, 
however measurements under investigation were collected during the adolescent 
growth spurt. While the size of the femoral head and the trochanters increase with age, 
especially around puberty, it is possible that early or later pubertal timing might exert 
distinct effects on these aspects of the proximal femur.  
On the other hand, rather than specific timing of puberty, the period of pubertal growth 
might represent a sensitive period for the development of unfavourable bone 
phenotype leading to increased risk of fracture or OA in later life. As suggested by Bass 
et al., during periods of fast growth (as in puberty) specific bone regions might be more 
responsive to genetic and/or environmental stimuli, compared with periods of steady 
growth or with stages near or at completion of growth (Bass et al., 1999). Consistent 
with this suggestion, Siebenrock et al. showed that cam-type deformity arises in 
childhood, often as a result of high impact sporting activity (Siebenrock et al., 2011). In 
addition, previous study in pre-professional soccer players (mean age 14.4), followed up 
for a mean period of 2.4 years, noted an increase in cam-type deformities between age 
12 and 14 years, which continued to increase from the age of 14 until closure of the 
growth plate (Agricola et al.). Furthermore, Packer et al. suggested that high impact 
activities and injuries taking place around critical periods of development can result in 
cam-type deformities, and the authors found no evidence for increase in cam-deformity 
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prevalence or severity following the closure of the growth plate (Packer & Safran, 2015). 
While in this chapter, the overall relationship between pubertal timing and hip shape in 
males was reflected by larger superolateral femoral heads, there was strong evidence 
for positive relationship between tempo and HSM9 – a mode possibly representative of 
cam-type deformity. In females, there was also some evidence of an association with 
this mode, however the magnitude of effect was weaker. Interestingly, when exploring 
the relationship between tempo and hip shape at age 18 in males, the strongest 
association seen was with HSM9 and this association persisted after adjustment for FMI, 
size and velocity, however the effect was in the opposite direction to that observed at 
age 14. Taken together, these findings suggest that pubertal growth, particularly in 
males, may represent a critical period for the development of cam-type deformity. 
 Changes in puberty in relation to future pathology 
Previous research has indicated a relationship between pubertal timing and adverse 
musculoskeletal outcomes in later life. For example, a study of the UK Biobank reported 
associations between early menarche and increased risk of OA as well as between 
increasing age at menarche and risk of OP (Day et al., 2015). What is more, a previous 
study by Finkelstein et al. found that men with a history of delayed puberty had a lower 
FN BMD, a factor likely to increase the risk of fracture in later life, compared with men 
with normal pubertal timing (Finkelstein et al., 1996). What is surprising is that I found 
no strong evidence to suggest a relationship between pubertal timing and hip shape 
quantified post puberty, suggesting that pubertal timing may not exert lasting effects on 
hip shape.  
 Strengths and limitations  
One of the strengths of this study includes non-subjective assessment of pubertal stage 
based on serial height measurements. Although the associations between Tanner stage 
and HSMs at age 14 were comparable to the associations between tempo and HSMs, it 
is important to bear in mind that while some studies found good agreement between 
PHV and secondary sexual characteristics, such as testicular volume (Bundak et al., 
2007) and age at menarche (Demirjian et al., 1985), others reported substantial 
variability in the timing of PHV across Tanner stages (Granados et al., 2015). For 
example, according to one study PHV is thought to occur between Tanner breast stages 
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2 and 3 and between Tanner genitalia stages 4 and 5 (Granados et al., 2015) or, 
according to Abbassi, between Tanner testis stages 3 and 4 (Abbassi, 1998).  
In the present study, clear associations between tempo and hip shape at age 14 were 
observed in males, while these were much weaker in females. One of the limitations of 
this study is the fact that by the time baseline hip DXA scans were performed in ALSPAC, 
the great majority of females had already entered puberty, making it difficult to detect 
effects on hip shape occurring in early puberty. On the other hand, effects occurring in 
later puberty should have been detectable had they been present. Finally, if pubertal 
timing exerted lasting effects on hip shape this would have likely been detected in 
females at age 14 and both sexes at age 18. Any future studies should consider matching 
males and females on maturational status in order to directly compare the effect of 
pubertal timing on hip shape in both sexes.  
 Conclusions  
This study offers some important insights into our understanding of periods critical for 
hip shape development. At age 14, I found strong evidence of an association between 
pubertal timing (as measured by growth tempo) and hip shape in males, suggesting this 
may be a sensitive period for environmental and other influences on hip shape which 
may ultimately determine the risk of hip OA and fracture in later life.  
The sex differences in relationships between pubertal timing and hip shape at age 14 
observed in this chapter might be due to variation in maturational status, i.e. compared 
with males, females were more advanced in terms of skeletal and sexual development 
as reflected by a higher proportion of females in advanced Tanner stages and the 
majority achieving PHV prior to TF 2 clinic attendance. However, given the lack of 
compelling evidence for a relationship between tempo and hip shape at age 14 in 
females and at age 18 in both sexes, it would seem that age at puberty does not exert 
lasting effect on hip shape post puberty.  
In conclusion, the results of this study indicate that puberty represents a critical period 
for hip shape development, in particular aspects of shape which may be related to 
future risk of hip OA and/or fracture. Therefore, stratification of at-risk individuals and 
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preventative measures early in life might reduce the risk of fracture and/or OA 
development in later life.  
Findings in this chapter suggest that age and sex differences observed in the preceding 
chapter could be partially attributed to differences in pubertal timing, given the strong 
associations between growth tempo and hip shape described in this chapter, 
particularly at age 14. However, weak associations between growth tempo and hip 
shape observed at age 18 suggest that pubertal timing may not exert lasting effects on 
hip shape, and thus cannot explain sex differences in hip shape that were observed at 
age 18.  
Moving forward, given the differences in pubertal stages at the time of TF 2 attendance 
and the fact that females mature quicker than males (as described in this chapter), the 
design of future studies investigating hip morphology should be carefully considered. In 
order to fully evaluate relationships with hip shape and related bone phenotypes across 
all pubertal stages, females should be recruited earlier than males while males should 
be followed for longer to account for longer period of the pubertal growth spurt, to 
allow matching of participants on their pubertal stage and thus direct comparison of the 




CHAPTER 5.  INVESTIGATING THE 
RELATIONSHIP BETWEEN BMD 
AND HIP SHAPE IN ALSPAC 
OFFSPRING  
 
5.1. Introduction and chapter aims 
OP and OA are both common age-related conditions associated with ill health, morbidity 
and significant economic burden (Jan Dequeker et al., 2003). While they are different 
diseases in terms of risk factors and genetics it is thought that bone metabolism plays a 
crucial role in the pathophysiology of both (Geusens & van den Bergh, 2016). On the one 
hand, low BMD (T-score of -2.5 or less) is used to diagnose OP and predict individual risk 
of osteoporotic fracture (Geusens & van den Bergh, 2016) whereas on the other, 
individuals with OA have been found to have increased BMD especially at weight 
bearing sites, such as hips and knees (Hardcastle et al., 2015b). As discussed previously, 
hip shape is also related to both disorders, having previously been found to be 
associated with hip fracture (Alonso et al., 2000; Gnudi et al., 1999) and the 
development of hip OA (Baker-LePain & Lane, 2010). Relationships of BMD and hip 
shape with OP and OA are generally thought to represent independent pathways (see 
Figure 5.1). However, given the biological pathways common to both conditions, and to 
different bone phenotypes, hitherto unexplored relationships may also exist between 
hip shape and BMD. 
Shared genetic factors may also contribute to the association between OP and OA, 
based on observations of significant shared heritability. For example, Antoniades et al. 
reported higher hip BMD in twins with hip OA compared with their unaffected cotwins, 
suggesting a role of shared genetic factors in hip OA and BMD (Antoniades et al., 2000). 
Consistent with this suggestion, a previous GWAS by Yerges‐Armstrong et al. identified 
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four BMD loci that were associated with knee OA (Yerges‐Armstrong et al., 2014), and 
one variant (rs7217932), located near the SOX9 gene, to be associated with hip OA 
(Yerges-Armstrong et al., 2014). More recently, in a GWAS by Hackinger et al. 
investigating shared aetiology between OA and BMD, 143 variants were found to be 
associated with OA and BMD, a number of which had known relevance to bone 
(Hackinger et al., 2017). Although these studies suggest that several BMD SNPs influence 
OA risk, whether BMD and hip shape share common genetic influences, helping to 
explain the association between OA and OP, is currently unknown. MR represents a 
useful framework to explore shared genetic contributions to hip BMD and hip shape. In 
its traditional sense, MR is used to assess a causal effect of modifiable exposure on an 
outcome. However, rather than being a cause or outcome, BMD and hip shape develop 
simultaneously, and are thus likely to be influenced by a common biological pathway 
(referred to as vertical pleiotropy (Swerdlow et al., 2016)).  
Figure 5.1 depicts known associations and pathways related to both OA and OP and the 
unknown association between BMD and hip shape, to be explored. In this chapter, I 
investigated whether shared developmental influences on hip BMD and hip shape might 
contribute to the OA-OP relationship, by firstly (i) investigating cross-sectional 
associations between hip BMD and the top ten HSMs in ALSPAC adolescents at age 14 
and 18; secondly ii) using one-sample MR, I aimed to determine the extent to which 
common genetic pathways underlie both BMD and hip shape. In the next chapter, I will 
investigate BMD and hip shape associations in adult women in order to provide better 




Figure 5.1 Schematic diagram representing relationship to be explored in this chapter 
(dashed blue line) and known pathways relevant to this analysis (solid black lines). 




Data were obtained from ALSPAC TF 2 and TF 4 clinics when the participants were on 
average 14 and 18 years old, respectively. The study population for observational 
analyses comprised individuals with complete data on outcome, exposure and 
confounders from each assessment clinic, and of those, individuals with genome-wide 
genetic data, comprised the study sample for MR analyses. For more details regarding 
data collection and cleaning please refer to the methods chapter (Chapter 2).   
5.2.2. Measures  
5.2.2.1. Outcome  
To quantify the shape of proximal femur, DXA images collected at TF 2 and TF 4 clinics 
were used. Images were analysed in Shape and to allow comparison between the time 
points scores from a consistent external adult reference SSM were applied to each data 
set (see Chapter 2 for details). The top ten HSMs were used as outcomes. For details see 
Chapter 2. 
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5.2.2.2. Exposure and covariate data 
DXA measured total hip BMD, acquired during TF 2 and TF 4 clinic (at mean ages of 13.8 
and 17.8 years, respectively), was used as exposure in the analysis. Age at clinic 
attendance, sex, height, lean and fat mass were considered potential confounders. For 
more details see Chapter 2.  
5.2.2.3. Genotyping 
ALSPAC participants were genotyped using the Illumina HumanHap550 quad genome-
wide SNP genotyping platform (Illumina Inc., San Diego, CA, USA). Quality control and 
exclusion criteria were performed, and data were imputed against the 1000 genomes 
reference panel (phase 1, version 3). For more details see Chapter 2.      
5.2.3. Statistical analysis 
5.2.3.1. Observational associations 
Cross-sectional associations between total hip BMD and hip shape at age 14 and 18 
were assessed using linear regression models. Firstly, age and sex adjusted analysis was 
performed (model 1) and subsequent model additionally adjusted for height, lean and 
fat mass (model 2). Sex differences were explored by comparing regression coefficients 
and their 95% CIs in gender stratified analysis and by formally testing for evidence of 
statistical interaction using a likelihood-ratio test. As the genetic risk score (GRS) was 
based on SNPs associated with FN BMD, observational associations between FN BMD 
and the top ten HSMs were also explored and compared with total hip BMD results. 
 
To provide intuitive visualization of results, the overall relationship between BMD and 
hip shape at each time point was modelled by simultaneously entering coefficients from 
linear regression into Shape software, for all modes showing evidence of an association 
with BMD (p<0.005). In order to aid visualization, coefficients entered into Shape, were 
multiplied by a factor of 10 and the figures are presented for combined and gender 
stratified results based on the fully adjusted model.  
Having found a number of associations with BMD, I further explored whether sex 
differences in hip shape (previously described in Chapter 3) could be explained by 
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differences in BMD. This was explored by further adjusting the model looking at sex 
differences in hip shape for BMD (model 3: adjusted for age, height, lean and fat mass 
and total hip BMD).  
5.2.3.2. Mendelian randomization 
In order to investigate shared genetic influences on BMD and hip shape, I performed 
one-sample MR analysis. Based on the largest meta-analysis to date of DXA measured LS 
and FN BMD by Estrada et al. in adults (Estrada et al., 2012), a genetic risk score (GRS) 
was constructed from 49 independent SNPs (for list of SNPs see Supplementary Table 
10.4.5 in Appendix 4) associated with FN BMD at the genome-wide level (p<5×10−8). 
Given the FN BMD SNPs were identified in adult GWASes, and therefore the published 
effect sizes might not represent the effect sizes in children, I constructed unweighted 
GRS. I used two-stage least squares (2SLS) instrumental variable (IV) analysis assuming 
an additive genetic model, to examine the association between GRS and the top ten 
HSMs. The strength of the instrument was assessed by examining the F-statistic (F > 10 
is regarded as a strong instrument (Staiger & Stock, 1997)). Linear regression to explore 
the strength of an association between the instrument and exposure was also 
performed. In addition, MR assumes that the instrument is independent of confounders, 
which was explored by examining associations between the GRS and confounders that 
were adjusted for in the observational analysis.  
 
5.3. Results 
5.3.1. Participant characteristics 
Table 5.1 shows the characteristics of study participants.  
A total of 4,428 participants (2,117 were male and 2,311 were female) who attended 
the TF 2 assessment clinic at a mean (SD) age of 13.8 (0.2) years had complete outcome 




A total of 4,369 participants (1,931 were male, 2,438 were female) who attended the TF 
4 assessment clinic, at a mean (SD) age of 17.8 (0.4) years, had complete outcome and 
covariate data. Of those, 3,175 individuals had complete phenotypic and genotypic data.  
At both time points males were taller, had greater lean mass and total hip BMD 
compared with females, whereas fat mass was greater in females compared with males.  
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Table 5.1; Characteristics of participants who attended TF 2 and TF 4 assessment 
clinics 
 
 TF 2 (Age 14) TF 4 (Age 18) 
  
N Mean (SD) p for 
sex 
diff* 
N Mean (SD) p for 
sex 
diff* 
Age M + F 4,428 13.8 (0.2) 0.36 4,369 17.8 (0.4) 0.59 
M 2,117 13.8 (0.2) 
 
1,931 17.8 (0.4) 
 
F 2,311 13.8 (0.2) 
 




M + F 4,428 163.4 (7.6) <0.001 4,369 171.2 (9.2) <0.001 
M 2,117 165.0 (8.7) 
 
1,931 178.7 (6.6) 
 
F 2,311 162.0 (6.2) 
 




M + F 4,428 13.9 (8.0) <0.001 4,369 18.4 (10.5) <0.001 
M 2,117 11.2 (7.7) 
 
1,931 14.1 (10.0) 
 
F 2,311 16.4 (7.5) 
 




M + F 4,428 38.0 (6.4) <0.001 4,369 45.7 (9.9) <0.001 
M 2,117 41.0 (7.2) 
 
1,931 55.2 (6.1) 
 
F 2,311 35.2 (4.0) 
 





M + F 4,428 1.0 (0.1) 0.006 4,369 1.1 (0.2) <0.001 
M 2,117 1.0 (0.1)  1,931 1.2 (0.2)  
F 2,311 0.99 (0.1)  2,438 1.1 (0.1)  
FN BMD 
(g/cm2) 
M + F 4,428 1.0 (0.1) 0.121 4,369 1.1 (0.1) <0.001 
M 2,117 0.97 (0.1)  1,931 1.14 (0.1)  
F 2,311 0.98 (0.1)  2,438 1.05 (0.1)  
*Unpaired t-test to assess the null hypothesis of no difference in distributions between 
males and females. Abbreviations: M (males), F (females) .
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5.3.2. Observational associations 
5.3.2.1. Age 14 
In minimally adjusted analyses adjusted for age and sex (model 1, males and females 
combined) there was strong evidence for an association between hip BMD and all 
modes except HSM2 (Figure 5.2). Following further adjustment for height, lean and fat 
mass (model 2) HSM1, HSM6 and HSM7 results were essentially unchanged, whereas 
associations with HSM8 and HSM10 were attenuated. In addition, the previously 
negative association between hip BMD and HSM3 switched to positive, whereas 
associations with HSM4 and HSM5 were strengthened. Interestingly, a strong positive 
association with HSM2 now emerged. On examining the association between BMD and 
HSM1, the adjustment for covariates made little difference to this result and similarly 
when adjusting for each covariate in turn, the beta coefficients remained broadly similar 
to the unadjusted estimate (results not shown). On the other hand, on examining the 
association between BMD and HSM5, when adjusting for each covariate in turn, the 
biggest change was observed following adjustment for lean mass and height 
(unadjusted beta 0.06 (0.04,0.09) p=4.9x10-8 vs. lean mass adjustment 0.15 (0.12,0.17) 
p=3x10-27; vs. height adjustment 0.13 (0.11,0.16) p=8.6x10-26). 
Figure 5.3 shows gender stratified results. There was strong evidence for gender 
interaction for modes 1 (p=0.002), 2 (p=0.005), 3 (p=0.001), 5 (p=5.8x10-8), and 9 
(p=2.6x10-10) (model 1) and HSM1 (p=0.004) and HSM9 (p=0.001) (model 2). The pattern 
of associations for modes 1, 2, 3, 4, 5, 8 and 10 were broadly similar (model 1 and 2) 
between sexes. However, some differences were noted. In particular, following 
confounder adjustment positive associations with HSM6, HSM7 and HSM9 emerged in 
females, whereas in males HSM7 and HSM9 results attenuated towards the null and 
there was no longer evidence of an association.  
When looking at the relationship between FN BMD and hip shape, the results were 
comparable with total hip BMD results (see Supplementary Table 10.4.1 for gender 
combined and Supplementary Table 10.4.2 for gender stratified results in Appendix 4). 
In general, associations between FN BMD and HSMs were slightly weaker in terms of the 
magnitude of effect, but in a consistent direction compared with total hip BMD results.  
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Figure 5.4 shows the overall relationship between higher hip BMD and hip shape, based 
on fully adjusted coefficients (model 2). In males and females combined, the total effect 
of increased hip BMD on hip shape was reflected by narrower FNW and changes in 
femoral head and greater and lesser trochanters. When the effect was plotted for males 
and females separately, no striking differences in the overall relationship between 





Figure 5.2 Linear regression coefficients with 95% CIs for the association between total 
hip BMD and the top ten HSMs in ALSPAC adolescents at age 14 (N=4,428). Results 
show SD change in HSM per SD increase in BMD. Model 1 adjusted for age and gender, 




Figure 5.3 Linear regression coefficients with 95% CIs for the association between total 
hip BMD and the top ten HSMs in ALSPAC adolescents at age 14, stratified by gender. 
Results show SD change in HSM per SD increase in BMD. Model 1 adjusted for age, 





Figure 5.4 Composite hip shape changes associated with higher hip BMD at age 14 based on fully adjusted coefficients (model 2) multiplied 
by a factor of 10. Dotted line (mean hip shape), solid line (overall change in hip shape per 10 x SD increase in BMD).
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5.3.2.2. Age 18 
Compared with age 14 results, the associations between hip BMD and HSMs at age 18 
(males and females combined) were broadly similar across the models (Figure 5.5). In 
minimally adjusted analyses (model 1, males and females combined) there was strong 
evidence for an association between hip BMD and several HSMs and following further 
adjustment for height, lean and fat mass associations with HSM2, HSM4, HSM5 and 
HSM9 were strengthened, associations with HSM1 and HSM6 remained unchanged, 
while association with HSM8 attenuated and there was no longer evidence of an 
association. Interestingly, associations with HSM3 and HSM7 emerged. Furthermore, the 
previously negative association with HSM10 switched to positive in the fully adjusted 
model, and there was evidence of an association in contrast to the fully adjusted result 
at age 14. There was strong evidence to suggest gender interaction for HSM5 (p≤9x10-4), 
HSM7 (p≤5.6x10-4) and HSM9 (p≤2.8x10-5) results (consistent for models 1 and 2).  
Similarly to age 14 results, when the analysis was stratified by gender some differences 
were observed (Figure 5.6). In males (minimally adjusted model) hip BMD was related to 
several modes and following full adjustment, there was evidence to suggest associations 
between hip BMD with the first five modes, and the direction of effect was consistent 
with age 14 results. However, in contrast with age 14 results, there was strong evidence 
for an association with HSM6 (both models) and some evidence for an association with 
HSM10 which emerged following adjustment for confounders. In females, the 
associations between BMD and hip shape were similar to age 14 results (both models), 
except there was little evidence for an association with HSM6 at age 18 (both models). 
The associations between FN BMD and hip shape (males and females combined) were 
comparable to the associations with total hip BMD (see Supplementary Table 10.4.3 in 
Appendix 4). Similarly, in gender stratified analysis the associations between FN BMD 
with HSMs were equivalent to those between total hip BMD (see Supplementary Table 
10.4.4 in Appendix 4), except the association between FN BMD and HSM2 which was 
weaker in males compared with total hip BMD result.  
On modelling the relationship between increased hip BMD across all HSMs, based on 
fully adjusted coefficients (model 2), findings were consistent across both time points 
(Figure 5.7 shows the effect at age 18). In gender combined analysis, the effect of 
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greater BMD was mainly reflected by narrower FNW, changes in the femoral head 
(smaller in superolateral and inferomedial aspects and larger in the medial aspect) and 
greater and lesser trochanters. When modelled in males and females separately, the 
effect was broadly similar reflecting narrower FNW and smaller greater trochanter with 
greater BMD. In addition, higher BMD was reflected by a smaller femoral head 
(superolateral and inferomedial aspects) in both sexes, and larger femoral head in the 
medial aspect which was more pronounced in females.  
 
 
Figure 5.5 Linear regression coefficients with 95% CIs for the association between total 
hip BMD and the top ten HSMs in ALSPAC adolescents at age 18 (N= 4,369). Results 
show SD change in HSM per SD increase in BMD. Model 1 adjusted for age and gender, 
model 2 adjusted for age, gender, height, lean and fat mass.  
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Figure 5.6 Linear regression coefficients with 95% CIs for the association between total 
hip BMD and the top ten HSMs in ALSPAC adolescents at age 18, stratified by gender. 
Results show SD change in HSM per SD increase in BMD. Model 1 adjusted for age, 




Figure 5.7 Composite hip shape changes associated with higher hip BMD at age 18 based on fully adjusted coefficients (model 2) multiplied 
by a factor of 10. Dotted line (mean hip shape), solid line (overall change in hip shape per 10 x SD increase in BMD). 
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5.3.3. Can sex differences in hip shape be explained by differences in BMD  
In Chapter 3, I found strong evidence for sex differences in several components of hip 
shape, independent of body size. Having found a number of relationships between BMD 
and hip shape, I further explored if sex differences in hip shape could be explained by 
differences in BMD between the sexes.  To explore this, multivariable linear regression 
exploring the effect of sex on hip shape was further adjusted for BMD.   
In Chapter 3, the differences in mean HSM scores between males and females were 
explored in unadjusted analysis (model 1), and in adjusted analysis controlling for age at 
clinic attendance, height, lean and fat mass (model 2). 
At age 14, further adjustment for hip BMD (Table 5.2, model 3) had little or no effect on 
the differences in HSM7, HSM8 and HSM9 scores between males and females, while the 
differences in HSM3 and HSM5 between sexes were strengthened. Interestingly, while 
there was little or no evidence for gender differences in HSM2 in unadjusted and body 
size adjusted analyses, respectively, following adjustment for BMD, evidence for gender 
differences emerged. In addition, following BMD adjustment sex differences in HSM4 
attenuated (with 30% decrease in beta coefficient).   
At age 18, further adjustment for hip BMD had little or no impact on HSM1, HSM3, 
HSM6, HSM8, HSM9 and HSM10 scores (Table 5.3, model 3); HSM2, HSM4 and HSM5 
results were attenuated (with decrease in beta coefficients of 30% and more); while 




Table 5.2; Differences in hip shape mode scores between males and females (age 14) 
 
Model 1 Model 2 Model 3 
HSM β (95% CI) p R2 β (95% CI) p R2 β (95% CI) p R2 
1 0.13 (0.11,0.15) 3.7x10-25 0.02 0.19 (0.16,0.22) 1.1x10-32 0.05 0.15 (0.11,0.18) 3.9x10-20 0.07 
2 0.06 (0.01,0.10) 0.013 1.4x10-03 -0.04 (-0.09,0.02) 0.163 0.09 -0.13+(-0.19,-0.08) 1.2x10-6 0.14 
3 -0.19 (-0.23,-0.15) 1.7x10-21 0.02 -0.35 (-0.40,-0.30) 5.6x10-46 0.11 -0.41+(-0.46,-0.36) 3.6x10-60 0.14 
4 0.22 (0.18,0.26) 4.8x10-28 0.03 0.18 (0.13,0.23) 1.1x10-12 0.03 0.13--(0.08,0.18) 8.6x10-7 0.05 
5 -0.18 (-0.23,-0.14) 6.1x10-15 0.01 -0.34 (-0.39,-0.28) 4.5x10-30 0.06 -0.43+(-0.49,-0.37) 3.7x10-47 0.1 
6 -0.14 (-0.18,-0.10) 9.8x10-12 0.01 -0.03 (-0.08,0.02) 0.210 0.03 -0.05 (-0.10,0.00) 0.056 0.03 
7 0.18 (0.15,0.22) 3.3x10-22 0.02 0.23 (0.19,0.28) 2.2x10-23 0.05 0.22 (0.17,0.26) 1.3x10-19 0.05 
8 -0.73 (-0.78,-0.67) 7.2x10-148 0.14 -0.87 (-0.93,-0.80) 2.3x10-145 0.22 -0.86 (-0.93,-0.80) 6.8x10-138 0.22 
9 0.12 (0.08,0.17) 1.5x10-7 0.01 -0.08 (-0.14,-0.03) 0.004 0.05 -0.10 (-0.16,-0.04) 5.2x10-4 0.05 
10 -0.01 (-0.04,0.03) 0.737 2.6x10-05 -0.02 (-0.06,0.03) 0.478 0.03 -0.02 (-0.06,0.03) 0.421 0.03 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows mean SD difference in HSM scores between males and females 
(N=4,428) and 95% CIs, p value and r squared (R2). Model 1: unadjusted, model 2: adjusted for age, height, lean and fat mass, model 3: 
model 2 + hip BMD. -- represents 30% or higher decrease in beta coefficient, + represents increase in beta coefficient following adjustment 
for BMD 
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Table 5.3; Differences in hip shape mode scores between males and females (age 18) 
 
Model 1 Model 2 Model 3 
HSM β (95% CI) p R2 β (95% CI) p R2 β (95% CI) p R2 
1 0.02 (-0.003,0.05) 0.084 0.001 0.09 (0.03,0.14) 0.001 0.005 0.07 (0.01,0.12) 0.015 0.01 
2 0.48 (0.43,0.52) 1.4x10-78 0.08 0.41 (0.31,0.51) 3.8x10-16 0.13 0.28--(0.18,0.38) 3.2x10-8 0.18 
3 0.13 (0.09,0.17) 5.1x10-11 0.01 0.17 (0.09,0.25) 4.6x10-5 0.05 0.13--(0.05,0.21) 0.002 0.06 
4 0.15 (0.11,0.20) 5.1x10-12 0.01 0.19 (0.10,0.28) 5.7x10-5 0.01 0.13 (0.04,0.22) 0.006 0.02 
5 0.39 (0.34,0.44) 5.7x10-53 0.05 0.29 (0.19,0.39) 3.4x10-8 0.06 0.19-- (0.09,0.30) 2.5x10-4 0.08 
6 -0.60 (-0.65,-0.55) 6.9x10-124 0.12 -0.53 (-0.63,-0.43) 1.2x10-24 0.13 -0.56 (-0.66,-0.45) 3.5x10-26 0.13 
7 0.003 (-0.04,0.04) 0.872 0.00 -0.09 (-0.18,-0.01) 0.036 0.04 -0.12+(-0.21,-0.03) 0.007 0.04 
8 -0.25 (-0.31,-0.20) 7.4x10-20 0.02 -0.31 (-0.42,-0.20) 4.5x10-8 0.05 -0.31 (-0.42,-0.20) 8.9x10-8 0.05 
9 0.49 (0.43,0.54) 2.0x10-72 0.07 0.33 (0.22,0.44) 4.8x10-9 0.08 0.29 (0.18,0.40) 3.6x10-7 0.08 
10 -0.07 (-0.11,-0.02) 0.004 0.002 -0.16 (-0.25,-0.06) 0.001 0.06 -0.18 (-0.27,-0.08) 2.4x10-4 0.06 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows mean difference in HSM scores between males and females 
(N=4,369) and 95% CIs, p value and r squared (R2). Model 1: unadjusted, model 2: adjusted for age, height, lean and fat mass., model 3: 
model 2 + hip BMD. -- represents 30% or higher decrease in beta coefficient, + represents increase in beta coefficient following adjustment 
for BMD  
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5.3.4. Mendelian randomization  
5.3.4.1. Association between BMD GRS and hip BMD  
Since the observational association between BMD and several HSMs persisted following 
adjustment for potential confounders, this suggests that important causal relationships 
may exist between BMD and hip shape, reflecting shared biological pathways, which I 
subsequently examined using a MR approach. There was strong evidence for an 
association between the BMD GRS derived using SNPs identified in adults, and hip BMD 
at both time points (Table 5.4), suggesting that despite age differences, this will prove 
useful for MR analyses of BMD in adolescents. At age 14, GRS explained 3% and 2% of 
variance in total hip and FN BMD, respectively. At age 18, GRS explained 3% of variance 
in total hip and FN BMD. This compares with 5.8% of genetic variance in FN BMD 
explained in adults (Estrada et al., 2012).   
5.3.4.2. Association between BMD GRS and confounders  
Associations between confounders and GRS are shown in Table 5.5. In general, there 
was no strong evidence for associations between GRS and confounders, except weak 
association between GRS and height at age 14 (p=0.02). While this could indicate a 
potential pleiotropic effect, the evidence is somewhat weak when considering the 
number of tests performed (0.05 α threshold corrected for 10 tests (five confounders 
tested at both time points) = 0.005).  
5.3.4.3. Mendelian randomization results  
At age 14 (Figure 5.8 and Supplementary Table 10.4.6 in Appendix 4), there was some 
evidence of positive associations between the hip BMD instrument and HSM1, HSM2 
and HSM5 and these results were in a consistent direction and of similar magnitude to 
the adjusted (for age, gender, height, lean mass and fat mass) observational associations 
when these analyses were restricted to individuals with complete genotype and 
phenotype data.  
At age 18 (Figure 5.9 and Supplementary Table 10.4.7 in Appendix 4), the MR analysis 
showed some evidence of positive associations between the hip BMD instrument and 
HSM2, HSM3 and HSM5. Associations with HSM2 and HSM5 were of similar magnitude 
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to the fully adjusted observational associations, whereas the magnitude of the effect of 
BMD on HSM3 was stronger compared with the observational effect.  
On comparing findings at both time points, associations with HSM2 and HSM5 were 
consistent across both time points in terms of the magnitude and direction of the effect. 
Both, positive HSM2 and HSM5 scores reflect smaller lesser trochanters. In addition, 
BMD was positively related to HSM1 at age 14, and although little evidence for an effect 
at age 18 was seen, the direction and magnitude of the effect was consistent with that 
at age 14. In addition, there was evidence for positive association between BMD and 
HSM3 at age 18 with comparable effect at age 14 although the evidence was weaker, 
with CIs overlapping zero. Positive HSM1 scores reflect loss of femoral head curvature 
and narrower femoral neck whereas positive HSM3 scores reflect narrower FNW and 




Table 5.4; Associations between genetic risk score and total hip and FN BMD at age 14 
and 18 
 SD change in outcome per 1 SD increase in GRS 
 Age 14 (N= 3,553) Age 18 (N = 3,175) 
Outcome β (95 % CI) p R2 β (95 % CI) p R2 
Hip BMD 0.18 (0.14, 0.21) 2.1x10-26 0.03 0.16 (0.13, 0.19) 1.6x10-19 0.03 
FN BMD 0.17 (0.14, 0.20) 9.3x10-25 0.02 0.17 (0.13, 0.20) 2.8x10-21 0.03 
Abbreviations: GRS (genetic risk score), CI (confidence interval). Table shows results of 
linear regression analysis between standardized unweighted genetic risk score and total 
hip and FN BMD in ALSPAC adolescents. Results are unit change in outcome per 
standard deviation increase in exposure, 95% CIs, p value and R2. 
 
Table 5.5; Associations between genetic risk score and confounders at age 14 and 18 
 
SD change in outcome per 1 SD increase in GRS 
 
Age 14 (N= 3,553) 
 
Age 18 (N = 3,175) 
Outcome β (95 % CI) p β (95 % CI) p 
Gender 0.01 (-0.01,0.03) 0.27 0.01 (0.00,0.03) 0.13 
Age at clinic attendance 0.00 (0.00,0.01) 0.38 0.01 (-0.01,0.02) 0.31 
Height 0.29 (0.04,0.54) 0.02 0.24 (-0.08,0.56) 0.15 
Lean mass 0.03 (-0.18,0.24) 0.81 -0.12 (-0.46,0.23) 0.51 
Fat mass 0.12 (-0.14,0.38) 0.38 0.16 (-0.19,0.52) 0.37 
Abbreviations: GRS (genetic risk score), CI (confidence interval). Table shows results of 
linear regression analysis between standardized unweighted genetic risk score and 
gender, age, height, lean and fat mass in ALSPAC adolescents. Results are unit change in 




Figure 5.8 Fully adjusted observational (dashed grey line) and MR (solid navy line) 
estimates and 95% CIs for the association between BMD and hip shape in ALSPAC 
adolescents at age 14.  
 
 
Figure 5.9 Fully adjusted observational (dashed grey line) and MR (solid navy line) 
estimates and 95% CIs for the association between BMD and hip shape in ALSPAC 




The relationship between BMD and hip shape with OA is well-established, however little 
is known about the relationship between BMD and OA-related endophenotypes. In this 
chapter, I examined the relationship between BMD and hip shape at age 14 and 18 in a 
cohort of ALSPAC adolescents and these analyses were followed up with MR approach 
to investigate shared genetic architecture underlying these relationships.   
 Summary of observational findings 
Observationally, I found strong evidence for associations between hip BMD and a 
number of HSMs at age 14 and age 18. In males, consistent associations between BMD 
and the first five modes were observed at both time points. While there was little 
evidence to suggest association with HSM6 at age 14, by the age of 18 there was robust 
evidence for an association and the effect was strengthened following confounder 
adjustment. In females, the effect of BMD on hip shape was consistent across the time 
points with the majority of modes related to BMD. Following adjustment for age, height, 
lean and fat mass these associations were strengthened (except HSM8 and HSM10 
results which attenuated and there was no longer evidence of an association). While 
there was evidence to suggest an association between BMD and HSM6 at age 14, there 
was little evidence for an association at age 18. In terms of the relationship between 
higher BMD across all HSMs combined, consistent associations were noted in both sexes 
across the time points, mainly reflecting narrower FNW, smaller greater trochanter and 
variation in femoral head (which appeared smaller in the superolateral and inferomedial 
aspects and larger in the medial aspect). 
 
In terms of sex differences in hip shape (previously described in Chapter 3), some 
associations were partly explained by differences in BMD. For example, sex differences 
in HSM4 at age 14 and HSM2, HSM4 and HSM5 at age 18 showed partial attenuation 
after adjustment for BMD. Interestingly, while there was previously no evidence of sex 
differences in HSM2 at age 14, these differences emerged following adjustment for 
BMD. One possible explanation for this could be due to opposing direction of effect 
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between confounder-exposure and confounder-outcome associations. For example, 
height, lean and fat mass were all negatively related to HSM2 (see Supplementary Table 
10.2.2 - Supplementary Table 10.2.4 in Appendix 2) whereas there was strong positive 
relationship between BMD and HSM2. Another possibility could be due to an artefact or 
measurement error.  
 Results in relation to published literature  
To my knowledge, this is the first study to explore the relationship between BMD and 
hip shape as quantified by SSM in a cohort of adolescents. One previous study explored 
the relationship between BMD and hip shape in a cohort of adults (mean age 63 years) 
from the MRC NSHD cohort (Pavlova et al., 2017). The authors reported an association 
between higher hip BMD and HSM3 in women and this mode reflected smaller neck-
shaft angle and greater acetabular coverage. This contrasts with findings in this chapter 
and is likely to reflect changes associated with age and other disease processes given 
the age of the MRC NSHD participants. The association between BMD and hip shape in 
this cohort was reflected by narrowing of FNW and variation in superolateral and 
inferomedial aspects of femoral head in both sexes. Hence, higher BMD was related to 
larger femoral heads (in the medial aspect). The relationship between FNW with 
osteoporotic fracture (Ego Seeman et al., 2001) and OA (Castaño‐Betancourt et al., 
2013b) has been investigated previously. In terms of OA risk, a previous study reported 
an association between wider FNW and higher risk of incident hip OA (Castaño‐
Betancourt et al., 2013b), suggesting that BMD-hip shape association is unlikely to 
explain the relationship between FNW and risk of OA. With regards to the relationship 
between FNW and hip fracture the evidence is conflicting, with previous studies 
reporting associations between both, wider and narrower FNW and hip fracture 
(Ahlborg et al., 2005; Alonso et al., 2000; Karlsson et al., 1996; Ego Seeman et al., 2001). 
Interestingly, larger femoral heads have been found to predict radiographic hip OA in a 
cohort of elderly women (Lynch et al., 2009), a feature similar to that observed when 
modelling the overall relationship between higher BMD and hip shape in adolescents in 
this study.  
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 Mendelian randomization  
Using a MR approach, I found some evidence for shared genetic mechanisms underlying 
BMD and hip shape. In particular, there was evidence for consistent positive 
associations between BMD and HSM2 (which observationally showed the strongest 
effect; fully adjusted betas =~0.2 in both sexes across the time points) and HSM5 at both 
time points. There was evidence of positive association with HSM1 at age 14 and HSM3 
at age 18. While there was little evidence to suggest association with HSM1 at age 18 
and HSM3 at age 14, the estimates were consistent between the time points and given 
the overlap of 95% CIs surrounding these estimates, an effect of BMD on hip shape 
cannot be ruled out hence follow up in a larger, independent cohort is required. HSM2, 
HSM3 and HSM5 all reflect variation in inferolateral aspect of femoral head, FNW and 
greater and lesser trochanters. HSM1 reflects variation in femoral head size and shape 
(variation is most pronounced in the medial aspect, additional variation in the 
superolateral and inferolateral aspects) along with FNW and greater and lesser 
trochanters.  
MR, which uses genetic variants as instrumental variables, is generally used to assess 
causality, which is important from a public health perspective as modifying causal 
exposures will in turn reduce disease risk or alter its course. However, in this context I 
used MR to evaluate the contribution of a common genetic pathway to two distinct 
developmental traits. For MR to be valid, several assumptions need to be met: the 
genetic instrument i) must be associated with the exposure of interest, ii) must not be 
associated with any confounders, and iii) must not directly influence the outcome, 
except through the exposure of interest. In this study, I found strong evidence for an 
association between GRS and DXA measured FN and total hip BMD (which satisfies the 
first assumption). When exploring the association between GRS and confounding 
variables, included in the observational analyses, no evidence for associations was 
found, except weak evidence for an association between GRS and height measured at 
age 14. While this could be a chance finding, given the number of tests that were 
performed, it is possible that this represents a true causal relationship. Consistent with 
this suggestion, a previous large-scale study in the UK Biobank reported that several loci 
for heel BMD were also related to height in the Genetic Investigation of Anthropometric 
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Traits (GIANT) consortium and this was also true for a number of DXA measured BMD 
loci (Kemp et al., 2017). Given the polygenic nature of genetic variants contributing to 
complex traits (Sivakumaran et al., 2011), it is possible that SNPs involved in skeletal 
growth and BMD acquisition also affect other traits. In this study, more than half of the 
variants included in the GRS were of unknown function to bone biology. While it is likely 
that some variants will have pleiotropic effects, the issue of horizontal vs. vertical 
pleiotropy needs to be carefully examined. While the latter (one variant has an effect on 
two or more traits that both influence the outcome via the same biological pathway) is 
not an issue for MR analysis, horizontal pleiotropy (one variant is associated with two 
traits which influence the outcome via independent biological pathways) could 
invalidate MR results (Yarmolinsky et al., 2018). One way of overcoming issues of 
horizontal pleiotropy would be to check published literature or GWAS databases for 
associations between BMD-related SNPs with other traits. This could then be followed 
up with a sensitivity analysis where only SNPs with known function and relevance are 
included and estimates between initial vs. restricted analyses are compared. In addition, 
statistical methods which detect and account for pleiotropy, such as MR-Egger 
regression and the weighted median estimator (Yarmolinsky et al., 2018), should also be 
considered.  
It is also worth noting that the GRS was based on BMD SNPs discovered in adult cohorts. 
While these SNPs may be responsible for BMD maintenance and bone loss, different 
variants might contribute to bone acquisition in adulthood. However, as shown in Table 
5.4 the instrument was strongly related to BMD in adolescence in my data and a 
previous study by Warrington et al. showed that BMD SNPs identified in adults were 
partly responsible for the rate of bone acquisition in adolescents (Warrington et al., 
2015).  
Despite strong observational evidence for associations between BMD and a number of 
HSMs, not all of these results were supported by MR. While the GRS was strongly 
associated with total hip and FN BMD at both time points and the F statistic (above 10) 
indicated good instrument strength, wide 95% CIs for the MR results that were observed 
in this chapter, are indicative of low power. For example, the power to detect an effect 
of BMD on HSM2, similar in magnitude to the observational estimate, was 72%, 
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however this would be much lower for the remaining modes which had smaller 
estimates. For that reason, these results should be followed up in a larger adolescent 
cohort to increase power and rule out chance finding.  
Nevertheless, MR results suggest that biological pathways underlying BMD variation 
could contribute to aspects of hip shape (such as variation in FNW described by HSM2, 
HSM3 and HSM5, and variation in femoral head size described by HSM1) which have 
previously been found to be associated with increased risk of OA (Castaño‐Betancourt et 
al., 2013b; Lynch et al., 2009) and/or fracture (Ego Seeman et al., 2001). In terms of 
specific pathways underlying BMD and hip shape and thus potential future risk of OA, 
Wnt pathway genes (associated with BMD in both adults and children) which play an 
important role in skeletal development and growth (Lodewyckx & Lories, 2009) also 
have a regulatory role in OA (Lane et al., 2017). In addition, recent hip shape GWAS 
meta-analysis in older adults (D. A. Baird et al., 2017) (using hip shape mode scores 
based on the same SSM template used throughout this thesis) found an association 
between SOX9 SNP and HSM5 (shape related to total hip BMD in observational and MR 
analysis), and this signal co-localised with that previously reported for SOX9 and hip 
BMD (D. A. Baird et al., 2017; Estrada et al., 2012). Inclusion of SOX9 in the hip BMD 
allele score is likely to have contributed to the relationship with HSM5 in MR analyses. 
Given the role of SOX9 in endochondral bone formation (Huang et al., 2001), these 
findings may reflect shared influences of longitudinal growth on hip shape and BMD. In 
order to identify specific pathways relevant to hip shape development, further analysis 
investigating the relationship between GRSes based on SNPs belonging to certain 
genetic pathways, such as Wnt signalling or RANK-RANKL-OPG, (an approach previously 
employed by Warrington et al. (Warrington et al., 2015)) should be undertaken. It is 
worth mentioning that although I found evidence for an association between a genetic 
instrument for BMD and hip shape, given the close relationship between these traits, a 
direct effect of BMD SNPs on hip shape cannot be ruled out. Therefore, future analysis 
should also explore the relationship between GRS based on variants with an established 
functional role with a clear effect on BMD. Furthermore, as our understanding of the 
genetic architecture underlying BMD (Kemp et al., 2017) and hip shape improves, future 
analysis could be extended to formally test for an overlap between BMD and hip shape 
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(Hackinger et al., 2017) enabling identification of additional shared loci and biological 
pathways common to these traits. If features likely to predict OA develop early in life 
this provides a window of opportunity for potential stratification of individuals into high 
risk groups and scope for early prevention. 
 Conclusions  
In this chapter, I explored the relationship between BMD and hip shape in ALSPAC 
adolescents. Observationally, BMD was related to a number of modes and the 
composite relationship between higher BMD and hip shape, which was reflected by 
narrower FNW and variation in femoral head, was consistent between sexes and across 
the time points. MR results suggested that shared genetic factors, presumably reflecting 
common biological mechanisms, influence both BMD and hip shape, partly explaining 
the association between these two traits in observational analyses. Hence, whereas hip 
shape may contribute to the association between OP and OA indirectly through 
biomechanical influences on hip shape, the present findings suggest that more direct 
biological relationship between hip shape and BMD may also play a role. Further studies 
in a larger sample of adolescents are justified to confirm these findings and identify 
specific pathways common to BMD variation and hip shape which will in turn help 
elucidate shared mechanisms related to OA and OP risk.  
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CHAPTER 6.  INVESTIGATING THE 
RELATIONSHIP BETWEEN BMD 
AND HIP SHAPE IN MIDDLE-AGED 
WOMEN  
 
6.1. Introduction chapter aims 
In the previous chapter, I found strong evidence for consistent observational 
associations between BMD and hip shape in ALSPAC adolescents at age 14 and 18. 
Furthermore, a MR results provided some evidence to suggest that shared genetic 
factors, influence both BMD and hip shape. Here, I repeated the observational analyses 
and used MR approach, in adult women from ALSPAC cohort, in order to gain 
understanding of shared genetic contributions to hip BMD and hip shape in adolescents 
and adult women. 
As described in the previous chapter the inverse relationship between OA and OP, as 
well as the role of hip shape in the development of hip OA and fracture risk prediction 
are well-established. In addition, previous studies found evidence for genetic overlap 
between BMD and OA suggesting shared genetic aetiology of these traits (Antoniades et 
al., 2000; Hackinger et al., 2017). However, whether BMD and hip shape share common 
genetic influences which might help explain the mechanisms underlying the OA-OP 
association, have not been explored previously.   
Therefore, the aims of this chapter are to 
(i) examine cross-sectional relationships between BMD and proximal femur shape in a 
cohort of adult women, and (ii) investigate whether shared genetic architecture 
underlies these relationships using two-sample MR analysis.  
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6.2. Methods 
6.2.1. Study population 
Data from ALSPAC mothers who attended the FoM 1 clinic, between 2008 and 2011, 
were used. The study population for observational analyses comprised mothers with 
complete data on exposure, outcomes and confounders, and of those, mothers with 
genome-wide genetic data, contributed to GWAS of hip shape. Summary statistics from 
hip shape GWAS in ALSPAC mothers (unpublished data) along with summary statistics 
from previously published GWAS of BMD (Estrada et al., 2012) were used for MR 
analysis.   
6.2.1.1. Outcome  
Hip shape in ALSPAC mothers was quantified in the same way as adolescent data (see 
Chapter 2 for full method description) and all images were aligned in Shape by Ben 
Faber and Denis Baird. Following shape alignment, Procrustes analysis and PCA were 
performed and the same adult reference SSM (described in section 2.5, Chapter 2) 
which was applied to adolescent data, was also applied to mothers’ images, allowing for 
direct comparison of adult and adolescent results. The top ten HSMs were used as 
outcome variables. For more details regarding hip shape quantification and data 
collection see Chapter 2. 
6.2.1.2. Exposure and covariate data 
DXA measured BMD, acquired during FoM 1 research clinic (at mean age of 48 years) 
was used as exposure. Age at clinic attendance, height, lean and fat mass were 
considered potential confounders. For more details regarding data collection and 
cleaning please refer to the methods chapter (Chapter 2, section 2.2.2.2).   
6.2.1.3. Genotyping 
ALSPAC participants were genotyped using the Illumina HumanHap550 quad genome-
wide SNP genotyping platform (Illumina Inc., San Diego, CA, USA). Quality control and 
exclusion criteria were performed, and data were imputed against the 1000 genomes 
reference panel (phase 1, version 3). For more details see Chapter 2, section 2.2.3.      
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6.2.2. Statistical analysis  
6.2.2.1. Cross-sectional analysis 
Descriptive statistics are expressed as means (SD). While selection of confounders was 
based on prior knowledge, univariable linear regression was used to assess the strength 
of statistical evidence of an association between each confounder with exposures and 
outcomes within this sample. Multivariable linear regression was used to explore the 
relationship between BMD and the top ten HSMs adjusting for age (model 1), and 
additionally for height, lean and fat mass (model 2). Results are expressed as regression 
coefficients (β) with 95% confidence intervals (i.e. SD change in HSM per SD increase in 
exposure). All cross-sectional analyses were performed in Stata version 14 (StataCorp, 
College Station, TX, USA). Though the primary analysis is with total hip BMD, the genetic 
instrument for BMD (see section 6.2.2.2 below) was based on SNPs associated with FN 
BMD, therefore observational associations between FN BMD and the top ten HSMs 
were also explored and compared with total hip BMD results. 
To provide intuitive visualization of results, the overall relationship between BMD and 
hip shape at each time point was modelled by entering coefficients from linear 
regression into Shape software, based on the fully adjusted model, for all modes 
showing evidence of an association with BMD (p<0.005). In order to aid visualization, all 
coefficients entered into Shape were multiplied by a factor of 10 (as in the previous 
chapter).  
6.2.2.2. Mendelian randomization 
Similarly to the previous chapter, I used a MR approach to investigate shared genetic 
influences on BMD and hip shape. In this instance, I was able to use a two-sample MR 
approach given the availability of GWAS results of BMD in adults (Estrada et al., 2012) 
and hip shape GWAS results in ALSPAC mothers (analysis performed by Denis Baird; 
unpublished data). In contrast to one-sample MR, this method uses summary statistics 
data (as opposed to one-sample MR which used person level data) and has the added 
advantage of increased statistical power. In addition, obtaining BMD and hip shape 
instruments from non-overlapping samples (as in this chapter) eliminates the issue of 
‘winners curse’ which can underestimate effects in one-sample MR setting (Lawlor, 
2016). 
 181 
SNP-exposure effects were based on the largest meta-analysis of DXA-measured FN and 
LS BMD by Estrada et al. (Estrada et al., 2012). I selected 49 SNPs (the same variants 
were used for analysis in Chapter 5) that were associated with FN BMD at genome-wide 
significant level (P < 5 × 10−8). FN BMD effect estimates based on a sample of 83,894 
(combined discovery (stage 1) and replication (stage 2) samples) were recorded. These 
estimates and therefore effect allele frequencies were consequently flipped to 
represent FN BMD increasing effects (see Supplementary Table 10.5.3 in Appendix 5 for 
a list of SNPs). To obtain the SNP-outcome effects, FN BMD associated SNPs were then 
looked up in summary statistics from hip shape GWAS of ALSPAC mothers, and the 
coefficients along with SEs were recorded. The SNP-exposure and SNP-outcome effects 
were harmonized (Hartwig et al., 2016) (i.e. variants not sharing the same allele pair 
between the data sets were identified and either corrected, where possible, or 
removed) and inverse-variance-weighted (IVW) approach using TwoSampleMR package 
in R version 3.4.1 was performed to estimate the overall effect of BMD increasing 
variants on hip shape.  
6.3. Results  
6.3.1. Sample characteristics 
Of 11,264 (82%) women invited to the assessment clinic, 4,834 (43%) attended. A total 
of 4,289 (89%) who attended the assessment clinic, had complete outcome and 
covariate data. Of those, a total of 3,111 contributed to hip shape GWAS. In comparison 
with the 9,511 women excluded because of non-clinic attendance or missing data, those 
with complete data were older at birth of their child, more likely to have a university 
degree, own their own property and were less likely to smoke when recruited to the 
study (Table 6.1). Table 6.2 shows the characteristics of women participating in the 
study. Their mean age was (SD) 47.9 (4.4) years, and mean BMI was 26.7 (5.6) kg/m2.   
Table 6.3 shows the means and SDs for the top ten HSMs. Compared to mean=0 and 
SD=1 when using individual cohort data, when using the combined adult reference SSM 
means ranged from -0.35 to 1.45 and SDs were in the range of 0.53-1, which most likely 
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reflects the differences between the scanners used for each cohort included in the adult 
reference SSM (as described previously in Chapter 2, section 2.5.2).  
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Table 6.1; Baseline characteristics in women who attended the research clinic, and had 
data available for exposure, outcome and main confounder variables, and women 
initially recruited but did not attend the first follow up clinic assessment of mothers 
 1Unpaired t-test for continuous variables and chi-square test for categorical variables to 
assess the null hypothesis of no difference in those who did and those who did not 
attend the follow-up clinic.
 Mean (SD) for continuous variables and prevalence n 
(%) for categorical variables 
Subjects with no data 
available  
N = 9,511 
Current study 
population  
N = 4,289 
 
Total N N (%) Total N N (%) P 
value1  
Age at birth of child (years)  9,511 27.2 (5.0) 4,289 29.6 
(4.5) 
<0.001 
Had a university degree at 
time of index pregnancy [n 
(%)] 
8,085 800 (9.9) 4,175 777 
(18.6) 
<0.001 





Owned property at time of 








Table 6.2; Characteristics of participating ALSPAC cohort study adult women (N=4,289) 
Variable Mean (SD) 
Age (years) 47.9 (4.4) 
Height (cm) 164.0 (6.2) 
Fat mass (kg) 27.2 (10.9) 
Lean mass (kg) 41.3 (5.1) 
Total hip BMD (g/cm2) 1.03(0.14) 
Femoral neck BMD (g/cm2) 0.99 (0.13) 
BMI (kg/m2) 26.7 (5.6) 
Abbreviations: SD (standard deviation), BMD (bone mineral density), BMI (body mass 
index). 
 
Table 6.3; Summary statistics for the top ten HSMs in ALSPAC mothers (N= 4,289) 
based on the adult reference SSM template 
HSM and % var. explained* Mean HSM score (SD) 
1 (42%) 1.45 (0.53) 
2 (13%) -0.01 (0.90) 
3 (8.5%) -0.31 (0.92) 
4 (6.1%) 0.32 (0.77) 
5 (4.1%) -0.35 (0.94) 
6 (3.4%) -0.01 (1.00) 
7 (2.6%) -0.14 (0.87) 
8 (2.5%) 0.06 (0.95) 
9 (1.8%) 0.34 (0.95) 
10 (1.5%) 0.11 (0.92) 
Abbreviations: HSM (hip shape mode), var (variance).  
*Variance explained in the adult reference model.   
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6.3.2. Cross-sectional associations 
6.3.2.1. Confounder- exposure and confounder- outcome associations  
Supplementary Table 10.5.6 and Supplementary Table 10.5.7 in Appendix 5 show the 
associations between confounders and exposures used in the main analysis. As 
expected, there was strong evidence for associations between all confounders and both, 
total hip and FN BMD.   
Supplementary Table 10.5.8 in Appendix 5 shows associations between each 
confounder and the top ten HSMs. There was strong evidence for an association 
between age and HSM3 and HSM4 and very weak evidence for an association with 
HSM10. There was strong evidence for an association between height and HSM2, HSM5, 
HSM8 and HSM10. There was strong evidence for an association between both fat and 
lean mass and the majority of HSMs, except HSM3 (lean mass), HSM4 and HSM6 (lean 
and fat mass).    
6.3.2.2. Total hip BMD and FN BMD associations 
In age adjusted analysis, there was strong evidence for an association between total hip 
BMD and HSM1, HSM3, HSM5, HSM6, HSM7 and HSM9 and weak evidence to suggest 
an association with HSM2 (model 1, Figure 6.1). Following adjustment for height, lean 
and fat mass associations with HSM1, HSM3, HSM6 and HSM9 remained unchanged, 
whereas associations with HSM2, HSM5, and HSM7 were strengthened and an 
association with HSM10 emerged (model 2, Figure 6.1).  
The overall relationship between higher hip BMD and hip shape, independent of age, 
height, lean and fat mass was reflected by narrower FNW, smaller lesser trochanter, 
larger femoral head in the medial aspect but smaller in the superolateral aspect (Figure 
6.2).  
Associations between FN BMD and hip shape were similar to that with total hip BMD 
results (both age adjusted and fully adjusted models, Supplementary Figure 10.5.1 in 
Appendix 5), however the magnitude of the effect in FN BMD analyses was generally 
weaker. In addition, while associations between total hip and FN BMD with HSM4 were 
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in the same direction, there was strong evidence for FN BMD association and little 
evidence for total hip BMD association (with confidence intervals overlapping 0).  
On modelling the relationship between increased FN BMD across all HSMs based on 
fully adjusted coefficients, findings were similar to that of total hip BMD (Supplementary 
Figure 10.5.2 in Appendix 5) with higher FN BMD associated with narrower FNW, smaller 
lesser trochanter and variation in femoral head (medial and superolateral aspects).  
 
 
Figure 6.1 Linear regression coefficients (black and dashed grey lines) with 95% CIs for 
the association between total hip BMD and the top ten HSMs. Results show SD change 
in HSM per SD increase in BMD. Model 1 adjusted for age, Model 2 additionally 





Figure 6.2 Hip shape changes observed per SD increase in total hip BMD based on fully 
adjusted coefficients (model 2) (to aid visualisation each coefficient was multiplied by 
a factor of 10). Multiple regression coefficients, showing associations with total hip 
BMD (see Supplementary Table 10.5.1 in Appendix 2) were entered into Shape 
software and the combined relationship between total hip BMD and hip shape 
plotted. Dotted line represents mean hip shape, solid line represents composite 
change in hip shape per 10 x SD increase in total hip BMD. 
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6.3.2.3. Adolescent vs. adult results  
Compared with fully adjusted observational associations between total hip BMD and hip 
shape in adolescent females (both time points) and adult women, there was strong 
evidence to suggest associations with HSM1, HSM2, HSM3, HSM5 and HSM7 in both, 
adolescent and adult women (Figure 6.3). In terms of the magnitude of the effect, 
associations with HSM2 and HSM5 were weaker in adult women compared with 
adolescents, associations with HSM1 and HSM3 were slightly stronger in adult women, 
whereas associations with HSM7 were similar to age 18 results, with a slightly weaker 
effect at age 14. Interestingly, while in adolescents’ hip BMD was positively related to 
HSM9 (at both time points) this association was negative in adult women.   
The combined relationship between higher hip BMD and hip shape (based on fully 
adjusted model) in both adolescent and adult women was very similar, with higher hip 
BMD associated with narrower FNW, smaller lesser trochanter and larger femoral head 
(medial aspect).  
 
Figure 6.3 Linear regression coefficients with 95% CIs for the association between total 
hip BMD and the top ten HSMs in adolescent females at age 14 (yellow line) and 18 
(blue line) years and adult women (red line). Analysis adjusted for age, height, lean 
and fat mass (model 2). 
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6.3.3.  Two-sample Mendelian randomization 
Having identified strong observational relationships between BMD and a number of 
HSMs, I followed this up with a two-sample MR approach. FN BMD GWAS identified 49 
SNPs at genome-wide level, and these were identified in the outcome GWAS (hip shape 
GWAS in 3,111 ALSPAC mothers). Of these SNPs, four were removed due to 
harmonization issues.  
Based on a total of 45 SNPs, there was no compelling evidence for an association 
between BMD and hip shape (Figure 6.4 and Supplementary Table 10.5.5 in Appendix 5). 
When looking at the relationship between BMD and HSM2 (which, in terms of the 
magnitude, showed the strongest observational effect), compared with the fully 
adjusted observational effect (0.13 (0.10, 0.15) p=5x10-20) the 2-sample IVW MR 
estimate was slightly stronger (0.17 (-0.03, 0.37) p=0.09), but there was still little 
evidence of an association. Similarly, the MR estimate for the association between BMD 
and HSM9 (-0.11 (-0.27, 0.06) p=0.2) appeared stronger and in a consistent direction 
with the observational effect (-0.06 (-0.09, -0.02 p = 3x10-36), but again the MR estimate 
was under-powered, with wide CIs overlapping 0. 
It is worth noting that the power to detect an effect of 0.13 with a sample size of 3,111 
was 63%, and sample size of N=~4,700 would be required to detect an effect of 0.13 at 
80% power. Therefore, larger samples are required in order to detect smaller effects (for 
example, to detect an effect of 0.11 with 80% power N= ~13,600 would be required) 




Figure 6.4 Linear regression (dashed grey lines) and Mendelian randomization (using 
inverse variance weighted method) estimates (solid navy line) between BMD and the 
top ten HSMs. Results are SD change in HSM per SD increase in BMD. Observational 
(Obs) associations adjusted for age, height, lean and fat mass and based on N= 4,289. 
 
 Adult vs. adolescent results  
While there was consistent evidence to suggest associations between BMD with HSM2 
and HSM5 at both time points in adolescents (using a one-sample MR approach), there 
was little evidence for an association between BMD and hip shape in adult women 
(using a two-sample MR approach). However, IVW estimates for HSM2 in mothers were 
consistent with the magnitude of effect in adolescents, in particular at age 14 (Figure 
6.5) with overlapping 95% CIs. While there was consistent evidence for an association 
between BMD and HSM5 in adolescents, IVW estimates in mothers were close to the 




Figure 6.5 One-sample (TSLS) and two-sample (IVW) MR estimates for the association 
between BMD and hip shape in ALSPAC adolescents at age 14 (yellow line) and 18 
(blue line) and ALSPAC mothers (red line). Abbreviations: TSLS (two-stage least 




In the previous chapter, I found strong evidence of observational associations between 
BMD and hip shape in ALSPAC adolescents and MR analysis provided evidence for 
shared genetic aetiology between these traits. In this chapter, I first investigated 
observational associations between BMD and hip shape in adult women and further 
explored whether this relationship could be due to shared genetic aetiology. 
 Summary of observational results  
Observationally, there was strong evidence for associations between hip BMD and a 
number of HSMs. Following adjustment for body size, associations with HSM2, HSM5 
and HSM7 were strengthened, while the remaining results were essentially unchanged.  
Associations between FN BMD and hip shape were comparable with total hip BMD 
results; however, the magnitude of FN BMD-hip shape associations was slightly weaker 
compared with the total hip BMD associations. In addition, while little evidence of an 
association between FN BMD and HSM2 was observed in the age adjusted model this 
association was strengthened following adjustment for body. One possible explanation 
for this could be due to opposing confounder-exposure and confounder-outcome 
associations, i.e. positive confounder-exposure and negative confounder-outcome 
associations which were observed in the current analysis. As expected, height, lean and 
fat mass were all positively associated with FN BMD, while the association with age was 
negative. With regards to confounder–outcome associations; both lean and fat mass 
were negatively associated with HSM2, and there was no evidence of an association 
between age and height with HSM2 (see Supplementary Table 10.5.6 and 
Supplementary Table 10.5.8 in Appendix 5). Another possibility could be due to artefact 
or measurement error. Finally, given similar findings when assessing the relationship 
between total hip BMD and HSM2 this result is likely to represent true underlying 
relationship between FN BMD and HSM2.   
The combined relationship between higher BMD and hip shape was represented by 
narrower FNW, smaller lesser trochanter and larger femoral head, particularly in the 
medial aspect.  
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 Adolescent vs. adult results  
When comparing adolescent with adult results consistent associations were observed 
with several modes. In general, the results were in a consistent direction, except the 
association with HSM9 which was positive in adolescents and negative in mothers. In 
terms of the magnitude of the effect, associations with HSM1 and HSM3 were stronger 
and associations with HSM2 and HSM5 were weaker in adult women compared with 
adolescents. However, when considering the magnitude of estimates, it should be noted 
that lower modes explain more variance compared with each subsequent mode (with 
HSM1 explaining the most variance in the dataset). Therefore, smaller effects in lower 
modes, i.e. 0.10 SD increase in HSM1 per SD increase in BMD observed in this chapter, 
could be of greater importance than 0.16 SD increase in HSM3 given the difference in 
variance explained by these modes (42% for HSM1 vs. 8.5% for HSM3). As described in 
Chapter 2, one of the limitations of SSM is that a model built for a particular dataset is 
only relevant to that dataset, making comparisons with other studies problematic. In my 
thesis, I tried to overcome this issue by applying the same SSM template (based on a 
large adult dataset based on over 19,000 images) to both adolescent and mothers’ 
images enabling direct comparison of each HSM between the time points. However, it 
needs to be noted that I was unable to calculate the variance explained in the 
adolescent dataset after applying the adult SSM template, thus making interpretation of 
the magnitude of beta coefficients in relation to variance explained by each mode 
difficult. However, similar means and distributions of the top ten modes (as shown in 
Chapter 2, section 2.5.2) observed in both, adolescents and adult females from ALSPAC, 
could suggest that the magnitude of effect is comparable. Therefore, the combined 
effect of higher BMD on hip shape was probably similar in both adolescents and adult 
women, with higher BMD reflecting narrower FNW and larger femoral heads. 
 Comparison with published literature 
While the relationships between higher BMD and OA (Hardcastle et al., 2015b) and the 
role of hip shape in OA development (Baker-LePain & Lane, 2010) and increased fracture 
risk (Gregory et al., 2004) are well-established, the associations between BMD and hip 
morphology have not been explored in detail. To my knowledge, only one previous 
study, in adults from the NSHD cohort who were all born in 1946, explored the 
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association between BMD and hip shape in men and women (Pavlova et al., 2017). In 
contrast to findings in this chapter, the authors reported an association between higher 
hip BMD and HSM3 in women and this mode reflected a lower neck-shaft angle and 
greater acetabular coverage. It is important to bear in mind that the mean (SD) age of 
women in the current study was 47.9 (4.4) years, compared with 63.3 (1.09) years in the 
NSHD cohort. As expected, mean (SD) total hip BMD in NSHD women was lower 
compared with ALSPAC women, 0.87 (0.13) vs. 1.03 (0.14) g/cm2, respectively. Due to 
the properties of SSM, the individual modes from the NSHD cohort cannot be directly 
compared with those from ALSPAC, although subjective, qualitative comparisons 
regarding variation described by these modes can be made. For example, HSM6 which 
was positively associated with BMD in ALSPAC mothers also reflected increased 
acetabular coverage, although not as pronounced as in the NSHD cohort, likely to be the 
result of age differences between these cohorts.    
The associations between BMD and hip shape, reported in this chapter, could 
conceivably contribute to the relationship between OP and OA. In a study by Lynch et 
al., larger femoral heads have been found to predict radiographic hip OA in a cohort of 
elderly women (Lynch et al., 2009), a feature similar to that observed when modelling 
the overall relationship between higher BMD and hip shape in adult women and 
adolescents (as discussed in the previous chapter). Conversely, Castano-Betancourt 
reported an association between wider FNW and higher risk of incident hip OA 
(Castaño‐Betancourt et al., 2013b), suggesting that BMD-hip shape association is 
unlikely to explain the relationship between FNW and risk of OA.   
In terms of the relationship between FNW and osteoporotic hip fractures, the evidence 
is inconclusive. While some studies reported associations between wider neck with hip 
fracture in both males and females (Alonso et al., 2000; Karlsson et al., 1996), others 
found reduced FNW in men with hip fractures (Ego Seeman et al., 2001) and narrower 
FNW in women was associated with increased risk of hip fracture (Ahlborg et al., 2005). 
Others yet, found that the association between femoral neck diameter and trochanteric 
hip fracture in a study of elderly women, fully attenuated following adjustment for age, 
height, weight and BMD (Duboeuf et al., 1997). It has been previously recognized that 
individual geometrical measurements are often highly correlated with those of body size 
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(Gregory & Aspden, 2008), therefore cannot be interpreted in isolation. More advanced 
quantification techniques independent of body size, such as SSM will be better suited 
for such analyses and may offer opportunities for identifying new predictors of hip 
fracture independent of both, BMD and body size.  
 Mendelian randomization 
In the observational analysis I adjusted for age, height, lean and fat mass, however it is 
possible that the relationship between BMD and hip shape could be explained by other 
factors that were either not measured or adjusted for. To avoid such issues and further 
explore the underlying mechanisms contributing to the BMD-hip shape relationship, the 
observational analysis was followed up with two-sample MR. There was no strong 
evidence to suggest association between BMD and hip shape in ALSPAC mothers.  
Compared with the adolescent results, HSM2 results were consistent in terms of 
direction with a slightly weaker magnitude of effect, however there was little evidence 
either for or against an effect, with wide 95% CIs. Compared with a one-sample 
approach, which requires person-level data (Chapter 5), a two-sample approach 
(employed in this chapter) uses summary level data. While the latter offers more power 
to detect causal effect compared with a one-sample approach, it requires strong 
instruments based on large non-overlapping samples. Compared with BMD instrument, 
based on a sample of approximately 84,000 individuals, hip shape GWAS relied on a 
sample of ~3,000 mothers thus resulting in less precise estimates (as reflected by larger 
SEs compared with BMD instrument). Therefore, in a two-sample setting any bias arising 
from a weak instrument is likely to bias the results towards the null (Burgess et al., 
2016b; Lawlor, 2016). In order to combat this bias, future analysis should consider using 
a stronger instrument for hip shape, for example recent results from hip shape GWAS 
meta-analysis based on approximately 16,000 individuals (D. A. Baird et al., 2017), as 
well as stronger instruments for BMD such as GWAS in 142,487 individuals from the UK 
Biobank study (Kemp et al., 2017). GWASes on large samples are likely to identify novel 
variants associated with BMD and hip shape and in turn are likely to explain larger 
proportion of variance in these traits thus resulting in better power for future analyses 
(Burgess et al., 2015). 
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 Conclusions  
In this chapter, I found strong observational evidence for associations between BMD 
and a number of HSMs. The overall relationship between higher BMD and hip shape, 
which was reflected by narrower FNW and variation in femoral head size was consistent 
with the results observed in adolescents and this finding may help to explain the inverse 
relationship between OP and OA. When using a MR approach to investigate shared 
genetic contributions to BMD and hip shape, there was little evidence of an association 
between BMD and hip shape in adults, most likely reflecting limited power. The 
suggestion from my findings that the relationship between BMD and hip shape 
contributes to the inverse relationship between OP and OA warrants further 
investigation based on a larger sample. 
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CHAPTER 7.  GENETIC VARIANTS 
ASSOCIATED WITH HIP SHAPE IN 
ADOLESCENTS  
 
7.1. Introduction and chapter aims 
As highlighted in Chapter 1, OA is a complex disease with an estimated heritability of 
between 30% and 65% (Warner & Valdes, 2016). Previous studies identified 21 loci 
associated with hip, knee and hand OA (Cibrián Uhalte et al., 2017) and a recent UK 
Biobank study identified a further nine loci, which together account for 26% of variance 
in OA (Zengini et al., 2018). OA is very heterogenous which might explain why a fairly 
modest number of OA-associated loci (compared with other complex traits such as 
diabetes) have been identified by GWAS to date. In order to increase power, recent 
studies have focused on OA-related endophenotypes and this approach is likely to 
identify genetic variants with functional potential. For example, a recent GWAS of 
Rotterdam study cohorts identified a number of novel variants associated with OA-
related endophenotypes (such as joint space width and JSN) (Boer et al., 2018), which is 
likely to improve our understanding of underlying disease mechanisms. Another GWAS 
of 770 cases with DDH and 3,364 healthy controls, in the NJR, identified rs143383 
polymorphism in GDF5 to be robustly associated with DDH case status (Hatzikotoulas et 
al., 2017), and the same variant has previously been reported to be associated with 
increased OA risk (Chapman et al., 2008). These findings are consistent with the 
suggestion that OA development is mediated through joint shape and variants 
associated with hip morphology are likely to mediate this relationship. Thus, studying 
genetics of hip shape may shed a light on disease pathogenesis and determine how early 
genetic risk factors for OA influence OA-related traits which might in turn point towards 
new disease modifying targets.  
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In this chapter I aim to:  
1) Identify genetic variants associated with hip shape in adolescents, and 
additionally  
a. perform a look-up of any adolescent genome-wide significant variants in 
an adult cohort,  
b. check previous literature for associations with other phenotypes and 
formally test for genetic correlations with other phenotypes. 
2) Determine if genetic variants associated with adult hip shape have similar effects 
on hip shape across adolescence.  




7.2.1. Study population 
Data were obtained from ALSPAC TF 2 and TF 4 clinics when the participants were on 
average 14 and 18 years old, respectively. The study population for current analyses 
comprised individuals with complete phenotypic and genotypic data. For more details 
regarding data collection and cleaning please refer to the methods chapter (Chapter 2).   
7.2.2. Data 
7.2.2.1. Genome- wide genetic data 
As described in Chapter 2, ALSPAC offspring were genotyped using Illumina 
HumanHap550 quad genome-wide SNP genotyping platform and were imputed to 1000 
Genomes. A number of quality checks were applied, and the analysis was restricted to 
individuals of European descent, as described previously. 
7.2.2.2. Outcome and covariate data 
Hip DXA images collected during TF 2 and TF 4 clinics were used to quantify the shape of 
the proximal femur. HSMs were generated and scores from a consistent external adult 
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reference SSM were applied to each data set (as described in Chapter 2). The first ten 
HSMs were used as outcomes as in previous chapters. Age at clinic attendance and sex 
were used as covariates in the analysis. For more details on data collection and 
quantification of hip shape see Chapter 2.  
7.2.3. Analysis 
7.2.3.1. GWAS analysis  
Linear regression analyses to explore the association between each SNP and the top ten 
HSM scores at age 14 and 18 were performed using SNPTEST v2.5. An additive genetic 
model was assumed, adjusting for age and sex.  
Example code (adapted from Lavinia Paternoster 
https://github.com/epxlp/GWAS_scripts) that was used to perform the analysis is 
available in Appendix 6.  
Any SNPs reaching genome wide significance (P<5x10-8), a threshold traditionally 
applied to GWAS findings (McCarthy et al., 2008), were looked up in MR-Base PheWAS 
(Hemani et al., 2016) (http://phewas.mrbase.org/) to identify other phenotypes that 
might be associated with these hip shape loci (genome-wide ‘suggestive’ threshold for 
associations with other traits was set to P<5x10-5).  
In order to explore the functional potential of hip shape associated SNPs, a look-up of 
these SNPs was performed in a summary expression quantitative trait loci (eQTLs) 
results in order to identify any correlations between these variants and all available 
tissue-specific gene expression levels using the GTEx portal 
(https://www.gtexportal.org/home/, accessed on 11/05/2018). The tissues that were 
available include whole blood, skeletal muscle or adipose tissues (for more details, 
please refer to GTEx portal).  
7.2.3.2. Replication 
A look-up of genome-wide-significant hits found in adolescents (across the time points) 
was performed (by Denis Baird) in corresponding HSM results in hip shape GWAS in 
ALSPAC mothers and meta-analysis of GWASes performed in other cohorts (including 
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Twins UK, MrOS, SOF, and Framingham). Both adult and adolescent analyses relied on 
the same SSM template, allowing direct comparison of adolescent and adult results.  
7.2.3.3. The effect of adult hip shape variants on adolescent hip shape   
Previous meta-analysis of GWAS in adults identified 9 loci associated with hip shape 
(five SNPs were associated with HSM1, three with HSM2 and one with HSM5) (D. A. 
Baird et al., 2017) and I looked up these loci within ALSPAC adolescent results in 
relevant modes at both time points.     
7.2.3.4. Look-up of known OA variants in adolescent hip shape 
Based on a 2016 review of candidate gene and GWA studies by Zengini et al. (Zengini et 
al., 2016) and the largest to date OA GWAS in the UK Biobank (Zengini et al., 2018), 17 
SNPs associated with hip OA at a genome-wide significant level (P<5x10-8) were selected 
(of these variants, three were just below the genome-wide significance with P<8x10-8; 
see Table 7.1 for a list of SNPs) and a look-up of these variants was performed in 
GWASes of the top ten HSMs at both, age 14 and age 18 results. The 0.05 α threshold 




Table 7.1; List of SNPs associated with hip OA available from previously published literature 
Index 
variant 
Nearest gene Ethnic 
group 
Joint site Sex RA RAF Reported OR (95% CI) Reported  
P value 
Ref. 
rs3771501 TGFA EUR hip both G 0.53 0.94 (0.92–0.96) 1.66×10−8 a 
rs6976 GLT8D1 EUR knee & hip both T 0.37 1.12 (1.08 - 1.16) 7.2x10-11 b 
rs10948172 SUPT3H- CDC5L EUR knee & hip M G 0.29 1.14 (1.09 - 1.20) 7.9x10-8 
rs9350591 FILIP1- SENP6 EUR hip both T 0.11 1.18 (1.12 - 1.25) 2.4x10-9 
rs11780978 PLEC EUR hip both A 0.39 1.13 (1.08–1.17) 1.98×10−9 a 
rs4836732 ASTN2 EUR hip F C 0.47 1.20 (1.13 - 1.27) 6.1x10-10 b 
rs10492367 KLHDC5- PTHLH EUR hip both T 0.19 1.14 (1.09 - 1.20) 1.5x10-8 
rs835487 CHST11 EUR hip both G 0.34 1.13 (1.09 - 1.18) 1.6x10-8 
rs11842874 MCF2L EUR knee & hip both A 0.93 1.17 (1.11 - 1.23) 2.1x10-8 
rs12901071 SMAD3 EUR knee & hip both A 0.68 1.08 (1.05 - 1.11) 3.1x10-10 c 
rs8044769 FTO EUR knee & hip F C 0.5 1.11 (1.07 - 1.15) 6.9x10-8 b 
rs864839 JPH3 EUR hip both T 0.7 1.08 (1.05–1.11) 2.1×10−8 a 
rs2521349 MAP2K6 EUR hip both A 0.37 1.13 (1.09–1.17) 9.95×10−10 
rs12982744 DOT1L EUR hip M C 0.74 1.17 (1.11 - 1.23) 7.8x10-9 b 
rs143383* GDF5 Asian 
and EUR 
knee & hip both T Asian 0.74, 
EUR N/A 
Asian 1.79 (1.53 - 2.09), 




rs6094710 NCOA3 EUR hip both A 0.04 1.28 (1.18 - 1.39) 7.9x10-9 b 
rs6516886 RWDD2B EUR hip both T 0.75 1.10 (1.06–1.14) 5.84×10−8 a 
*rs143383 was not available in ALSPAC data, instead rs143384 (R2=0.82, D'=0.99) was used as a proxy. Abbreviations:  RA (reported risk 
allele), RAF (reported risk allele frequency), OR (odds ratio), EUR (European), M (males), F (females). Ref. a: (Zengini et al., 2018); b: 
(Zengini et al., 2016); c: (Hackinger et al., 2017). 
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7.2.3.5. Genetic correlation between hip shape and other phenotypes 
In previous chapters, I investigated shared genetic aetiology between BMD and hip 
shape using one-sample MR in adolescents (Chapter 5) and two-sample MR in ALSPAC 
mothers (Chapter 6), however, for many complex traits, the proportion of heritability 
explained by SNPs reaching genome-wide significance is small, therefore these methods 
often suffer from low power and weak instrument bias (B. Bulik-Sullivan et al., 2015). In 
this chapter, I used LD Hub (http://ldsc.broadinstitute.org/ldhub/) (accessed 8 -10 May 
2018) (Zheng et al., 2017), an online platform for LD score regression (B. K. Bulik-Sullivan 
et al., 2015), to estimate the shared genetic aetiology between hip shape in adolescence 
and BMD as well as a range of other phenotypes using all SNPs in the genome, rather 
than just the genome-wide significant ones. LD Hub contains summary-level GWAS 
results for over 170 phenotypes from various publicly available data sources and 
provides an automated LD score regression analysis pipeline. This method (first 
proposed by Bulik-Sullivan et al. (B. K. Bulik-Sullivan et al., 2015)) relies on SNP 
correlations, i.e. SNPs in high LD will have higher X2 values as opposed to SNPs in low LD. 
To estimate the genetic correlations between two traits, Z-scores (BETA/SE) from each 
study are calculated and regressed onto the LD score and genetic covariance is then 
estimated from the slope.   
Summary level data for the top ten HSMs from age 14 and age 18 GWASes were 
uploaded in LD Hub. SNP heritability (h2) and SE were estimated and used to calculate Z-
scores (h2/SE) in order to inform further analysis. Genetic correlation estimates for traits 
with heritability Z-scores below 2 are unreliable (Zheng et al., 2017), therefore only 
HSMs with heritability Z-scores ≥ 2 were selected to perform genetic correlations 
between hip shape and all traits available in LD Hub (including anthropometric and bone 
traits, such as FN and LS BMD, amongst other traits).  
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7.3. Results  
7.3.1. Participant characteristics  
Complete outcome and genetic data were available from 3,550 and 3,175 individuals at 
a mean age of 13.8 and 17.8 years respectively. After applying filtering steps 8,310,190 
imputed SNPs were available for analysis.  
7.3.2. GWAS at age 14, 18 and replication in adult cohort  
In adolescents, several SNPs were associated with hip shape at a genome-wide 
significant level (p<5x10-8). Top hits were then pruned using the SNAP tool (Pers et al., 
2014) to select independent loci. QQ and Manhattan plots were generated (see 
Supplementary Figure 10.6.1 - Supplementary Figure 10.6.20 for Manhattan and QQ 
plots in Appendix 6) and genomic inflation factors for all HSMs at both time points were 
close to 1.   
At age 14, two SNPs showed associations with hip shape (Table 7.2).  
rs8079830, an intergenic variant on chromosome 17 located near SOX9 (Figure 7.1) was 
associated with HSM1 (effect allele: C, beta=-0.06, p=1.76x10-8). This variant was also 
associated with HSM1 in ALSPAC mothers (beta=-0.06, p=4.87x10-5) and adult meta-
analysis (which excluded ALSPAC mothers) (beta=-0.03, p=1.9x10-8) and showed weaker 
evidence of an association with HSM1 at age 18 (beta=-0.03, p=0.001).  
rs1827922 an intergenic variant, near ANKRD50, on chromosome 4 (Figure 7.2) was 
associated with HSM3 (effect allele: C, beta=0.10, p=3.69x10-8) with no robust evidence 
for an association at age 18 (beta= 0.01, p=0.546) and no evidence of an association in 
ALSPAC mothers (beta= -0.005, p=0.862), while there was very weak evidence for an 
association in adult meta-analysis (beta=0.02, p=0.048).  
At age 18, three SNPs were associated with hip shape (Table 7.3). 
rs10748285, a non-coding intronic variant in RP11-114H23.1 located on chromosome 12 
(Figure 7.3) was associated with HSM1 (effect allele: T, beta=0.06, p =2.76x10-8) and 
there was weak evidence of an effect of this variant on HSM1 at age 14 (beta= 0.02, 
p=0.017) with little evidence of an association in ALSPAC mothers (beta=0.02, p=0.084) 
and adult meta-analysis (beta=0.008, p=0.234). 
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rs8111495, residing in an intron of DUXA on chromosome 19 (Figure 7.4), was 
associated with HSM5 at both time points, with weaker magnitude of an effect and 
weaker evidence for an association at age 14 (effect allele: A, beta=0.10, p=1.23x10-5) 
compared with age 18 result (beta=0.15, p=2.52x10-8). There was little evidence to 
suggest an association of this variant with HSM5 in ALSPAC mothers (beta=0.02, 
p=0.480) and adult meta-analysis (beta=0.02, p=0.194). 
rs1111767, an intronic SNP in AL391117.1 located on chromosome 9 (Figure 7.5), was 
associated with HSM6 (effect allele: G, beta=-0.13, p=2.34x10-9). The effect of this 
variant on HSM6 at age 14 was much weaker compared with age 18 effect with little 
evidence of an association (beta=-0.03, p=0.091), similarly no evidence of an effect was 
observed in ALSPAC mothers (beta=0.01, p=0.787) and weak evidence of an association 
in adult meta-analysis, with the effect being in the opposite direction (beta=0.02, 
p=0.038).  
These SNPs were investigated in MR-Base PheWAS to identify potential associations 
with other traits. rs8079830, associated with HSM1 at age 14, showed association with 
height and knee pain in the UK Biobank study (Table 7.4). rs8111495, associated with 
HSM5 at age 18, showed strong relationship with fibroblastic disorders (e.g. dupuytren’s 
contracture) as well as associations with lower limb and total body mass in the UK 
Biobank study (Table 7.5). rs1111767, associated with HSM6 at age 18, showed evidence 
for associations with educational phenotypes in two independent cohorts: UK Biobank 
and the Social Science Genetic Association Consortium (SSGAC) (Table 7.6). 
There was no compelling evidence (no associations below the pre-specified genome 
wide suggestive threshold) for associations between rs1827922 and rs10748285 (found 
to be associated with HSM3 at age 14 and HSM1 at age 18, respectively) with other 




Table 7.2; Genome-wide significant hits for hip shape at age 14 in ALSPAC adolescents and a look-up of these loci in adolescent and 
adult GWAS 




ADULT meta-analysis  
(N= 12,823) 
HSM SNP CHR EA EAF Beta SE P Beta P Beta P Beta P 
1 rs8079830 17 C 0.66 -0.06 0.01 1.76x10-8 -0.03 0.001 -0.06 4.87x10-5 -0.03 1.9x10-8 
3 rs1827922 4 C 0.28 0.10 0.02 3.69x10-8 0.01 0.546 -0.005 0.862 0.02 0.048 
*adjusted for age and sex, adult meta-analysis excluded ALSPAC mothers. Abbreviations: SNP (Single nucleotide polymorphism), 
CHR (chromosome), EA (effect allele), EAF (effect allele frequency), SE (standard error), P (p value). 
 
Table 7.3; Genome-wide significant hits for hip shape at age 18 in ALSPAC adolescents and a look-up of these loci in adolescent and 
adult GWAS 




ADULT meta-analysis  
(N= 12,823) 
HSM SNP CHR EA EAF Beta SE P Beta P Beta P Beta P 
1 rs10748285 12 T 0.58 0.06 0.01 2.76x10-8 0.02 0.017 0.02 0.084 0.008 0.234 
5 rs8111495 19 A 0.72 0.15 0.03 2.52x10-8 0.10 1.23x10-5 0.02 0.480 0.02 0.194 
6 rs1111767 9 G 0.69 -0.13 0.02 2.34x10-9 -0.03 0.091 0.01 0.787 0.02 0.038 
*adjusted for age and sex, adult meta-analysis excluded ALSPAC mothers. Abbreviations: SNP (Single nucleotide polymorphism), 





Figure 7.1 Regional association plot for rs8079830 locus associated with HSM1 at age 
14. The y axis represents the negative logarithm (base 10) of the 
variant P value (likelihood ratio test), and the x axis represents the position on the 
chromosome, with names and location of genes and nearest genes shown at the 
bottom. Purple diamond represents the variant with the lowest P value and colours 




Figure 7.2 Regional association plot for rs10857102 (in high LD >0.8 with rs1827922) 
locus associated with HSM3 at age 14. The y axis represents the negative logarithm 
(base 10) of the variant P value (likelihood ratio test), and the x axis represents the 
position on the chromosome, with names and location of genes and nearest genes 
shown at the bottom. Purple diamond represents the variant with the lowest P 






Figure 7.3 Regional association plot for rs7969867 (in high LD >0.8 with rs10748285) 
locus associated with HSM1 at age 18. The y axis represents the negative logarithm 
(base 10) of the variant P value (likelihood ratio test), and the x axis represents the 
position on the chromosome, with names and location of genes and nearest genes 
shown at the bottom. Purple diamond represents the variant with the lowest P 





Figure 7.4 Regional association plot for rs8111495 locus associated with HSM5 at age 
18. The y axis represents the negative logarithm (base 10) of the 
variant P value (likelihood ratio test), and the x axis represents the position on the 
chromosome, with names and location of genes and nearest genes shown at the 
bottom. Purple diamond represents the variant with the lowest P value and colours 




Figure 7.5 Regional association plot for rs7025847 (in high LD >0.8 with rs1111767) 
locus associated with HSM6 at age 18. The y axis represents the negative logarithm 
(base 10) of the variant P value (likelihood ratio test), and the x axis represents the 
position on the chromosome, with names and location of genes and nearest genes 
shown at the bottom. Purple diamond represents the variant with the lowest P 
value and colours of the remaining points correspond to the degree of LD with the 
top variant.  
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Table 7.4; Look-up of rs8079830 associated with HSM1 at age 14 in MR Base PheWAS showing traits associated with this SNP reaching 
suggestive genome-wide significance level (P<5x10-5)  
Trait Consortium Sex N EA OA Beta P SE Cases Controls 
Standing height UK Biobank M & F 336,474 C T -0.009 1.6x10-7 0.002 NA NA 
Comparative height size at age 10 UK Biobank M & F 332,021 C T -0.008 1.4x10-6 0.002 NA NA 
Pain type(s) experienced in last month: Knee 
pain 
UK Biobank M & F 336,650 C T -0.004 1.8x10-5 0.001 71,561 265,089 
Abbreviations: EA (Effect allele), OA (Other allele), SE (Standard error). 
Table 7.5; Look-up of rs8111495, associated with HSM5 at age 18, in MR Base PheWAS showing traits associated with this SNP reaching 
suggestive (P<5x10-5)  and genome-wide significance level (P<5x10-8)  
Trait Consortium Sex N EA OA Beta P SE Cases Control
s 
Diagnoses - main ICD10: M72 
Fibroblastic disorders 
UK Biobank M & F 337,199 A C -0.001 2.2x10-10 0.000 1,862 335,337 
Leg predicted mass (right) UK Biobank M & F 331,285 A C 0.009 3.1x10-6 0.002 NA NA 
Leg fat-free mass (right) UK Biobank M & F 331,285 A C 0.008 5.1x10-6 0.002 NA NA 
Leg fat-free mass (left) UK Biobank M & F 331,258 A C 0.008 9.2x10-6 0.002 NA NA 
Leg predicted mass (left) UK Biobank M & F 331,253 A C 0.008 1.0x10-5 0.002 NA NA 
Whole body fat-free mass UK Biobank M & F 331,291 A C 0.008 2.5x10-5 0.002 NA NA 
Impedance of leg (right) UK Biobank M & F 331,301 A C -0.011 2.6x10-5 0.003 NA NA 
Impedance of leg (left) UK Biobank M & F 331,296 A C -0.010 4.5x10-5 0.003 NA NA 
Abbreviations: EA (Effect allele), OA (Other allele), SE (Standard error). 
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Table 7.6; Look-up of rs1111767 associated with HSM6 at age 18 in MR Base PheWAS showing traits associated with this SNP reaching 
suggestive genome-wide significance level (P<5x10-5)  
Trait Consortium Sex N EA OA Beta P SE Cases Controls 
Qualifications: College or University 
degree 
UK Biobank M & F 334,070 G A 0.006 2.5x10-7 0.001 106,305 227,765 
Years of schooling SSGAC F 182,286 A G -0.017 1.7x10-6 0.004 NA NA 
Years of schooling SSGAC M & F 293,723 A G -0.013 1.8x10-6 0.003 NA NA 
Neuroticism SSGAC M & F 170,911 A G 0.018 2.4x10-6 0.004 NA NA 
Abbreviations: EA (Effect allele), OA (Other allele), SE (Standard error), SSGAC (Social Science Genetic Association Consortium).
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7.3.3. The effect of adult hip shape variants on adolescent hip shape   
Table 7.7 shows the SNPs associated with adult hip shape (D. A. Baird et al., 2017) and a 
look-up of these SNPs in adolescent GWAS at age 14 and 18. Five SNPs were associated 
with HSM1, two with HSM2 and one with HSM5 and these SNPs were looked up in 
relevant HSMs in adolescents.  
A number of variants affecting hip shape in adults were also found to be associated with 
hip shape in adolescents, however the evidence for these associations was generally 
weaker. The strongest associations were seen for two SNPs, rs2158915 (associated with 
HSM1 in adults) and rs2160442 (associated with HSM5 in adults) (both in complete 
linkage, R2=1.0), near SOX9, and these variants were associated with HSM1 and HSM5 
respectively at both time points (consistent with the direction of the effect in adults). 
There was strong evidence for an association between rs10743612 (associated with 
HSM1 in adults), an intergenic SNP between KLHL42 and PTHLH and HSM1 at both time 
points. Furthermore, rs73197346 (between RUNX1 and MIR802; associated with HSM1 
in adults) was strongly related to HSM1 at age 14 with consistent direction of an effect 
at age 18, although much weaker evidence. In addition, rs6537291 SNP (associated with 
HSM2 in adults) near HHIP (associated with height and implicated in endochondral bone 
formation) was associated with adolescent HSM2 at both time points and the 
magnitude of the effect was similar to the effect reported in adults. Another variant, 
rs1966265 (a missense SNP of FGFR4, associated with HSM2 in adults) was associated 
with HSM2 at age 18 and there was some evidence to suggest an association at age 14. 
Finally, there was weak evidence of an association between intronic SNP, rs1885245 in 
ASTN2 (associated with HSM2 in adults), and HSM2 at age 14, but no robust evidence 




Table 7.7; Hip shape meta-analysis results (adjusted for age and gender) and look-up in ALSPAC adolescent GWAS (adjusted for age and 
gender) 
   Adult meta-analysis N=15,934 Age 18 GWAS N=3,175 Age 14 GWAS N=3,550 
HSM SNP Locus BETA P BETA1 P BETA2 P 
1 rs2158915 SOX9 -0.13 8.47x10-27 -0.05 3.25 x10-6 -0.05 9.94 x10-8 
1 rs1243579 GSC 0.12 2.85x10-14 0.02 0.086 0.03 0.01 
1 rs10743612 KLHL42-PTHLH 0.09 2.91x10-12 0.04 0.003 0.05 1.13 x10-5 
1 rs73197346 RUNX1- MIR802 -0.11 2.52x10-10 -0.03 0.026 -0.05 2.38 x10-4 
1 rs59341143 NKX3-2 0.098 6.53x10-10 0.02 0.093 0.02 0.102 
2 rs1966265 FGFR4 0.13 3.73x10-20 0.07 0.003 0.05 0.018 
2 rs6537291 HHIP -0.07 1.01x10-9 -0.07 0.001 -0.06 0.001 
2 rs1885245 ASTN2 0.07 4.95x10-9 0.01 0.545 0.04 0.019 
5 rs2160442 SOX9 -0.09 5.18x10-14 -0.10 2.83 x10-6 -0.07 1.36 x10-4 
Abbreviations: HSM (Hip shape mode), SNP (Single nucleotide polymorphism), P (p value). 
1Results from hip shape GWAS in ALSAPC adolescents (age 18), adjusted for age and gender  
2Results from hip shape GWAS in ALSAPC adolescents (age 14), adjusted for age and gender 




7.3.4. Look-up of known OA variants in adolescent hip shape  
A look-up of hip OA associated variants, based on previously published literature, was 
performed in GWAS of adolescent hip shape at both time points (Figure 7.6 - Figure 
7.10).  
The strongest evidence was seen for an association between rs10492367 (KLHDC5- 
PTHLH) and HSM1 at age 14 (beta= 0.05, p= 4.0x10-5) and there was some evidence of 
an association at age 18 (beta= 0.03, p=0.01) (Figure 7.6).  
There was some evidence of consistent associations between rs10948172 (SUPT3H -
CDC5L) and HSM3 (Figure 7.7) at both time points (age 14 beta= 0.05, p=0.006; age 18 
beta= 0.05, p=0.002). Similarly, there was some evidence for consistent associations 
between the same variant and HSM4 across the time points (age 14 beta= 0.05, 
p=0.004, age 18 beta= 0.06, p=0.002) (Figure 7.7). In addition, there was weak evidence 
of an association between rs11780978 (PLEC) and HSM4 at age 18 (beta=-0.05, 
p=0.008), but no robust evidence for an association at age 14 (Figure 7.7).       
Two SNPs showed evidence for an association with HSM5 at age 18, rs9350591 (FILIP1 - 
SENP6; beta=-0.09, p=0.008) and rs11842874 (MCF2L; beta=0.014, p=5.5x10-4) (Figure 
7.8). While consistent in terms of the direction of effect, the evidence for associations at 
age 14 was much weaker.   
There was some evidence of an association between rs6094710 (NCOA3) and HSM8 at 
age 14 (beta -0.14, p=0.009) with little evidence of an association at age 18 (Figure 7.9). 
Finally, there was evidence of an association between rs143384 (GDF5) and HSM9 at 




Figure 7.6 A look-up of published hip OA variants in ALSPAC HSM1 and HSM2 GWASes 
at age 14 (in black) and age 18 (in blue). Figure shows beta coefficients (black and navy 
dots) with 95% CIs (black and navy lines) for the association between hip OA SNPs and 
hip shape. Beta coefficients represent SD change in HSM per risk allele (betas were 
flipped to correspond to OA risk allele, for details see Table 7.1). SNPs with p<0.01 are 
marked with **. 
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Figure 7.7 A look-up of published hip OA variants in ALSPAC HSM3 and HSM4 GWASes 
at age 14 (in black) and age 18 (in blue). Figure shows beta coefficients (black and navy 
dots) with 95% CIs (black and navy lines) for the association between hip OA SNPs and 
hip shape. Beta coefficients represent SD change in HSM per risk allele (betas were 
flipped to correspond to OA risk allele, for details see Table 7.1). SNPs with p<0.01 are 





Figure 7.8 A look-up of published hip OA variants in ALSPAC HSM5 and HSM6 GWASes 
at age 14 (in black) and age 18 (in blue). Figure shows beta coefficients (black and navy 
dots) with 95% CIs (black and navy lines) for the association between hip OA SNPs and 
hip shape. Beta coefficients represent SD change in HSM per risk allele (betas were 
flipped to correspond to OA risk allele, for details see Table 7.1). SNPs with p<0.01 are 




Figure 7.9 A look-up of published hip OA variants in ALSPAC HSM7 and HSM8 GWASes 
at age 14 (in black) and age 18 (in blue). Figure shows beta coefficients (black and navy 
dots) with 95% CIs (black and navy lines) for the association between hip OA SNPs and 
hip shape. Beta coefficients represent SD change in HSM per risk allele (betas were 
flipped to correspond to OA risk allele, for details see Table 7.1). SNPs with p<0.01 are 





Figure 7.10 A look-up of published hip OA variants in ALSPAC HSM9 and HSM10 
GWASes at age 14 (in black) and age 18 (in blue). Figure shows beta coefficients (black 
and navy dots) with 95% CIs (black and navy lines) for the association between hip OA 
SNPs and hip shape. Beta coefficients represent SD change in HSM per risk allele 
(betas were flipped to correspond to OA risk allele, for details see Table 7.1). SNPs 
with p<0.01 are marked with **. 
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7.3.5. Genetic correlation between hip shape and other phenotypes  
Based on Z-score values, genetic correlations between selected modes and a wide range 
of traits available in LD hub were performed. Only modes with Z-score values ≥2 were 
selected for analysis, these were HSM1, HSM2, HSM5 and HSM8 at both time points, 
HSM9 at age 14 and HSM3 and HSM7 at age 18 (a total of 5 modes at age 14 and 6 
modes at age 18). 
Genetic correlations between HSMs at age 14 and other phenotypes are shown in Figure 
7.11-Figure 7.15. In general, there was some evidence for genetic correlations with a 
wide range of variables including respiratory, educational and anthropometric traits. 
Both HSM1 (Figure 7.11) and HSM5 (Figure 7.13) showed genetic correlations with 
respiratory traits and metabolites (primarily lipids), and FN BMD (HSM5 only), however 
the evidence was weak (p<0.05). HSM2 showed weak evidence of genetic correlation 
with years of schooling, lipid metabolites and height (Figure 7.12). Similarly, there was 
weak evidence of genetic correlations between HSM8 and sleep duration, age at 
menarche and alanine (Figure 7.14). Finally, HSM9 was most strongly genetically 
correlated with height (rg = 0.23, p=0.004) and there was weaker evidence of genetic 
correlation with other traits including sleep duration, educational traits or extreme 
height amongst other traits (p~0.01 or less) (Figure 7.15).  
Genetic correlations between HSMs at age 18 and other phenotypes are shown in Figure 
7.16-Figure 7.21. As for age 14, at age 18 there was weak evidence of genetic 
correlation between HSM1 and mean diameter for LDL particles, and in contrast with 
age 14 results there was weak evidence of genetic correlation with autism spectrum 
disorder (p<0.05) (Figure 7.16). HSM2 showed genetic correlations with a number of 
traits, the majority of which comprised lipid metabolites, educational traits and obesity 
(and these traits were also genetically correlated with HSM2 at age 14) with blood lipids, 
years of schooling and childhood obesity showing the strongest evidence of genetic 
correlation (p≤0.009) (Figure 7.17). There was weak evidence of genetic correlation 
between HSM3 and glucose, autism spectrum disorder and LS BMD (p<0.05) (Figure 
7.18). Similarly, to age 14 result, at age 18 HSM5 was genetically correlated with 
respiratory and lipid traits and unlike age 14 result there was some evidence for genetic 
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correlation with height (p=0.01) (Figure 7.19). HSM7 was genetically correlated with a 
number of different traits, majority of which represented body size, with BMI showing 
the strongest evidence of genetic correlation (p=0.005) (Figure 7.20). At both time 
points, HSM8 was genetically correlated with personality trait, whereas at age 18 there 
was also evidence of genetic correlations with intelligence (p=0.006), heart rate 







Figure 7.11 Volcano plot for genetic correlation results between HSM1 at age 14 and a range of traits. Each dot represents different 
trait; pink dots indicate traits with evidence of genetic correlation (P<0.05) and black dots indicate traits with no evidence of genetic 




Figure 7.12 Volcano plot for genetic correlation results between HSM2 at age 14 and a range of traits. Each dot represents different 
trait; pink dots indicate traits with evidence of genetic correlation (P<0.05) and black dots indicate traits with no evidence of genetic 
correlation. Traits showing evidence of an association are labelled and p value is given in brackets. 
 225 
 
Figure 7.13 Volcano plot for genetic correlation results between HSM5 at age 14 and a range of traits. Each dot represents different 
trait; pink dots indicate traits with evidence of genetic correlation (P<0.05) and black dots indicate traits with no evidence of genetic 
correlation. Traits showing evidence of an association are labelled and p value is given in brackets. 
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Figure 7.14 Volcano plot for genetic correlation results between HSM8 at age 14 and a range of traits. Each dot represents different 
trait; pink dots indicate traits with evidence of genetic correlation (P<0.05) and black dots indicate traits with no evidence of genetic 




Figure 7.15 Volcano plot for genetic correlation results between HSM9 at age 14 and a range of traits. Each dot represents different 
trait; pink dots indicate traits with evidence of genetic correlation (P<0.05) and black dots indicate traits with no evidence of genetic 




Figure 7.16 Volcano plot for genetic correlation results between HSM1 at age 18 and a range of traits. Each dot represents different 
trait; pink dots indicate traits with evidence of genetic correlation (P<0.05) and black dots indicate traits with no evidence of genetic 
correlation.  Traits showing evidence of an association are labelled and p value is given in brackets. 
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Figure 7.17 Volcano plot for genetic correlation results between HSM2 at age 18 and a range of traits. Each dot represents different 
trait; pink dots indicate traits with evidence of genetic correlation (P<0.05) and black dots indicate traits with no evidence of genetic 
correlation.  Traits showing evidence of an association are labelled and p value is given in brackets. Abbreviations: m_lipids (metabolite: 
lipids), yrs (years), overwt. (overweight). 
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Figure 7.18 Volcano plot for genetic correlation results between HSM3 at age 18 and a range of traits. Each dot represents different 
trait; pink dots indicate traits with evidence of genetic correlation (P<0.05) and black dots indicate traits with no evidence of genetic 
correlation.  Traits showing evidence of an association are labelled and p value is given in brackets. 
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Figure 7.19 Volcano plot for genetic correlation results between HSM5 at age 18 and a range of traits. Each dot represents different 
trait; pink dots indicate traits with evidence of genetic correlation (P<0.05) and black dots indicate traits with no evidence of genetic 
correlation.  Traits showing evidence of an association are labelled and p value is given in brackets. 
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Figure 7.20 Volcano plot for genetic correlation results between HSM7 at age 18 and a range of traits. Each dot represents different 
trait; pink dots indicate traits with evidence of genetic correlation (P<0.05) and black dots indicate traits with no evidence of genetic 
correlation.  Traits showing evidence of an association are labelled and p value is given in brackets. 
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Figure 7.21 Volcano plot for genetic correlation results between HSM8 at age 18 and a range of traits. Each dot represents different 
trait; pink dots indicate traits with evidence of genetic correlation (P<0.05) and black dots indicate traits with no evidence of genetic 




In this chapter, I explored the genetic influences on hip shape in adolescents by 
performing the first GWAS of adolescent hip shape, as quantified by SSM.  
There was strong evidence of consistent associations between rs8079830, a variant 
located near SOX9, and HSM1 at both adolescent time points and in adults. HSM1 
reflects variation in femoral head and FNW, which both have previously been found to 
be associated with hip OA and/or fracture risk (Alonso et al., 2000; Baker-LePain & Lane, 
2010; Karlsson et al., 1996). Interestingly, rs2158915 (also near SOX9) was also found to 
be associated with both HSM1 and HSM5 in an adult hip shape GWAS meta-analysis. 
Although in modest linkage with the SNP identified in adolescent GWAS (r2 = 0.3315, 
D’=1.0), further investigation, such as co-localisation analysis (Giambartolomei et al., 
2014), is justified to determine whether these associations share the same signal within 
the genomic region. Consistent with shared genetic influences on hip shape and BMD 
described in chapters 5 and 6, the SOX9 locus associated with HSM1 and HSM5 in adult 
GWAS, was previously found to be related to FN BMD (D. A. Baird et al., 2017). Given 
the role of SOX9 (Huang et al., 2001) as a key transcription factor in chondrocyte cell 
fate specification and in endochondral bone formation, these findings may reflect an 
influence of longitudinal growth on hip shape which may in turn play a role in OA 
development. Consistent with this suggestion, a look-up of rs8079830 in MR Base 
PheWAS showed a strong association with height in the UK Biobank and a recent paper 
by Zengini et al. (Zengini et al., 2018) confirmed a causal effect of height on OA using a 
MR approach. Another interesting finding resulting from a look-up in MR Base PheWAS 
included an association between rs8079830 and knee pain (likely due to OA) in the UK 
Biobank, consistent with a previous case report in a patient presenting with severe knee 
pain who was subsequently diagnosed with hip OA (S. Lam & Amies, 2015).  
At age 18, there was evidence to suggest an association between rs8111495 and HSM5, 
which reflects variation in femoral head, FNW and greater and lesser trochanters. While 
this variant also showed association with hip shape at age 14, there was little evidence 
of an association in adults. Interestingly, a previous GWAS reported an association 
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between rs11672517 (in linkage with rs8111495; R2 = 0.75) and Dupuytren’s contracture 
(Ng et al., 2017), a highly heritable disorder of the connective tissue. Additionally, a look 
up in MR Base PheWAS, revealed strong evidence for an association with fibroblastic 
disorders in the UK Biobank resource (with Dupuytren’s contracture being one of them). 
Dupuytren’s contracture is characterized by development of hardened nodules in the 
palm of the hand which usually precede the development of bands. As the disease 
progresses, formed bands lead to contraction and permanent flexion in the affected 
digits. The nodules are thought to be the result of abnormal deposition of type III 
collagen, which is usually absent in normal adult palmar fascia (W. L. Lam et al., 2010; 
Ng et al., 2017; Townley et al., 2006). Previous reports suggest that the presence of type 
III collagen in regions of adult articular cartilage arise in response to mechanical injury 
(Aigner et al., 1993). A study by Hosseininia et al. reported that deposition of type III 
collagen in articular cartilage was more pronounced in femoral heads from OA patients 
compared with femoral heads from hip fracture patients (Hosseininia et al., 2016). This 
abnormal deposition of cartilage might be the result of abnormal mechanical loading 
resulting from altered hip shape and the same biological pathways underlying 
Dupuytren’s contracture may also be implicated in alterations of hip shape. 
Furthermore, variants implicated in Wnt signalling pathways have been found to be 
associated with both Dupuytren’s contracture (Ng et al., 2017) and knee and hip OA 
(Lane et al., 2017) .   
Finally, rs1111767 was strongly associated with HSM6 at age 18 and there was little 
evidence to suggest an association at age 14. A look-up of this variant in MR Base 
PheWAS, revealed strong associations with educational phenotypes. Surprisingly, the 
largest OA meta-analysis to date reported genetic correlation between OA and 
educational attainment amongst other traits (Zengini et al., 2018). While these 
represent seemingly unrelated phenotypes, previous epidemiological studies reported 
clear relationship between low educational attainment and symptomatic hip OA 
(Cleveland et al., 2013) as well as radiographic and symptomatic knee OA (Callahan et 
al., 2011). It has been argued that individuals with higher educational attainment are 
more likely to make healthier choices (Brennan et al., 2012) (which might in turn reduce 
their risk of obesity, a well-recognized risk factor for OA (Baker-LePain & Lane, 2010)) 
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which will in turn reduce their risk of OA. It is possible that altered hip shape established 
early in life coupled with exposure to other risk factors, such as obesity, may predispose 
individuals to OA in later life, which could potentially explain the observed association 
with educational attainment. However, the relationship between hip shape and 
education (as reported in this chapter) may be confounded due to underlying 
population structure. Haworth et al. demonstrated that individual SNPs were associated 
with birth location within the UK Biobank (thought to represent a homogenous 
population) and this structure could not be fully accounted for when adjusting for 
traditional covariates such as Principal Components or study centre which has the 
potential to induce bias in genetic studies (Haworth et al., 2018). Although, it is currently 
unclear to what extent this may confound such relationships.  
 The effect of adult hip shape variants on adolescent hip shape   
There was strong evidence to suggest that variants associated with adult hip shape were 
also related to adolescent hip shape. In particular, genes implicated by the strongest 
associations with hip shape in adolescents, namely SOX9 (associated with HSM1 and 
HSM5), PTHLH (associated with HSM1) and HHIP (associated with HSM2) are known to 
be involved in endochondral bone formation. Both, negative HSM1 and HSM2 scores 
reflect a larger femoral head (in the inferolateral aspect) and wider FNW, whereas 
negative HSM5 scores reflect a narrower FNW and larger lesser trochanter. Both FNW 
and variation in femoral head size have previously been found to be related to the risk 
of OA in later life. For example, wide FN (Castaño‐Betancourt et al., 2013b) and femoral 
head deformities (Doherty et al., 2008; Heijboer et al., 2012; Ledingham et al., 1992) 
were found to be associated with increased risk of OA in previous studies. This 
reinforces the suggestion that subtle morphological changes in hip shape predispose to 
the onset of OA. 
 Look-up of known OA variants  
When considering the associations between previously established hip OA loci and hip 
shape in adolescence, the strongest evidence was seen for an effect of rs10492367 
(located between KLHDC5 (Kelch domain containing 5) and PTHLH (parathyroid 
hormone-like hormone)) on HSM1. This SNP is in moderate linkage with rs10743612 (r2= 
0.74), a variant identified from the adult hip shape GWAS and subsequently found to be 
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associated with HSM1 in adolescents, as described above. The role of PTHrP in bone 
remodelling as well as its importance in endochondral bone formation are well 
recognized (Martin, 2016). However, further studies are justified to confirm the 
functional role of this variant and how it may modify the relationship between hip shape 
and OA. While there was suggestive evidence for an effect of other hip OA implicated 
variants on a number of HSMs, likewise their functional relevance is unknown.  
 Genetic correlations with other traits 
In terms of genetic correlations between hip shape and other traits, I identified a 
number of correlations with a number of different phenotypes, however considering the 
number of tests carried out and lack of adjustment for multiple testing the evidence was 
relatively weak, and these results require replication in an independent sample. FN BMD 
was negatively correlated with HSM5 at age 14 and LS BMD was positively correlated 
with HSM3 at age 18, consistent with MR findings presented in chapter 5, which showed 
associations between BMD and HSM5 at age 14 and HSM3 at age 18. A number of 
modes showed correlations with height and obesity (i.e. at age 14, HSM2 and HSM9 
were positively correlated with height, at age 18 HSM5 and HSM8 were also positively 
correlated with height, whereas HSM2 and HSM7 were both positively correlated with 
obesity). This is consistent with previous findings that most variants associated with hip 
shape in adults were also associated with height (D. A. Baird et al., 2017). It is worth 
noting that given the relatively small sample size of adolescent hip shape GWAS and 
heritability Z-scores outside the accepted threshold (less than 2) for some of the modes, 
these results require further replication with larger sample size (>5000) and this should 
also be followed up using genome-wide complex trait analysis (GCTA (J. Yang et al., 
2011)) which relies on a restricted maximum likelihood approach. However, while these 
results need to be interpreted with caution, given the well-established role of hip shape 
in OA and the role obesity plays in increasing the risk of OA, the correlation between 
BMI and HSM7 (rg=0.28, p=0.005) found in this chapter is plausible, i.e. excessive weight 
might result in excessive wear of the cartilage and thus altered bone proportions 
(Widhalm et al., 2016) which will in turn predispose individuals to an increased risk of 
hip OA. Consistent with this suggestion, recent GWAS in the UK Biobank reported 
genetic correlation between BMI and hip OA (rg=0.28, p=4x10-4) and the authors were 
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able to confirm the causal role of BMI on OA risk using MR approach (Zengini et al., 
2018). With regards to genetic correlations between hip shape and other traits observed 
in this chapter, a MR approach might be usefully employed to further examine these 
relationships.  
  
 Strengths and limitations 
This study represents the first GWAS of hip shape in adolescence. Since I used the same 
SSM template as that in a recent meta-analysis of adult hip shape GWAS (D. A. Baird et 
al., 2017), I was able to directly compare adolescent results with those of adults. While 
some of the variants associated with hip shape in adolescence were also replicated in 
adult cohorts, future studies should aim to replicate these findings in an independent 
adolescent cohort. Given the fact that some of the adolescent hip shape variants were 
not replicated in adults, this might suggest that distinct genetic variants are implicated 
in hip shape development in adolescence as opposed to changes in hip shape occurring 
in adult life.  
One of the primary goals of GWAS is to better understand the architecture of complex 
traits which might in turn be utilised clinically as better understanding of disease 
mechanisms might point towards new therapeutic targets. While GWAS is a powerful 
tool in identifying genetic variants associated with complex traits, the results are not 
directly informative in terms of the causal gene or underlying biological mechanisms 
linking the genetic variants with a trait of interest. Further analytical and molecular 
approaches are necessary to bridge the knowledge gap and better understand 
mechanisms underlying these associations. In this chapter, GWAS findings were 
followed up with different analytical approaches and these results, from look-ups and 
LD score regression, are likely representative of genetic pleiotropy, consistent with the 
suggestion of pleiotropic abundance in many complex traits (Sivakumaran et al., 2011). 
Furthermore, while some of the variants identified in this study point towards 
biologically relevant loci and might thus shed a light on biological pathways relevant to 
hip shape development and subsequent OA and fracture risk, further functional studies 
are necessary to determine the likely causal variants and genes. Although eQTL analysis 
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showed no associations with any of the tissue types available in GTEx, further 
investigation in relevant tissue types would need to be undertaken (one possibility 
would be to look-up these hits in an osteoblast eQTL genome-wide dataset (Grundberg 
et al., 2009)).  
Another important limitation of this study includes the modest sample size. Most 
genetic variants associated with complex traits confer small to modest effects, 
therefore, large sample sizes are required to detect common variants associated with 
these traits. Nevertheless, ALSPAC currently represents the only study with repeated 
measures of hip shape at two critical time points during adolescence (pre- and post-
puberty). Despite the sample size, I was able to detect SNPs reaching genome-wide 
significance and replicate some of these findings in adult cohorts. However, these 
findings should be replicated in independent adolescent cohorts. For example, the 
minimum sample size required to detect SNP-trait association of smaller magnitude (i.e. 
beta of 0.1 SD) with 80% power at GWAS significance level (p<5 x 10-8) and with MAF of 
0.1, the sample size would need to increase to 1 million individuals and even more in the 
case of rare variants (Visscher et al., 2017).  
 Conclusions 
This study represents the first GWAS of hip shape in adolescents at age 14 and 18.  
Despite the relatively small sample size, I was able to detect associations with SNPs with 
potential relevance to bone biology, as exemplified by a variant near SOX9, which was 
also associated with height, and another variant near PTHLH, both associated with 
HSM1. While these results reflect shared influences of longitudinal growth on hip shape, 




CHAPTER 8.  DISCUSSION  
 
8.1. Aims of this PhD 
OA is the most common form of arthritis associated with a significant economic and 
health burden, affecting 240 million people worldwide. There is currently no treatment 
available which would cure it. Despite identifying several risk factors for OA, the 
pathophysiology still remains to be elucidated. Hip shape is thought to be one of the 
most important risk factors for hip OA, and it has also been found to be associated with 
the risk of osteoporotic hip fracture. Therefore, better understanding of factors 
influencing the development of hip shape, will help to elucidate mechanisms underlying 
the development of OA and point towards new opportunities for prevention. 
 
The overarching aim of this thesis was to describe the development of hip shape in 
ALSPAC adolescents and explore factors influencing this process. In order to describe 
the variation in hip shape and make direct comparison between hip shape measured at 
age 14 and 18, as well as comparison with adult hip shape, SSM based on adult 
reference SSM (comprising over 19,000 hip DXA images) was developed and applied to 
adolescent images. Using this adult reference SSM, I aimed to first describe sex 
differences in hip shape and associations with pubertal timing. To investigate 
mechanisms and potential pathways contributing to hip shape development, I 
investigated the relationships between BMD and hip shape (in adolescents and adult 
women) before exploring genetic influences on hip shape using GWAS.    
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8.2. Key findings of this research 
8.2.1. Variation in hip shape in relation to sex and pubertal timing  
In Chapter 3, I explored sex differences in hip shape in peri-pubertal and post-pubertal 
children from the ALSPAC cohort and observed sex differences in various aspects of hip 
shape at both time points investigated. At age 14, males had a larger femoral head and 
lesser trochanter compared with females and these differences were independent of 
height, lean and fat mass. At age 18, males had a larger FNW and lesser trochanter 
whereas females appeared to have larger femoral head medially. However, these 
differences were largely attenuated following adjustment for height, lean and fat mass 
with only subtle differences in FNW and lesser trochanter still remaining.  
 
When exploring the relationship between tempo (a marker of pubertal timing) and hip 
shape (Chapter 4), at age 14 the associations were stronger in males compared with 
females, however by age 18 these were comparable across sexes showing weak 
associations with tempo. It needs to be noted that when comparing associations with 
hip shape between early vs. late maturing males at age 14 clear differences in various 
aspects of hip shape were observed. Compared with late maturers, early maturing boys 
had a wider FNW, bigger lesser trochanter and smaller superolateral femoral head, 
whereas differences in early vs. late maturing females were harder to discern. When 
these differences were modelled for hip shape measured at age 18, no considerable 
differences between early vs. late maturers were noted in either sex suggesting no 
lasting effect of pubertal timing on hip shape. The results observed at age 14 were 
consistent with published literature. One study in Spanish boys, aged between 9 and 16 
years, reported that the size of FN and lesser trochanter increased with age (Pujol et al., 
2016). Furthermore, other studies suggest that puberty is a critical period for the 
development of cam deformity (a well-known risk factor for hip OA related to shape of 
the superolateral femoral head also found to be related to tempo at age 14) especially 
as a result of high impact activities. For example, Heijboer et al. followed-up soccer 
players for a mean period of 2.4 years and noted an increase in cam-type deformities 
between the ages of 12 and 14 years, which continued to increase from the age of 14 
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years until closure of the growth plate (Heijboer et al., 2014).  
Weak associations between tempo and hip shape at age 18 observed in this thesis are 
consistent with previous study in females, aged between 20–30 years, which found no 
relationship between age at menarche and FNW (Pasco et al., 1999) suggesting that 
pubertal timing does not exert lasting effects on hip shape and its components.  
Taken together, findings of this research extend those reported in the literature, 
suggesting that puberty represents an important period for the development of hip 
shape, particularly for aspects that are likely to be related to future hip pathology (such 
as cam-type deformity which is related to hip OA (Heijboer et al., 2012) and variation in 
FNW, previously investigated in relation to hip fracture (Ahlborg et al., 2005; Alonso et 
al., 2000; Karlsson et al., 1996; Ego Seeman et al., 2001)).  
 
8.2.2. Relationship between BMD and hip shape  
The inverse relationship between OA and OP, as well as the role of hip shape in the 
development of hip OA and hip fracture risk prediction are well-established (Baker-
LePain & Lane, 2010; Geusens & van den Bergh, 2016; Gregory et al., 2004). However, to 
what extent does the relationship between higher BMD and hip shape contribute to the 
association between reduced hip fracture risk and hip OA remains to be elucidated. In 
addition, BMD and hip shape could be influenced by common molecular pathways, 
consistent with findings from the recent hip shape GWAS which identified a number of 
loci previously found to be related to BMD (D. A. Baird et al., 2017). Therefore, in 
Chapters 5 and 6 I explored the previously unknown relationships between BMD and hip 
shape in ALSPAC children and mothers. Observationally, BMD was associated with a 
number of HSMs and these associations were consistent across both adolescent time 
points and in ALSPAC mothers. Higher BMD was associated with a narrower FNW and 
larger femoral head medially in both adolescents and mothers. The associations 
between BMD and hip shape, reported in this thesis, could conceivably contribute to the 
relationship between OP and OA. For example, a previous study in elderly women 
reported associations between larger femoral heads and increased risk of RHOA (Lynch 
et al., 2009). On the other hand, I found higher BMD to be associated with narrower 
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FNW. While wider FNW has been found to be associated with hip OA (Castaño‐
Betancourt et al., 2013b) these findings would not explain why higher BMD is associated 
with hip OA. In terms of BMD-hip shape associations and their contribution to hip 
fracture, a finding of higher BMD associated with narrower FNW was unexpected and is 
difficult to explain given the known associations between both higher BMD and wider 
FNW with reduced risk of fracture (Ahlborg et al., 2005; Ego Seeman et al., 2001), 
although the evidence for the latter is conflicting (Gregory & Aspden, 2008).    
Having found strong observational evidence for an association between BMD and hip 
shape, I followed up these results with a MR approach to determine the extent to which 
common genetic pathways underlie both BMD and hip shape. In adolescents, I found 
consistent evidence of associations between BMD with HSM2 and HSM5 across both 
time points, and evidence of an association with HSM1 and HSM3 at age 14 and 18, 
respectively. While MR findings suggest that biological pathways underlying BMD 
variation could contribute to aspects of hip shape (such as variation in FNW described 
by HSM2, HSM3 and HSM5, and variation in femoral head size described by HSM1) 
which have previously been found to be associated with increased risk of OA (Castaño‐
Betancourt et al., 2013b; Lynch et al., 2009) and/or fracture (Ego Seeman et al., 2001), 
not all observational results were confirmed with MR, either reflecting low power due to 
limited sample size or simply chance finding. In ALSPAC mothers’, MR results showed no 
robust evidence of an association between BMD and hip shape. 
 
8.2.3. Genetic influences on adolescent hip shape  
In Chapter 7, I undertook the first GWAS of hip shape in adolescents and despite the 
modest sample size, five loci reached genome-wide significance (P<5x10-8). This analysis 
identified robust associations between a variant near SOX9 (rs8079830) and HSM1 at 
age 14 and 18. In addition, this variant was also strongly related to hip shape in adults 
based on a look-up of adult hip shape GWAS. Another important finding was that a 
variant residing in an intron of DUXA (rs8111495) was found to be associated with HSM5 
in adolescents at both time points, but there was no evidence of a corresponding 
association in adults. Interestingly, a variant in high linkage with rs8111495 (rs11672517 
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R2 = 0.75) was previously found to be associated with Dupuytren’s contracture, which is 
a disorder of connective tissue (Ng et al., 2017). Finally, rs1111767 was strongly 
associated with HSM6 at age 18, but there was little evidence to suggest association at 
age 14 and no compelling evidence of an association in adults. In a look-up of a previous 
GWAS in the UK Biobank study, this SNP was associated with educational phenotypes. 
While previous observational evidence showed a strong relationship between 
educational attainment and symptomatic hip and knee OA (Callahan et al., 2011; 
Cleveland et al., 2013), recent genetic studies suggest that finer population structure 
could confound these relationships (Haworth et al., 2018) and may suggest this is an 
erroneous association. For example, in the UK Biobank geographic location was found to 
be associated with individual SNPs and these associations persisted when adjusting for 
traditional measures of population structure such as principal components (Haworth et 
al., 2018), however to what extent these associations could confound the relationships 
observed in this thesis is currently unknown.  
 
Based on results from the largest to date meta-analysis of adult hip shape (D. A. Baird et 
al., 2017) which relied on the same SSM template used throughout this thesis, a look-up 
in adolescent GWAS showed that a number of variants associated with adult hip shape 
were also associated with adolescent hip shape. These included consistent associations, 
across adolescent time points, with variants implicated in endochondral bone formation 
such as SOX9 (associated with HSM1 and HSM5),  PTHLH (associated with HSM1) and 
HHIP (associated with HSM2). Interestingly, in a look-up of previously established OA 
SNPs, rs10492367 (located between KLHDC5 and PTHLH) was associated with HSM1 and 
showed the strongest evidence of an association. In addition, this variant was in 
moderate linkage with rs10743612 (r2= 0.74), a SNP which showed evidence of 
associated with HSM1 in both, adults and adolescents.  
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8.3. Contribution of this research  
The findings of this research make several contributions to the current literature. Firstly, 
this thesis describes the first study to quantify and describe the variation in the shape of 
proximal femur as measured by SSM in ALSPAC adolescents at two different time points. 
While previous studies investigated sex differences in hip morphology in adolescents 
(Forwood et al., 2004; Sayers et al., 2010; M. C. Wang et al., 1997), these mainly focused 
on individual geometrical indices rather than the entire contour of the proximal femur 
including the femoral head, trochanters, femoral shaft and acetabular sourcil. Although 
sexual dimorphism in skeletal size, mass, strength and geometry is well recognized 
(Callewaert et al., 2010; Sayers et al., 2010; Ego  Seeman, 2001), the approach to study 
sex differences in femoral morphology in this thesis is novel. Nevertheless, the findings 
were consistent with previous literature showing that males have wider FNW than 
females (Sayers et al., 2010) and the size of lesser trochanter increased with age as 
shown in previous study in Spanish males (Pujol et al., 2016). In contrast to the study in 
Spanish individuals, I was able to describe variation in the entire contour of femoral 
head as well as variation in the acetabular sourcil.  
Furthermore, in line with previous literature, this study confirmed that puberty is a 
critical period for hip shape development and applying SSM allowed detailed 
quantification of proximal femur morphology as opposed to single geometrical 
measurements which are highly correlated with measures of body size. Although no 
lasting effects of pubertal timing on hip shape were observed in this thesis, previous 
studies reported an association between delayed puberty and increased risk of fracture 
in both males and females (Bonjour & Chevalley, 2014; Finkelstein et al., 1996; 
Finkelstein et al., 1992) likely reflecting relationships with suboptimal bone quality 
rather than hip morphology.  
 
 BMD and hip shape 
The relationships between hip shape with hip OA and fracture are well-established. 
While associations with BMD could partly explain these relationships, the role of hip 
shape could also contribute. However, to date little is known about the relationship 
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between BMD and hip shape. The observational results of a positive relationship 
between BMD and hip shape could reflect a possible shared contribution of femoral 
head size to associations between BMD and hip OA, whereas the relationship between 
higher BMD and narrower FNW could have implications for understanding of 
pathogenesis of hip fracture. In order to explore if BMD and hip shape share common 
genetic influences, I used a MR approach. I found some evidence for shared genetic 
mechanisms underlying BMD and hip shape, however further studies are necessary to 
determine the specific pathways contributing to the BMD-hip shape relationship and 
their role in OA and OP risk. Although there was no robust evidence of associations in 
adults, the results were in a consistent direction with the observational results. Both, 
adolescent and adult MR analyses appear to be underpowered and require further 
replication in larger samples.  
 Genetics of hip shape  
OA is highly heterogenous and an increasing number of studies focus on OA-related 
endophenotypes in order to increase power and identify genetic variants with likely 
functional potential. In this thesis, a number of genetic variants associated with adult 
hip shape were successfully replicated in adolescents, suggesting that the mechanisms 
which contributed to later clinically relevant bone phenotypes may start having an 
impact early in life and therefore highlighting the need for early preventative measures. 
Of the adults’ variants most strongly related to hip shape in adolescents, most loci were 
implicated in endochondral bone formation, suggesting shared genetic influences on hip 
shape and longitudinal growth. Furthermore, GWAS in adolescents identified additional 
SNPs which did not replicate in adults, either reflecting distinct genetic influences on hip 
shape across the investigated time points or false positive results.  
 
Finally, in the light of the findings of this research, the advice given to young individuals 
at risk of OP and OA, if they could be identified, should follow the standard guidelines. In 
terms of reducing future risk of OA, modifiable risk factors such as obesity, joint injury 
and modification of high impact sporting activities, particularly during growth, should be 
targeted (Bijlsma & Knahr, 2007; Pun et al., 2015). In terms of future risk of OP, 
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preventative strategies in adolescence should be aimed at maximising the attainment of 
peak bone mass (one of the key predictors of BMD in later life (Lane, 2006)), with 
factors such as exercise, adequate calcium intake and vitamin D levels known to play a 
role (Colì, 2013; Gordon et al., 2017).  
 
8.4. Strengths and limitations 
 SSM 
One of the strengths of this research includes the use of SSM, which offers a novel 
approach to study subtle changes in hip morphology and this is the first time SSM has 
been applied to describe variation in hip shape in a cohort of adolescents. SSM offers a 
powerful approach which has been successfully applied to study variation in hip shape 
associated with the incidence (An et al., 2016; Castaño‐Betancourt et al., 2013a) and 
progression of OA (Ahedi et al., 2017), as well as associations with hip fracture (Baker‐
LePain et al., 2011) in adult cohorts. However, a major drawback is that as each model is 
data driven, the HSMs generated are unique to the sample used, thus the results cannot 
be directly cross-compared with other studies. One of the key strengths of this study is 
the application of an adult reference SSM to adolescent hip DXA data at two different 
time points, which firstly enabled me to directly compare associations with HSMs 
between the time points in adolescents and compare these findings with results in 
adults. However, by using this approach I was unable to estimate the variance explained 
by each HSM after the adult reference SSM has been applied to the adolescent DXA 
images. As described previously, this makes the comparison between the magnitude of 
effect between adolescent and adult results difficult. Conventionally, the first HSM 
explains the most variance in the dataset with less variance explained by the subsequent 
modes. However, whether each mode explains the same percentage of variance in 
adolescent modes after the adult template has been applied remains to be established, 
but it is reasonable to assume that the top HSMs still capture the largest proportion of 
variance in the dataset and any future studies should attempt to estimate the variance 
explained in the model when applying reference template to another dataset.  
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Furthermore, whilst SSM quantifies the entire contour of the proximal femur, it is not 
specifically designed to evaluate cam deformities and therefore may not be sensitive 
enough or there may not be enough cases to detect cam deformities in this population. 
It has been suggested that exposure to high impact sports in adolescence, before the 
closure of growth plates, is the most significant risk factor for the development of cam 
deformity (Zadpoor, 2015) and other factors such as genetics, trauma and male sex are 
also thought to contribute (Chaudhry & Ayeni, 2014; Kuhns et al., 2015). Previous 
studies have also suggested that paediatric hip disorders, such as SCFE, predispose to 
the development of cam FAI (Giles et al., 2013; Pun et al., 2015) suggesting 
multifactorial influences on cam development. In order to study the development of 
cam deformity, specific measures for defining the degree of the deformity (alpha angle 
and femoral head-neck offset are amongst the most commonly used (Ehrmann et al., 
2015; Morris et al., 2018)) along with hip images at an earlier age and data on risk 
factors are needed.  
Another potential limitation of this study concerns the magnitude of effects observed 
and their clinical relevance. For example, unadjusted sex differences described  in 
Chapter 3 ranged from -0.73 to 0.22 SDs, and from -0.6 to 0.49 SDs at the age of 14 and 
18, respectively. These were of similar magnitude to differences previously reported 
between males and females from the MRC NSHD cohort (Pavlova et al., 2017). However, 
these studies relied on different SSM templates and the results cannot be directly 
compared. 
It needs to be noted that while it is difficult to determine which aspects of hip shape are 
relevant for specific disease outcomes (such as fracture or hip OA), applying the same 
template used in this thesis to other disease cohorts will enable the identification of 
specific hip shapes associated with outcomes of interest (this has already been done in 
the MrOS cohort; unpublished results). In addition, future studies employing sub-
regional models (as demonstrated in previous study by Baird et al. (Baird et al., 2018)) 
will help to further determine relevant aspects of shape related to disease outcomes.   
Potential methodological limitations of this research lie in the fact that the SSM was 
semi-automated, hence required some manual point placement and/or realignment. 
While this might result in inconsistency in point placement, repeatability and 
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reproducibility of this method were assessed and intra- and inter-repeatability scores 
were in good agreement (section 2.4.2, Chapter 2) and within the limit of previously 
reported values (Faber et al., 2017). Finally, this research was potentially limited by the 
use of 2D images to study complex, multidimensional shape which could potentially bias 
the results due to hip rotation. However, the DXA scans in ALSPAC were acquired 
according to standardized operating procedures whereby the feet are internally rotated, 
and the positioning is fixed, thus any rotation will represent normal variation. However, 
it needs to be noted that rotation in the adult population (from whom reference data 
was acquired and applied to the adolescent data), if present, could arise due to both, 
anatomical variation or reflect associations with a disease (i.e. the degree of hip rotation 
required for DXA positioning may be limited in patients with hip pain). In addition, the 
effect of subtle positioning errors should be accounted for during Procrustes analysis 
and positioning errors observed in ALSPAC had little influence on the overall model 
performance as previously described (Chapter 2, section 2.4.1). Finally, it needs to be 
noted that repeatability studies were only performed at one point in time (following the 
completion of marking up of TF 4 images). Although both intra- and inter-repeatability 
scores were in good agreement, if consistency of point placement changed over time 
this could result in lower precision of the estimated exposure-outcome associations 
(Kirkwood & Sterne, 2003).  
 
 Study design  
ALSPAC represents a unique, rich resource of phenotypic, environmental and genetic 
data spanning across generations. It enabled me to study the development of hip shape 
in adolescents at two important time points, i.e. in peri-puberty and post-puberty and 
compare associations with sex and pubertal timing between these time points. In 
addition, I was able to compare BMD-hip shape associations in adolescents with that of 
ALSPAC mothers and the availability of genetic data enabled me to further examine 
whether underlying genetic pathways contribute to these associations. Although I was 
able to explore BMD-hip shape associations at multiple time points only data from adult 
females was available thus no comparisons were made with adult males. In addition, the 
observed sex differences in hip shape were not adjusted for pubertal stage. Consistent 
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with previous studies (Marshall & Tanner, 1969, 1970), females were considerably more 
advanced in puberty compared with males (as exemplified by earlier aPHV; 11.8 vs. 13.5 
years in females and males, respectively; discussed previously in Chapter 4) and full 
adjustment for pubertal stage could not be done due to lack of pre-pubertal girls 
attending the TF 2 assessment clinic. It is therefore possible that the observed sex 
differences in hip shape at age 14 could partly reflect those in skeletal maturation.  
The generalisability of the findings in this thesis are subject to certain limitations. The 
generalisability of the findings in this thesis are subject to certain limitations. Due to 
delay in image acquisition and given the time constraints, not all available hip DXA 
images collected as part of TF 2 clinic were aligned in Shape. During the course of image 
alignment it was decided that, of the remaining images, only those who had both, 
genetic data and DXA image acquired at TF 4 clinic will be aligned. It is possible that 
individuals with scans who were not aligned due to time constraints (1,255 (20.9%) 
images out of 5,991 singleton images) and those excluded due to issues with image 
quality were different to those who were included in the analysis. However, I was 
unable to explicitly compare those with DXA images who were included versus excluded 
from my analysis as the ALSPAC data team were unable to successfully link all IDs for 
excluded images, but my comparison of those included in my analysis versus the rest of 
ALSPAC showed that children attending TF 2 and TF 4 clinics were more likely to be 
white and of female sex compared with those who did not attend (as described 
previously (Chapter 2, section 2.6.2). It needs to be noted that if excluded individuals 
differ from those included the estimates reported in this thesis (based on complete 
cases) may be biased. Furthermore, missing data reduces sample size and therefore 
precision. However, the risk of bias depends on the type of missing data (Sterne et al., 
2009). For example, if the outcome (in this case hip shape) is missing at random and the 
probability of hip shape data being missing is unrelated to unobserved values of hip 
shape, given the exposure and factors of interest included in the model, the complete-
case analysis is unlikely to be biased. Similarly, if the outcome or exposure are missing 
completely at random the complete case-analysis will be unbiased. However, if the 
outcome is missing not at random, i.e. the outcome is related to missingness given the 
other variables included in the model the estimates will be biased (Daniel et al., 2012). 
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In terms of TF 2 DXA data that were excluded due to time constraints, these were not 
excluded for any systematic reason and were therefore assumed to be missing 
completely at random and are thus unlikely to have substantially biased the estimates 
reported in this thesis. While loss to follow up is inevitable in longitudinal studies and 
the number of individuals diminishes with time, the numbers available for analysis were 
still fairly large considering other observational studies which used SSM to study in hip 
shape (Ahedi et al., 2017; Pavlova et al., 2017).It needs to be noted that while fairly 
large for observational epidemiology, the sample size for genetic analyses was relatively 
small. Nevertheless, I was able to perform the first GWAS of hip shape in adolescents 
and, despite the relatively small sample size in this context, I was able to detect 
associations with SNPs with potential relevance to bone biology. However, these results 
need to be confirmed as no replication in independent adolescent cohort of hip shape 
was performed. Another potential limitation of this study is the fact that approximately 
98% of cohort participants were of white European descent. This may have implications 
for generalisability of these results and given the previously reported ethnic differences 
in hip morphology (Martel-Pelletier et al., 2016) these results are likely to be 
generalisable to European populations only.  
Although the statistical evidence for a number of observational associations reported in 
this thesis was strong, these findings are limited by the use of a cross-sectional design, 
which makes it difficult to establish the direction of effect and causality. However, I used 
a MR approach (where possible) to overcome shortcomings of conventional 
epidemiology (predominantly confounding).  
 
 Causal analysis 
One of the advantages of the ALSPAC dataset is the availability of genetic data which 
enables the exploration of causal inferences based on observational associations. In this 
thesis, I was able to follow up observational associations between BMD and hip shape in 
both ALSPAC adolescents and mothers using a MR approach. However, a number of 
limitations need to be highlighted. Firstly, the instrument for BMD relied on SNPs 
discovered in adult cohorts. While this might not be an appropriate instrument of choice 
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for the adolescent analyses, the GRS was strongly related to BMD at both adolescent 
time points and a previous study showed that BMD SNPs identified in adults were partly 
responsible for the rate of bone acquisition in adolescents (Warrington et al., 2015). On 
one hand, the inclusion of multiple variants in the GRS may improve the precision of an 
estimate, while on the other hand it may increase the potential for pleiotropy. It needs 
to be noted that the power of MR analyses in my thesis was low (as shown in Appendix 
5, section 10.5.2) and although statistical methods to detect and account for pleiotropy 
can be used, such as MR-Egger regression and weighted median estimator (Yarmolinsky 
et al., 2018), these methods often suffer from low power and require large sample sizes 
(Bowden et al., 2016) and were therefore not performed given the already limited 
sample sizes in my analyses. In addition, inclusion of a subset of SNPs, with known 
function and relevance would be more appropriate when using MR in the same context 
as used in this thesis (as a means for identifying specific biological pathways underlying 
two related traits). Finally, MR is most commonly used to test for causal relationships 
between given exposure and an outcome, however, it is possible that assumption 3 
(genetic variant used as an instrument must not directly influence the outcome, except 
through the exposure of interest; as previously outlined in Chapter 2, section 2.6.5) 
could be violated. Therefore, in my thesis, I used MR in a context of shared genetic 
influences. 
 
8.5. Future research 
A natural progression of this work is to analyse the associations between hip shape and 
OA-case status applying the same SSM template which was used throughout this thesis. 
This in turn will enable future research in adolescent studies to focus on those aspects 
of hip morphology more strongly related to pathology in later life. This has already been 
done in the MrOS cohort (Blank et al., 2005; Orwoll et al., 2005) which comprised over 
4,000 participants with data on hip shape quantified on hip DXA scans at baseline and 
prevalent RHOA (defined as Croft score ≥2) obtained 4.6 years later. Both unadjusted 
and fully adjusted models (adjusted for site, age, height, weight and ethnicity) showed 
associations between modes 2, 3, 4 and 9 with RHOA (Faber et al., unpublished results), 
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with modes 3 and 4 showing the strongest associations. Interestingly, in a look up of 
known hip OA-associated variants in adolescent hip shape GWAS, rs10948172 (SUPT3H -
CDC5L) was consistently associated with HSM3 and HSM4 at both time points (as 
described in Chapter 7, section 7.3.4).    
Furthermore, the sample size in adolescent hip shape GWAS was small and therefore 
requires replication in independent adolescent cohorts in order to confirm the findings 
reported in this thesis. As previously suggested, the number of loci discovered in GWAS 
is directly proportional to sample size (Visscher et al., 2017), therefore increasing sample 
size by using paediatric and/or adolescent cohorts with suitable data (such as the 
Gothenburg Osteoporosis and Obesity Determinants (GOOD) Study which collected hip 
DXA scans in men aged 19 years (Lorentzon et al., 2005), The Western Australian 
Pregnancy Cohort (Raine) which collected hip DXA scans at age 20 years (Straker et al., 
2017), the 1990 birth to twenty study in South Africa with repeated hip DXA scans 
between age 9 -15 years (Richter et al., 2007), or Tasmanian birth cohort with repeated 
hip DXA scans between ages 8 – 25 years (Y. Yang et al., 2018)) will increase power and 
may help to identify new variants associated with hip shape. These results can then be 
followed up using molecular approaches including in vitro studies (relying on cell culture 
techniques) or in vivo studies (knocking out genes in animal models) in order to identify 
causal variants underlying these associations.  
Using a MR approach, I found evidence that shared genetic factors influence both BMD 
and hip shape and future studies should be repeated in a larger sample in order to see if 
these findings are replicated in an adequately powered study. While in Chapter 5 the 
BMD instrument was based on SNPs previously found to be associated with adult BMD, 
GRS based on these variants was strongly related to BMD in adolescents. Furthermore, 
the majority of BMD variants associated with BMD in children and adolescents are also 
associated with BMD in adults (Kemp et al., 2016). However, it is possible that bone 
related variants are strongly related to developmental processes occurring earlier in life 
as opposed to those that occur in adult life (Medina-Gomez et al., 2012). For example, 
recent GWAS meta-analysis identified age-specific genetic effects on BMD (i.e. rs754388 
located within RIN3 was associated with BMD in children less than 15 years old, but not 
in adults)(Medina-Gomez et al., 2018). Therefore, future analyses should consider using 
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GRSs based on pathway specific variants (i.e. those related to Wnt signalling or RANK-
RANKL-OPG pathways) or variants specific to paediatric and adolescent BMD. As GWAS 
sample sizes increase, the discovery of genetic variants will also increase, providing 
better instruments for MR analysis. The other improvement that could be made to the 
genetic instrument would be inclusion of SNPs with known functional roles. Having good 
functional knowledge of SNPs included in GRS, larger sample size and better methods to 
address pleiotropy will provide valuable insights to our understanding of hip shape 
development and future pathology associated with hip shape.  
My thesis explored the relationship between pubertal growth and hip shape. As 
described in Chapter 4, puberty is critical for hip shape development and further 
investigation of factors which may have an unfavourable impact on hip shape during this 
period is justified. This will enable stratification of individuals into those mostly at risk 
and provide opportunities for preventative measures early in life which might reduce 
the risk of fracture and/or OA development in later life. In addition, while the results 
presented in Chapter 4 most likely represent changes in hip shape associated with 
pubertal growth rather that the relationship with pubertal timing, further studies using a 
MR approach could be applied to determine the nature of pubertal timing on hip shape.  
A number of studies suggest that cam deformities develop in response to vigorous PA 
(Palmer et al., 2018; Siebenrock et al., 2011) and changes in hip morphology around 
puberty are driven by mechanical stimuli, e.g. increase in body mass places greater 
strain on developing bone (van der Meulen et al., 1996). Data on PA including objective 
measures, as assessed by accelerometery, as well as questionnaire-based data has been 
collected in ALSPAC at several time points. It would be of particular interest to explore if 
associations between PA and modes found to be related to RHOA (i.e. HSM3 and HSM4 
identified in MrOS) exist in order to better understand OA pathogenesis.  
As described previously, SSM provides the means to quantify the entire outline of 
proximal femur as opposed to individual geometric measurements. However, for 
associations with modes describing variation in several components of hip shape (e.g. 
HSM1 which describes variation in femoral head and neck along with greater and lesser 
trochanters) it can be difficult to determine whether individual or combinations of these 
components are driving given associations. Therefore, further sub-regional models 
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based on a subset of points (focusing on the femoral head, superior joint space and 
region around anterolateral head-neck junction) can be constructed to distinguish 
influences acting on global femur morphology from those impacting specific 
components of shape (this approach has been used previously to explore the 
associations between known OA loci and hip shape as described by Baird et al. (Baird et 
al., 2018)). Using the same SSM template employed throughout this thesis, this 
approach could be first applied to clarify relationships between hip shape and OA in 
adults and secondly this could be followed up in adolescents to provide better 
understanding, and perhaps filtering of hip shape components which might be directly 
associated with OA and other exposures.  
 
8.6. Conclusions  
In conclusion, this is the first study to characterise hip shape development across 
adolescence as assessed by SSM in ALSPAC offspring at age 14 and 18. The findings in 
this thesis suggest that sexual dimorphism in hip shape can be discerned in early 
adolescence and consistent with previous studies, I found that puberty is a critical 
period for the development of hip shape, including aspects of shape previously found to 
be related to hip pathology in later life. I found strong observational evidence for the 
association between BMD and hip shape, which in part, could be explained by shared 
genetic factors underlying these traits. Further studies in a larger sample of adolescents 
are necessary to confirm these findings and identify specific pathways common to BMD 
variation and hip shape which will in turn help elucidate shared mechanisms related to 
OA and OP risk. Finally, genetic variants implicated in endochondral bone formation 
which were previously found to be associated with adult hip shape appear to influence 
hip shape in adolescents consistent with a contribution of longitudinal growth on hip 
shape. In addition, genetic variants associated with adolescent hip shape which did not 
replicate in adults may suggest distinct genetic influences on hip shape in adolescents 
vs. adults and warrants further investigation. 
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Supplementary Table 10.2.1; Associations between age at clinic attendance and the 
top ten HSMs at both time points 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of 
linear regression analysis between age at clinic attendance and the top ten HSMs in 
ALSPAC adolescents at age 14 and age 18. Regression coefficients represent SD change 
in HSM per one-year increase in age at clinic attendance, 95% CIs and p value.  
 
Age 14 (N=4,428) Age 18 (N=4,369) 
HSM β (95% CI) p β (95% CI) p 
1 0.08 (0.02,0.14) 0.008 0.00 (-0.03,0.03) 0.781 
2 -0.05 (-0.16,0.06) 0.348 -0.01 (-0.07,0.05) 0.772 
3 -0.11 (-0.20,-0.01) 0.034 -0.01 (-0.06,0.04) 0.773 
4 0.08 (-0.02,0.17) 0.131 0.01 (-0.04,0.07) 0.639 
5 -0.08 (-0.20,0.03) 0.154 -0.05 (-0.11,0.01) 0.094 
6 0.13 (0.03,0.23) 0.011 0.12 (0.05,0.18) <0.001 
7 0.11 (0.02,0.20) 0.017 -0.01 (-0.06,0.04) 0.709 
8 -0.40 (-0.54,-0.26) <0.001 0.06 (-0.01,0.12) 0.105 
9 -0.07 (-0.18,0.04) 0.231 -0.05 (-0.12,0.01) 0.112 
10 -0.08 (-0.17,0.01) 0.069 -0.03 (-0.09,0.03) 0.301 
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Supplementary Table 10.2.2; Associations between height and the top ten HSMs at 
both time points 
 
Age 14 (N=4,428) Age 18 (N=4,369) 
HSM β (95% CI) p β (95% CI) p 
1 0.004 (0.002,0.01) <0.001 0.00 (0.00,0.00) 0.796 
2 -0.02 (-0.02,-0.02) <0.001 -0.02 (-0.03,-0.02) <0.001 
3 -0.01 (-0.01,-0.01) <0.001 0.00 (0.00,0.00) 0.632 
4 -0.01 (-0.01,-0.01) <0.001 -0.01 (-0.01,0.00) <0.001 
5 -0.02 (-0.02,-0.01) <0.001 -0.02 (-0.02,-0.02) <0.001 
6 0.00 (0.00,0.00) 0.999 0.02 (0.02,0.02) <0.001 
7 0.01 (0.01,0.01) <0.001 0.00 (0.00,0.00) 0.058 
8 -0.02 (-0.03,-0.02) <0.001 0.00 (0.00,0.01) 0.121 
9 -0.02 (-0.02,-0.01) <0.001 -0.02 (-0.02,-0.02) <0.001 
10 -0.01 (-0.01,0.00) <0.001 0.00 (0.00,0.00) 0.389 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of 
linear regression analysis between height and the top ten HSMs in ALSPAC adolescents 
at age 14 and age 18. Regression coefficients represent SD change in HSM per unit 
increase in height, 95% CIs and p value.  
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Supplementary Table 10.2.3; Associations between lean mass and the top ten HSMs at 
both time points 
 
Age 14 (N=4,428) Age 18 (N=4,369) 
HSM β (95% CI) p β (95% CI) p 
1 0.003 (0.002,0.01) <0.001 0.0002 (0.00,0.00) 0.629 
2 -0.03 (-0.03,-0.03) <0.001 -0.03 (-0.03,-0.02) <0.001 
3 -0.02 (-0.02,-0.02) <0.001 -0.01 (-0.01,-0.01) <0.001 
4 -0.01 (-0.02,-0.01) <0.001 -0.01 (-0.01,0.00) <0.001 
5 -0.01 (-0.02,-0.01) <0.001 -0.02 (-0.02,-0.02) <0.001 
6 0.01 (0.00,0.01) <0.001 0.03 (0.02,0.03) <0.001 
7 0.001 (-0.001,0.004) 0.435 0.00 (-0.01,0.00) <0.001 
8 -0.01 (-0.01,-0.01) <0.001 0.01 (0.00,0.01) <0.001 
9 -0.03 (-0.03,-0.02) <0.001 -0.02 (-0.02,-0.02) <0.001 
10 -0.01 (-0.01,-0.01) <0.001 0.00 (0.00,0.00) 0.039 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of 
linear regression analysis between lean mass and the top ten HSMs in ALSPAC 
adolescents at age 14 and age 18. Regression coefficients represent SD change in HSM 
per unit increase in lean mass, 95% CIs and p value.  
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Supplementary Table 10.2.4; Associations between fat mass and the top ten HSMs at 
both time points 
 
Age 14 (N=4,428) Age 18 (N=4,369) 
HSM β (95% CI) p β (95% CI) p 
1 0.00 (0.00,0.01) <0.001 0.001 (0.0003,0.003) 0.006 
2 -0.02 (-0.02,-0.02) <0.001 -0.01 (-0.01,-0.01) <0.001 
3 -0.02 (-0.02,-0.02) <0.001 -0.01 (-0.01,0.00) <0.001 
4 0.00 (0.00,0.01) 0.004 0.00 (0.00,0.00) 0.797 
5 0.00 (-0.01,0.00) 0.076 0.01 (0.00,0.01) <0.001 
6 -0.01 (-0.01,-0.01) <0.001 -0.01 (-0.02,-0.01) <0.001 
7 0.00 (0.00,0.00) 0.445 -0.01 (-0.01,-0.01) <0.001 
8 -0.03 (-0.03,-0.03) <0.001 -0.02 (-0.02,-0.01) <0.001 
9 0.00 (0.00,0.00) 0.534 0.01 (0.01,0.01) <0.001 
10 -0.01 (-0.01,-0.01) <0.001 -0.02 (-0.02,-0.01) <0.001 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of 
linear regression analysis between fat mass and the top ten HSMs in ALSPAC 
adolescents at age 14 and age 18. Regression coefficients represent SD change in HSM 
per unit increase in fat mass, 95% CIs and p value.  
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Supplementary Figure 10.3.1 Mean growth curve (black line) and velocity (blue 
dashed-line) plots estimated by SITAR for males. Vertical dotted line represents age at 
peak height velocity (equivalent to tempo measure). 
 
Supplementary Figure 10.3.2 Mean growth curve (black line) and velocity (blue 
dashed-line) plots estimated by SITAR for females. Vertical dotted line represents age 
at peak height velocity (equivalent to tempo measure).
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Supplementary Table 10.4.1; The association between FN BMD and top ten HSMs in 
ALSPAC offspring at age 14 (N=4,428) 
 
Model 1 Model 2 
HSM β (95% CI) p β (95% CI) p 
1 0.08 (0.07,0.10) <0.001 0.07 (0.06,0.09) 1.3 x10-22 
2 -0.01 (-0.03,0.01) 0.327 0.16 (0.13,0.18) 7.3 x10-34 
3 -0.02 (-0.04,0.00) 0.05 0.13 (0.11,0.15) 6.3 x10-30 
4 0.07 (0.05,0.09) 7.1 x10-11 0.13 (0.11,0.15) 1.8 x10-26 
5 0.06 (0.03,0.08) 1.4 x10-06 0.19 (0.16,0.21) <0.0001 
6 0.02 (0.00,0.04) 0.085 0.03 (0.01,0.05) 0.015 
7 0.03 (0.01,0.05) 3.8 x10-03 0.01 (-0.01,0.03) 0.275 
8 -0.15 (-0.18,-0.12) 6.7 x10-29 -0.02 (-0.05,0.02) 0.328 
9 -0.04 (-0.07,-0.02) 0.0001 0.06 (0.03,0.08) 2.5 x10-05 
10 -0.05 (-0.07,-0.03) 2.4 x10-08 -0.01 (-0.03,0.01) 0.45 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of 
linear regression analysis between FN BMD and the top ten HSMs in ALSPAC 
adolescents. Results are unit change in HSM per standard deviation increase in 
exposure, 95% CIs and p value. Model 1 age and sex adjusted; model 2 additionally 
adjusted for height, lean and fat mass. 
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Supplementary Table 10.4.2; The association between FN BMD and top ten HSMs in 
ALSPAC offspring at age 14, stratified by gender 
  
Model 1 Model 2 
 
HSM β (95% CI) p β (95% CI) p 
Males 
N= 2,117 
1 0.11 (0.09,0.13) 1.8 x10-30 0.10 (0.07,0.12) 2.2 x10-16 
2 -0.05 (-0.08,-0.02) 2.3 x10-03 0.15 (0.11,0.19) 1.0 x10-14 
3 -0.06 (-0.09,-0.03) 2.8 x10-05 0.12 (0.09,0.16) 1.8 x10-12 
4 0.05 (0.02,0.08) 3.2 x10-04 0.15 (0.11,0.18) 1.8 x10-15 
5 0.01 (-0.03,0.04) 0.634 0.20 (0.16,0.24) 2.7 x10-22 
6 0.02 (-0.01,0.05) 0.209 0.02 (-0.02,0.05) 0.407 
7 0.05 (0.03,0.08) 7.5 x10-05 0.00 (-0.03,0.03) 0.881 
8 -0.21 (-0.24,-0.17) 2.8 x10-24 -0.03 (-0.07,0.02) 0.246 
9 -0.11 (-0.14,-0.08) 5.3 x10-12 0.01 (-0.03,0.05) 0.524 
10 -0.06 (-0.08,-0.03) 2.5 x10-05 -0.02 (-0.05,0.01) 0.267 
      
Females 
N=2,311 
1 0.06 (0.05,0.08) 6.9 x10-14 0.06 (0.04,0.08) 2.2 x10-09 
2 0.03 (0.00,0.06) 0.097 0.16 (0.13,0.20) 2.3 x10-19 
3 0.02 (-0.01,0.05) 0.142 0.14 (0.11,0.17) 7.6 x10-18 
4 0.08 (0.05,0.10) 1.9 x10-08 0.12 (0.09,0.15) 5.8 x10-14 
5 0.10 (0.07,0.13) 1.9 x10-10 0.16 (0.13,0.20) 1.2 x10-17 
6 0.02 (-0.01,0.04) 0.238 0.04 (0.01,0.07) 7.8E-03 
7 0.00 (-0.02,0.03) 0.814 0.04 (0.01,0.07) 0.022 
8 -0.10 (-0.13,-0.06) 3.1 x10-08 -0.01 (-0.05,0.03) 0.727 
9 0.02 (-0.01,0.05) 0.271 0.09 (0.05,0.13) 3.0 x10-06 
10 -0.04 (-0.07,-0.02) 2.5 x10-04 0.00 (-0.03,0.03) 0.994 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of 
linear regression analysis between FN BMD and the top ten HSMs in male and female 
adolescents. Results are unit change in HSM per standard deviation increase in 
exposure, 95% CIs and p value. Model 1 age adjusted; model 2 additionally adjusted for 
height, lean and fat mass. 
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Supplementary Table 10.4.3; The association between FN BMD and top ten HSMs in 
ALSPAC offspring at age 18 (N=4,369) 
 
Model 1 Model 2 
HSM β (95% CI) p β (95% CI) p 
1 0.04 (0.03,0.06) 9.5 x10-12 0.04 (0.03,0.06) 3.6 x10-08 
2 0.03 (0.01,0.06) 0.017 0.13 (0.11,0.16) 9.6 x10-21 
3 0.02 (-0.01,0.04) 0.14 0.06 (0.04,0.09) 3.1 x10-08 
4 0.07 (0.05,0.10) 1.4 x10-10 0.11 (0.08,0.13) 2.9 x10-16 
5 0.12 (0.10,0.15) 1.0 x10-20 0.17 (0.14,0.20) 1.5 x10-30 
6 0.01 (-0.02,0.03) 0.452 0.01 (-0.02,0.04) 0.619 
7 -0.04 (-0.06,-0.02) 2.6 x10-04 0.01 (-0.01,0.04) 0.316 
8 -0.01 (-0.04,0.02) 0.543 0.05 (0.02,0.08) 1.3 x10-03 
9 0.05 (0.03,0.08) 1.5 x10-04 0.09 (0.05,0.12) 7.5 x10-08 
10 -0.05 (-0.08,-0.03) 8.8 x10-06 0.02 (-0.01,0.04) 0.25 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of 
linear regression analysis between FN BMD and the top ten HSMs in ALSPAC 
adolescents. Results are unit change in HSM per standard deviation increase in 
exposure, 95% CIs and p value. Model 1 age and sex adjusted; model 2 additionally 





Supplementary Table 10.4.4; The association between FN BMD and top ten HSMs in 
ALSPAC offspring at age 18, stratified by gender 
  
Model 1 Model 2 
HSM β (95% CI) p β (95% CI) p 
Males 
N = 1,931 
1 0.04 (0.03,0.06) 2.6 x10-06 0.04 (0.02,0.07) 9.6 x10-05 
2 0.00 (-0.03,0.04) 0.864 0.09 (0.05,0.12) 2.6 x10-05 
3 -0.01 (-0.04,0.02) 0.424 0.03 (0.00,0.07) 0.043 
4 0.07 (0.04,0.10) 4.7 x10-06 0.11 (0.07,0.15) 5.4 x10-09 
5 0.08 (0.05,0.12) 5.0 x10-07 0.13 (0.09,0.17) 1.9 x10-10 
6 0.05 (0.01,0.08) 0.011 0.05 (0.01,0.10) 0.012 
7 -0.09 (-0.11,-0.06) 4.0 x10-10 -0.04 (-0.07,-0.01) 0.022 
8 0.01 (-0.03,0.05) 0.534 0.08 (0.04,0.13) 4.2 x10-04 
9 -0.03 (-0.06,0.01) 0.117 0.00 (-0.04,0.04) 0.836 
10 -0.04 (-0.07,-0.01) 0.014 0.03 (-0.01,0.07) 0.12 
      
Females 
N=2,438 
1 0.04 (0.03,0.06) 9.2 x10-07 0.04 (0.02,0.06) 4.6 x10-05 
2 0.06 (0.03,0.10) 0.001 0.18 (0.14,0.22) 1.5 x10-18 
3 0.05 (0.02,0.08) 0.003 0.10 (0.06,0.13) 6.6 x10-09 
4 0.08 (0.04,0.11) 6.9 x10-06 0.11 (0.08,0.15) 1.2 x10-09 
5 0.16 (0.13,0.20) 1.4 x10-16 0.21 (0.17,0.25) 5.3 x10-22 
6 -0.03 (-0.07,0.00) 0.083 -0.04 (-0.07,0.00) 0.082 
7 0.01 (-0.02,0.05) 0.435 0.06 (0.02,0.10) 1.1 x10-03 
8 -0.03 (-0.07,0.01) 0.10 0.03 (-0.02,0.07) 0.243 
9 0.14 (0.10,0.18) 6.4 x10-11 0.17 (0.12,0.22) 1.9 x10-12 
10 -0.07 (-0.11,-0.03) 1.1 x10-04 0.00 (-0.04,0.04) 0.898 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of 
linear regression analysis between FN BMD and the top ten HSMs in male and female 
adolescents. Results are unit change in HSM per standard deviation increase in 
exposure, 95% CIs and p value. Model 1 age adjusted; model 2 additionally adjusted for 




Supplementary Table 10.4.5; List of SNPs used to generate genetic risk score for FN 
BMD 





1 1 DNM3 rs479336 0.25 G T 
2 1 WLS rs17482952 0.92 A G 
3 1 WLS rs12407028 0.6 T C 
4 1 WNT4 rs7521902 0.76 C A 
5 1 ZBTB40 rs6426749 0.18 C G 
6 2 PKDCC rs7584262 0.22 T C 
7 2 ANAPC1 rs17040773 0.81 A C 
8 2 GALNT3 rs1346004 0.51 G A 
9 3 KIAA2018 rs1026364 0.34 T G 
10 3 CTNNB1 rs430727 0.57 C T 
11 4 IDUA rs3755955 0.84 G A 
12 4 MEPE rs6532023 0.33 T G 
13 5 MEF2C rs1366594 0.54 A C 
14 6 CDKAL1/SOX4 rs9466056 0.62 G A 
15 6 RSPO3 rs13204965 0.77 A C 
16 6 ESR1 rs7751941 0.77 G A 
17 6 C6orf97 rs4869742 0.71 C T 
18 7 WNT16 rs3801387 0.27 G A 
19 7 ABCF2 rs7812088 0.12 A G 
20 7 STARD3NL rs6959212 0.66 C T 
21 7 SLC25A13 rs4727338 0.66 C G 
22 8 TNFRSF11B/OPG rs2062377 0.43 T A 
23 9 FUBP3 rs7851693 0.64 C G 
24 10 MBL2/DKK1 rs1373004 0.89 G T 
25 10 CPN1 rs7084921 0.42 T C 
26 11 ARHGAP1 rs7932354 0.3 T C 
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27 11 DCDC5 rs163879 0.32 C T 
28 11 SOX6 rs7108738 0.17 G T 
29 11 LRP5 rs3736228 0.84 C T 
30 12 KLHDC5/PTHLH rs7953528 0.18 A T 
31 12 ERC1/WNT5B rs2887571 0.25 G A 
32 12 C12orf23 rs1053051 0.48 C T 
33 12 HOXC6 rs736825 0.64 C G 
34 12 SP7 rs2016266 0.32 G A 
35 13 TNFSF11/RANKL rs9533090 0.51 C T 
36 14 RPS6KA5 rs1286083 0.18 C T 
37 14 MARK3 rs11623869 0.65 G T 
38 16 NTAN1 rs4985155 0.33 G A 
39 16 AXIN1 rs9921222 0.52 C T 
40 16 C16orf38/CLCN7 rs13336428 0.59 G A 
41 16 SALL1/CYLD rs1566045 0.20 C T 
42 16 FOXL1 rs10048146 0.81 A G 
43 17 SMG6 rs4790881 0.70 A C 
44 17 SOX9 rs7217932 0.47 A G 
45 17 SOST rs4792909 0.38 T G 
46 17 C17orf53 rs227584 0.29 C A 
47 18 FAM210A rs4796995 0.64 A G 
48 18 TNFRSF11A/RANK rs884205 0.76 C A 
49 20 JAG1 rs3790160 0.52 T C 
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 Supplementary Table 10.4.6; Mendelian randomization (using two-stage least squares) and observational analyses to explore 
associations between hip BMD and top ten hip shape modes in ALSPAC adolescents at age 14 
 OBS - Model 1 OBS -Model 2 TSLS (unweighted GRS) 
HSM β (95% CIs) p β (95% CIs) p β (95% CIs) p 
1 0.10 (0.08,0.11) 2.9 x10-46 0.09 (0.07,0.11) 1.2 x10-28 0.10 (0.03,0.18) 0.008 
2 0.03 (0.01,0.06) 0.016 0.21 (0.18,0.24) 2.6 x10-48 0.17 (0.02,0.31) 0.023 
3 -0.02 (-0.05,0.00) 0.029 0.13 (0.10,0.15) 2.5 x10-24 0.10 (-0.03,0.23) 0.144 
4 0.05 (0.03,0.08) 2.2 x10-06 0.10 (0.08,0.13) 3.1 x10-14 -0.04 (-0.17,0.09) 0.561 
5 0.07 (0.05,0.10) 2.7 x10-08 0.20 (0.17,0.23) 9.2 x10-41 0.22 (0.07,0.37) 0.004 
6 0.02 (-0.01,0.04) 0.139 0.03 (0.00,0.06) 0.029 -0.04 (-0.17,0.10) 0.523 
7 0.04 (0.02,0.06) 7.1 x10-05 0.03 (0.01,0.05) 0.015 0.07 (-0.03,0.20) 0.150 
8 -0.14 (-0.17,-0.11) 1.9 x10-20 -0.01 (-0.05,0.02) 0.477 -0.17 (-0.35,0.02) 0.074 
9 -0.06 (-0.08,-0.03) 1.4 x10-05 0.05 (0.02,0.08) 0.001 0.11 (-0.04,0.25) 0.151 
10 -0.04 (-0.06,-0.02) 1.0 x10-04 0.01 (-0.02,0.03) 0.658 -0.02 (-0.14,0.09) 0.662 
Table shows results of linear regression analysis (OBS) and two-stage least squares Mendelian randomization analysis (TSLS) between total 
hip BMD and genetic risk score (GRS) for hip BMD and the top ten hip shape modes (HSMs) in 3,553 ALSPAC adolescents (analysis 
restricted to individuals with complete phenotypic and genotypic data). Model 1 = age and gender adjusted, Model 2 = model 1 plus 
height, lean and fat mass. Results are standard deviation (SD) change in HSM per SD increase in exposure, 95% CIs and p value.
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Supplementary Table 10.4.7; Mendelian randomization (using two-stage least squares) and observational analyses to explore 
associations between hip BMD and top ten hip shape modes in ALSPAC adolescents at age 18 
 OBS - Model 1 OBS -Model 2 TSLS (unweighted GRS) 
HSM β (95% CIs) p β (95% CIs) p β (95% CIs) p 
1 0.04 (0.04,0.02) 3.2 x10-06 0.03 (0.02,0.05) 2.4 x10-04 0.07 (-0.03,0.16) 0.159 
2 0.10 (0.10,0.07) 3.8 x10-11 0.23 (0.20,0.26) 3.0 x10-40 0.21 (0.13,0.40) 0.036 
3 0.01 (0.01,-0.01) 0.408 0.06 (0.03,0.09) 1.9 x10-05 0.16 (0.01,0.31) 0.041 
4 0.06 (0.06,0.03) 7.6 x10-06 0.09 (0.06,0.13) 3.2 x10-09 -0.03 (-0.19,0.13) 0.685 
5 0.10 (0.10,0.07) 2.2 x10-10 0.16 (0.13,0.20) 4.3 x10-19 0.20 (0.01,0.40) 0.039 
6 0.04 (0.04,0.01) 0.008 0.04 (0.01,0.08) 0.02 -0.04 (-0.23,0.15) 0.678 
7 -0.01 (-0.01,-0.03) 0.642 0.06 (0.03,0.08) 2.4 x10-04 -0.04 (-0.19,0.11) 0.628 
8 -0.06 (-0.06,-0.09) 6.3 x10-04 -0.02 (-0.06,0.02) 0.296 -0.05 (-0.23,0.17) 0.650 
9 0.04 (0.04,0.01) 0.021 0.08 (0.04,0.11) 1.1 x10-04 0.03 (-0.17,0.23) 0.750 
10 -0.03 (-0.03,-0.06) 0.048 0.05 (0.02,0.08) 0.003 0.07 (-0.11,0.24) 0.443 
Table shows results of linear regression analysis (OBS) and two-stage least squares Mendelian randomization analysis (TSLS) between total 
hip BMD and genetic risk score (GRS) for hip BMD and the top ten hip shape modes (HSMs) in 3,175 ALSPAC adolescents (analysis 
restricted to individuals with complete phenotypic and genotypic data). Model 1 = age and gender adjusted, Model 2 = model 1 plus 
height, lean and fat mass. Results are standard deviation (SD) change in HSM per SD increase in exposure, 95% CIs and p value.
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10.5. Appendix 5  
 Appendix for chapter 6 
 
Supplementary Figure 10.5.1 Linear regression coefficients (black and dashed grey 
lines) with 95% CIs for the association between FN BMD and the top ten HSMs. Model 




Supplementary Figure 10.5.2 Hip shape changes observed per SD increase in FN BMD 
based on fully adjusted coefficients (model 2) (to aid visualisation each coefficient was 
multiplied by a factor of 10). Multiple regression coefficients, showing associations 
with FN BMD (see Supplementary Table 10.5.2 in Appendix 5 ), were entered into 
Shape software and the combined relationship between FN BMD and hip shape 
plotted. Dotted line represents mean hip shape, solid line represents composite 




Supplementary Table 10.5.1; Association between hip BMD and top ten HSMs in 
ALSPAC mothers (N= 4,286) 
 
Model 1 Model 2 
HSM β (95% CI) p β (95% CI) p 
1 0.10 (0.08,0.11) <0.001 0.10 (0.08,0.11) <0.001 
2 0.03 (0.01,0.06) 0.015 0.13 (0.10,0.15) <0.001 
3 0.14 (0.12,0.17) <0.001 0.16 (0.13,0.19) <0.001 
4 0.02 (0.00,0.05) 0.075 0.02 (-0.01,0.05) 0.158 
5 0.07 (0.04,0.10) <0.001 0.13 (0.10,0.16) <0.001 
6 0.05 (0.02,0.08) 0.003 0.05 (0.01,0.08) 0.009 
7 0.05 (0.02,0.08) <0.001 0.10 (0.07,0.13) <0.001 
8 -0.02 (-0.05,0.01) 0.144 0.00 (-0.03,0.03) 0.987 
9 -0.07 (-0.10,-0.04) <0.001 -0.06 (-0.09,-0.02) <0.001 
10 -0.01 (-0.04,0.02) 0.526 0.04 (0.01,0.07) 0.011 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of 
linear regression analysis between total hip BMD and the top ten HSMs in male and 
female adolescents. Results are unit change in HSM per standard deviation increase in 
exposure, 95% CIs and p value. Model 1 age adjusted; model 2 additionally adjusted for 




Supplementary Table 10.5.2; Association between FN BMD and top ten HSMs in 
ALSPAC mothers 
 
Model 1 Model 2 
HSM β (95% CI) p β (95% CI) p 
1 0.08 (0.06,0.09) <0.001 0.07 (0.05,0.09) <0.001 
2 0.02 (-0.01,0.05) 0.154 0.08 (0.05,0.10) <0.001 
3 0.14 (0.11,0.16) <0.001 0.15 (0.12,0.18) <0.001 
4 0.04 (0.02,0.06) 0.001 0.04 (0.02,0.07) <0.001 
5 0.06 (0.03,0.09) <0.001 0.10 (0.07,0.13) <0.001 
6 0.04 (0.01,0.07) 0.012 0.04 (0.00,0.07) 0.026 
7 0.03 (0.00,0.05) 0.041 0.06 (0.03,0.09) <0.001 
8 0.00 (-0.03,0.03) 0.866 0.03 (0.00,0.07) 0.031 
9 -0.06 (-0.09,-0.03) <0.001 -0.04 (-0.07,-0.01) 0.012 
10 -0.04 (-0.06,-0.01) 0.015 0.00 (-0.03,0.03) 0.869 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of 
linear regression analysis between FN BMD and the top ten HSMs in male and female 
adolescents. Results are unit change in HSM per standard deviation increase in 
exposure, 95% CIs and p value. Model 1 age adjusted; model 2 additionally adjusted for 
height, lean and fat mass.  
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Supplementary Table 10.5.3; Estimated effects of genome-wide significant SNPs 
associated with FN BMD based on meta-analysis of GWA studies in 83,894 individuals 
(discovery and replication stages combined) 
 
chr gene SNP beta EA EAF pval 
1 1 WLS rs12407028 0.05 T 0.6 3.44 x10-23 
2 1 WLS rs17482952 0.08 A 0.93 1.30 x10-11 
3 1 DNM3 rs479336 0.04 G 0.26 8.50 x10-15 
4 1 ZBTB40 rs6426749 0.11 C 0.17 7.40 x10-57 
5 1 WNT4 rs7521902 0.04 C 0.69 2.80 x10-09 
6 2 GALNT3 rs1346004 0.05 G 0.5 1.10 x10-25 
7 2 ANAPC1 rs17040773 0.04 A 0.76 1.51 x10-09 
8 2 PKDCC rs7584262 0.04 T 0.23 1.27 x10-09 
9 3 KIAA2018 rs1026364 0.03 T 0.37 4.80 x10-10 
10 3 CTNNB1 rs430727 0.06 C 0.52 4.40 x10-25 
11 4 IDUA rs3755955 0.06 G 0.84 1.46 x10-14 
12 4 MEPE rs6532023 0.06 T 0.34 4.90 x10-26 
13 5 MEF2C rs1366594 0.08 A 0.54 4.50 x10-61 
14 6 RSPO3 rs13204965 0.04 A 0.76 8.10 x10-12 
15 6 C6orf97 rs4869742 0.05 C 0.69 4.10 x10-18 
16 6 ESR1 rs7751941 0.04 G 0.79 1.60 x10-09 
17 6 CDKAL1/SOX4 rs9466056 0.04 G 0.62 2.73 x10-13 
18 7 WNT16 rs3801387 0.08 G 0.26 5.20 x10-40 
19 7 SLC25A13 rs4727338 0.08 C 0.67 8.10 x10-48 
20 7 STARD3NL rs6959212 0.04 C 0.68 1.20 x10-13 
21 7 ABCF2 rs7812088 0.05 A 0.13 7.28 x10-09 
22 8 TNFRSF11B/OPG rs2062377 0.06 T 0.43 9.10 x10-25 
23 9 FUBP3 rs7851693 0.05 C 0.64 3.37 x10-22 
24 10 MBL2/DKK1 rs1373004 0.04 G 0.87 1.45 x10-08 
25 10 CPN1 rs7084921 0.03 T 0.39 9.30 x10-10 
26 11 DCDC5 rs163879 0.03 C 0.32 2.10 x10-08 
27 11 LRP5 rs3736228 0.05 C 0.84 4.80 x10-11 
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28 11 SOX6 rs7108738 0.08 G 0.17 1.10 x10-32 
29 11 ARHGAP1 rs7932354 0.05 T 0.31 5.10 x10-18 
30 12 C12orf23 rs1053051 0.03 C 0.48 9.60 x10-10 
31 12 SP7 rs2016266 0.03 G 0.32 3.70 x10-10 
32 12 ERC1/WNT5B rs2887571 0.03 G 0.23 6.49 x10-09 
33 12 HOXC6 rs736825 0.04 C 0.56 1.10 x10-09 
34 12 KLHDC5/PTHLH rs7953528 0.05 A 0.18 1.87 x10-12 
35 13 TNFSF11/RANKL rs9533090 0.054 C 0.51 9.84 x10-11 
36 14 MARK3 rs11623869 0.04 G 0.65 5.20 x10-16 
37 14 RPS6KA5 rs1286083 0.05 C 0.19 2.20 x10-15 
38 16 FOXL1 rs10048146 0.05 A 0.8 1.00 x10-14 
39 16 C16orf38/CLCN7 rs13336428 0.04 G 0.57 1.49 x10-16 
40 16 SALL1/CYLD rs1566045 0.06 C 0.2 1.94 x10-22 
41 16 NTAN1 rs4985155 0.03 G 0.33 1.74 x10-10 
42 16 AXIN1 rs9921222 0.03 C 0.52 5.18 x10-12 
43 17 C17orf53 rs227584 0.06 C 0.3 2.56 x10-24 
44 17 SMG6 rs4790881 0.05 A 0.69 9.75 x10-19 
45 17 SOST rs4792909 0.04 T 0.37 1.95 x10-11 
46 17 SOX9 rs7217932 0.03 A 0.46 1.92 x10-11 
47 18 FAM210A rs4796995 0.03 A 0.63 4.85 x10-08 
48 18 TNFRSF11A/RANK rs884205 0.04 C 0.73 3.18 x10-10 
49 20 JAG1 rs3790160 0.04 T 0.5 3.61 x10-12 
Abbreviations: EA: effect allele, EAF: effect allele frequency 
Analysis was based on 45 SNPs  (4 SNPs were removed due to harmonization issues: 
rs17482952, rs4792909, rs2062377, rs736825)
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Supplementary Table 10.5.4; Observational associations between femoral neck BMD 
and the top ten HSMs 
 
Model 1 Model 2 
HSM β (95% CI) p β (95% CI) p 
1 0.08 (0.06,0.09) <0.001 0.07 (0.05,0.09) <0.001 
2 0.02 (-0.01,0.05) 0.15 0.08 (0.05,0.10) <0.001 
3 0.14 (0.11,0.16) <0.001 0.15 (0.12,0.18) <0.001 
4 0.04 (0.02,0.06) 0.001 0.04 (0.02,0.07) <0.001 
5 0.06 (0.03,0.09) <0.001 0.10 (0.07,0.13) <0.001 
6 0.04 (0.01,0.07) 0.01 0.04 (0.00,0.07) 0.03 
7 0.03 (0.00,0.05) 0.04 0.06 (0.03,0.09) <0.001 
8 0.00 (-0.03,0.03) 0.87 0.03 (0.00,0.06) 0.03 
9 -0.06 (-0.08,-0.03) <0.001 -0.04 (-0.07,-0.01) 0.01 
10 -0.03 (-0.06,-0.01) 0.02 0.00 (-0.03,0.03) 0.87 
Table shows results of the association between FN BMD and the top ten HSMs in 4,286 
adult ALSPAC women. Model 1 was adjusted for age, model 2 was additionally adjusted 




Supplementary Table 10.5.5; Results for two sample MR to investigate association 
between BMD and the top ten HSMs in ALSPAC mothers 
HSM Method  est (95% CI) pval 
1 MR Egger -0.25 (-0.56,0.05) 0.11 
1 Weighted median 0.07 (-0.07,0.21) 0.34 
1 Inverse variance weighted 0.02 (-0.09,0.12) 0.72 
2 MR Egger -0.01 (-0.61,0.59) 0.98 
2 Weighted median 0.08 (-0.15,0.32) 0.49 
2 Inverse variance weighted 0.17 (-0.03,0.37) 0.09 
3 MR Egger -0.09 (-0.62,0.43) 0.74 
3 Weighted median 0.06 (-0.17,0.29) 0.60 
3 Inverse variance weighted 0.10 (-0.07,0.27) 0.26 
4 MR Egger 0.08 (-0.38,0.53) 0.74 
4 Weighted median -0.09 (-0.30,0.11) 0.36 
4 Inverse variance weighted -0.06 (-0.21,0.09) 0.40 
5 MR Egger -0.45 (-1.00,0.10) 0.12 
5 Weighted median -0.09 (-0.32,0.14) 0.44 
5 Inverse variance weighted -0.01 (-0.19,0.18) 0.96 
6 MR Egger 0.22 (-0.27,0.72) 0.38 
6 Weighted median -0.06 (-0.31,0.20) 0.66 
6 Inverse variance weighted 0.00 (-0.16,0.17) 0.97 
7 MR Egger 0.15 (-0.28,0.58) 0.50 
7 Weighted median 0.05 (-0.17,0.27) 0.66 
7 Inverse variance weighted 0.07 (-0.07,0.21) 0.34 
8 MR Egger -0.62 (-1.20,-0.05) 0.04 
8 Weighted median -0.20 (-0.45,0.05) 0.12 
8 Inverse variance weighted -0.13 (-0.33,0.06) 0.19 
9 MR Egger -0.02 (-0.52,0.48) 0.94 
9 Weighted median -0.12 (-0.34,0.11) 0.31 
9 Inverse variance weighted -0.11 (-0.27,0.06) 0.20 
10 MR Egger 0.34 (-0.11,0.80) 0.15 
10 Weighted median 0.03 (-0.19,0.25) 0.78 
10 Inverse variance weighted 0.001 (-0.15,0.15) 0.99 
Abbreviations: HSM (hip shape mode), est (estimate), CI (confidence interval) 




10.5.2. Power in MR analysis  
While there is currently no online calculator for two-sample MR, as an approximation an 
online calculator for power calculations in one-sample setting was used 
https://sb452.shinyapps.io/power/.  
The power to detect an effect of 0.13, given sample size of 3,111, would be 65%. 
Assuming the R2 (variance explained in BMD by the genetic instrument) in this study was 
similar to that reported in adults. Sample size required in order to achieve 80% power 
would be 4700.  
 
Supplementary Table 10.5.6; Univariate associations between potential confounders 
and FN BMD in a sample of 4,286 adult women 
Exposure Outcome β (95% CI) p 
Age FN BMD -0.04 (-0.05,-0.03) <0.001 
Height FN BMD 0.03 (0.03,0.04) <0.001 
Lean mass FN BMD 0.06 (0.06,0.07) <0.001 
Fat mass FN BMD 0.03 (0.02,0.03) <0.001 
Abbreviations: CI (confidence interval). Table shows results of linear regression analysis 
between each confounder and FN BMD in ALSPAC mothers. Regression coefficients 
represent unit change in outcome per unit change in exposure, 95% CIs and p value.  
 
Supplementary Table 10.5.7; Univariate associations between potential confounders 
and total hip BMD in a sample of 4,286 adult women 
Exposure Outcome β (95% CI) p 
Age hip BMD -0.03 (-0.04,-0.03) <0.001 
Height hip BMD 0.02 (0.01,0.02) <0.001 
Lean mass hip BMD 0.07 (0.06,0.07) <0.001 
Fat mass hip BMD 0.03 (0.03, 0.04) <0.001 
Abbreviations: CI (confidence interval). Table shows results of linear regression analysis 
between each confounder and total hip BMD in ALSPAC mothers. Regression 
coefficients represent unit change in outcome per unit change in exposure, 95% CIs and 
p value.  
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Supplementary Table 10.5.8; Univariate associations between potential confounders 
and the top ten HSMs in a sample of 4,286 adult women  
exposure HSM β (95% CI) p 
Age 1 0.000 (-0.003,0.004) 0.802 
Age 2 -0.001 (-0.007,0.005) 0.716 
Age 3 0.012 (0.006,0.018) 1.5x10-04 
Age 4 0.009 (0.004,0.015) 3.7x10-04 
Age 5 0.002 (-0.004,0.008) 0.56 
Age 6 0.000 (-0.006,0.007) 0.943 
Age 7 0.004 (-0.001,0.010) 0.136 
Age 8 0.003 (-0.003,0.009) 0.347 
Age 9 -0.001 (-0.008,0.005) 0.666 
Age 10 -0.007 (-0.014,-0.001) 0.021 
    
Height 1 0.000 (-0.003,0.003) 0.947 
Height 2 0.006 (0.002,0.011) 0.004 
Height 3 0.000 (-0.005,0.004) 0.855 
Height 4 -0.003 (-0.007,0.000) 0.089 
Height 5 -0.010 (-0.015,-0.006) 1.5x10-05 
Height 6 -0.001 (-0.006,0.004) 0.715 
Height 7 -0.001 (-0.005,0.004) 0.817 
Height 8 -0.015 (-0.020,-0.010) 1.7x10-10 
Height 9 -0.003 (-0.008,0.002) 0.212 
Height 10 -0.008 (-0.013,-0.004) 2.3x10-04 
    
Fat mass 1 0.004 (0.003,0.005) 9.4x10-08 
Fat mass 2 -0.014 (-0.016,-0.011) 4.2x10-27 
Fat mass 3 0.004 (0.001,0.006) 5.9x10-03 
Fat mass 4 0.000 (-0.002,0.002) 0.782 
Fat mass 5 -0.005 (-0.007,-0.002) 2.9x10-04 
Fat mass 6 0.002 (-0.001,0.005) 0.166 
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Fat mass 7 -0.004 (-0.006,-0.002) 1.3x10-03 
Fat mass 8 -0.005 (-0.008,-0.003) 1.2x10-04 
Fat mass 9 -0.004 (-0.007,-0.001) 2.6x10-03 
Fat mass 10 -0.008 (-0.010,-0.005) 5.3x10-09 
    
Lean mass 1 0.006 (0.003,0.009) 3.2x10-04 
Lean mass 2 -0.019 (-0.024,-0.014) 1.2x10-12 
Lean mass 3 0.000 (-0.005,0.006) 0.933 
Lean mass 4 0.002 (-0.003,0.006) 0.405 
Lean mass 5 -0.018 (-0.024,-0.013) 4.1x10-11 
Lean mass 6 0.003 (-0.003,0.008) 0.392 
Lean mass 7 -0.015 (-0.020,-0.010) 9.3x10-09 
Lean mass 8 -0.009 (-0.015,-0.004) 9.1x10-04 
Lean mass 9 -0.011 (-0.017,-0.006) 4.7x10-05 
Lean mass 10 -0.016 (-0.021,-0.011) 4.1x10-09 
Lean mass 5 -0.018 (-0.024,-0.013) 4.1x10-11 
Lean mass 6 0.003 (-0.003,0.008) 0.392 
Lean mass 7 -0.015 (-0.020,-0.010) 9.3x10-09 
Lean mass 8 -0.009 (-0.015,-0.004) 9.1x10-04 
Lean mass 9 -0.011 (-0.017,-0.006) 4.7x10-05 
Lean mass 10 -0.016 (-0.021,-0.011) 4.1x10-09 
Abbreviations: HSM (hip shape mode), CI (confidence interval). Table shows results of 
linear regression analysis between each confounder and the top ten HSMs in ALSPAC 
mothers. Regression coefficients represent SD change in HSM per unit change in 
exposure, 95% CIs and p value.  
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10.6. Appendix 6  
 Appendix for chapter 7 
Template code to run GWAS analysis of hip shape in ALSPAC adolescents using SNPTEST. 
Code adapted from Lavinia Paternoster’s script (available here 
https://github.com/epxlp/GWAS_scripts) 
#!/bin/bash 
#PBS -r n 
# 
#PBS -l walltime=36:00:00,nodes=1:ppn=1 




















 -assume_chromosome template \ 
 -frequentist 1 \ 
 -method expected \ 
 -pheno HSMmode_13vsComb \ 
 -use_raw_phenotypes \ 
 -cov_names age_at_clinic_13 sex \ 









Supplementary Figure 10.6.1 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM1 GWAS at age 14 
  
Supplementary Figure 10.6.2 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM2 GWAS at age 14 
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Supplementary Figure 10.6.3 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM3 GWAS at age 14 
  
Supplementary Figure 10.6.4 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM4 GWAS at age 14 
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Supplementary Figure 10.6.5 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM5 GWAS at age 14 
  
Supplementary Figure 10.6.6 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM6 GWAS at age 14 
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Supplementary Figure 10.6.7 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM7 GWAS at age 14 
  
Supplementary Figure 10.6.8 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM8 GWAS at age 14 
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Supplementary Figure 10.6.9 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM9 GWAS at age 14 
  
Supplementary Figure 10.6.10 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM10 GWAS at age 14 
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Supplementary Figure 10.6.11 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM1 GWAS at age 18 
  
Supplementary Figure 10.6.12 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM2 GWAS at age 18 
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Supplementary Figure 10.6.13 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM3 GWAS at age 18 
  
Supplementary Figure 10.6.14 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM4 GWAS at age 18 
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Supplementary Figure 10.6.15 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM5 GWAS at age 18 
  
Supplementary Figure 10.6.16 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM6 GWAS at age 18 
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Supplementary Figure 10.6.17 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM7 GWAS at age 18 
  
Supplementary Figure 10.6.18 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM8 GWAS at age 18 
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Supplementary Figure 10.6.19 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM9 GWAS at age 18
  
 
Supplementary Figure 10.6.20 Manhattan (left-hand side) and QQ (right hand-side) plots for HSM10 GWAS at age 18 
 
